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Abstract
Objectives: Inhibition of voltage-gated K+ (Kv) channels in pulmonary arterial smooth 
muscle cells (PASMCs) contributes to the development of hypoxic pulmonary 
vasoconstriction (HPV). Mitochondria have been proposed as the major oxygen sensing 
organelles in PASMCs. Although a role for mitochondrial-dependent cellular redox 
state changes that modulate Kv channels has been proposed, the precise mechanism of 
the interaction between Kv channels and mitochondria remains unclear. To understand 
these mechanisms the effect of various mitochondrial inhibitors on Kv channel currents 
(IKv) were investigated in rat PASMCs and PAs. Comparisons were drawn to the 
mesenteric circulation.
Methods: Patch-clamp technique under different intracellular conditions and in the 
presence of a variety of pharmacological tools. Three key parameters of Ikv were
O I
assessed; activation, inactivation and Ikv block. Additionally, Mg and Ca fluorescent 
measurements were performed and whole vessel contractility was assessed using a 
Mulvany-Halpem myograph.
Results: The mitochondrial uncoupler CCCP, and mitochondrial electron transport 
chain (mETC) inhibitors, rotenone, myxothiazol, antimycin and cyanide, induced 
similar significant changes in all three Ikv parameters. Antimycin-induced effects, as the 
most pronounced were studied in detail. It was found that these effects 1) cannot be 
entirely explained by changes in cellular redox state, 2) are mimicked by the ATP 
synthase inhibitor oligomycin, 3) were significantly inhibited by cell dialysis with 5 
mM Na2ATP, EDTA or with 5 (instead of 0.5) mM MgCl2, whereas intracellular 
MgATP partially reversed the effect, 4) both CCCP and antimycin caused a significant 
increase in intracellular Mg2+ (Mg2+i) and 5) hypoxia caused an increase in Mg2+i and a 
leftward shift in Ikv activation, mimicking the effect of mitochondrial inhibitors .
Additionally, the involvement of the Na+-Mg2+ (NME), alongside the Na+-Ca2+ (NCE) 
and Na+-H+ (NHE) exchangers on 7kv activation and block was evaluated using various 
extracellular and intracellular conditions. 1 ) Na+0 removal (to block the exchangers) 
caused i) a leftward in 7kv activation, ii) a significant increase in the slope of the 
dependency and iii) a decrease in the maximal whole-cell conductance. 2) Removal of
IV
o  I
external Mg , intracellular EDTA and 100 pM amiloride, a putative NME inhibitor, all 
significantly attenuated Na+0-dependent effects on 7kv. 3) The effects on 7kv activation 
were significantly attenuated by 3 pM KB-R7943 (a reverse mode inhibitor of the NCE) 
and extracellular alkalanisation by 0.6 pH unit (the conditions facilitating accumulation
I I
of intracellular Na ), but not by elevated [Ca ]j, intracellular BAPTA, extracellular 
acidification or by the NHE inhibitor 5-(N-methyl-N-isobutyl) amiloride.
Significant differences between pulmonary and mesenteric circulation were found, 
suggesting specificity of the observed mechanism to the pulmonary circulation.
Conclusions: Collectively, these findings suggest the presence of a novel
04-mitochondrial-mediated Mg i-dependent mechanism in the regulation of Kv channels 
in PASMCs, which could be involved in HPV. It also suggests that Kv channel activity
04 -at physiological membrane potentials in PASMCs chiefly depends on Mg i
04"concentration determined by the balance between the extracellular Mg influx and 
release and its extrusion by the NME, thus representing a novel regulatory mechanism 
for Kv channels in PASMCs. Despite some similarities the same overall mechanism 
was not present in MASMCs.
V
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large conductance Ca -activated K channel
[Ca2+]i intracellular calcium concentration
cADP-ribose cyclic adenoside diphosphate- ribose
CaM Ca -calmodilin complex
cAMP 3’5’-adenosine monophosphate
CCE capacitative calcium exchange
cGMP 3 ’ 5 ’-guanosine monophosphate
CH chronic hypoxia
ChTx charybdotoxin
CICR calcium induced calcium release
cm cell capacitance
CO carbon monoxide
COPD chronic obstructive pulmonary disease
DAG diacylglycerol




E-C coupling electromechanical cell coupling
EETs epoxyeicosatrienoic acids
EGTA ethylene glycol-bis (p-aminoethyl ether)-N, N, N ’, N ’-tetra-acetic acid
Ek K+ equilibrium potential given by Nemst equation




ETa, ETb Endothelin-1 receptor subtype A or B
FCS fetal calf serum
Gmax peak IKv conductance
HEPES N-2-hydroxyethylpaperazine-N-2-ethanesulphonic acid
H2O2 hydrogen peroxide
hPASMC human pulmonary artery smooth muscle cells
HPV hypoxic pulmonary vasoconstriction
ka slope factor of Ikv activation
K atp ATP sensitive K+ channel
Kca calcium activated K+ channel
KCNQ Kv long QT or Kv7 channels
inwardly rectifier K+ channel 
kh slope factor of Ikv inactivation
Kndp nucleotide diphosphate regulated ATP sensitive K+ channel





IKv voltage gated K+ current in VSMCs
Ikvi Kvl type of K+ current in rat conduit PASMCs
Ikv2 Kv2 type K+ current in rat conduit PASMCs
Ik n  non-inactivating current
Iieak leak current
Inorm normalised current
Isoc store operated channel current
I-V current -  voltage relationship
KO knock out
LQT long QT syndrome
MASMC mesenteric artery smooth muscle cell
mETC mitochondrial electron transport chain
MLCK myosin light chain kinase
mRNA messenger ribonucleic acid
NADPH nicotinamide adenine dinucleotide phosphate-oxidase
VII
NCE sodium-calcium exchanger





NSCC non-selective cation channel
PAH pulmonary arterial hypertension
PASMC pulmonary artery smooth muscle cell
PH pulmonary hypertension
PBS phosphate buffered saline
PKA protein kinase A
PKC protein kinase C
PKG protein kinase G
PIP2 phosphatidyl inositol di-phosphate
PLC phospholipase C
P-Loop pore forming loop
P02 partial oxygen pressure
PP perforated patch
PSS physiological salt solution
R regression coefficient
ROCC receptor operated cation channel
ROK Rho kinase
ROS reactive oxygen species
RT-PCR reverse transcription polymerase chain reaction
RyR ryanodine receptor
SERCA sarcoplasmic-endoplasmic Ca2+ ATPase
s.e.m. standard error of the mean
siRNA small interfering ribonucleic acid
SMC smooth muscle cell
soc store operated channel
SO' superoxide ion
SR sarcoplasmic reticulum
SUR2B sulphonyl urea receptor subunit 2B
VIII
TASK TWIK related Acid Sensitive K+ channel
TEA tetraethylammonium
TM transmembrane
TRP transient receptor potential channels
TRPC classical or canonical TRP channels
TRPM melastatin related TRP channels
TRPV vanilloid TRP channels
TTX tetrodotoxin
TWIK twin pore weakly inwardly rectifying potassium channel
t x a 2 thromboxane A2
Va half-activation potential
vh half inactivation potential
AVa relative change in Va
AVh relative change in Vh
vm membrane potential
vocc voltage operated calcium channel
VSMC vascular smooth muscle cell
v/v volume by volume
w/v weight by volume
A'Fm change in mitochondrial membrane potential
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1.1 Vascular smooth muscle
Understanding vascular-related pathophysiological disease states requires extensive 
knowledge of the complex vessel structure and functional organisation in the 
cardiovascular system (Pugsley & Tabrizchi, 2000). Despite variation in different 
vascular beds, a common histological level of blood vessels is shared. Blood vessels 
contain elastic tissue laid in concentric layers (highly extensible) interspersed with 
collagen (reinforcing stiffness) and circumferentially arranged smooth muscle cells 
(SMCs). Three distinct regions (tunicas) have been described: tunica intima, tunica 
media and tunica adventitia. The major vessels in mammals consist mainly of tunica 
media, primarily composed of SMCs and elastin fibres. There is variation in the 
number of smooth muscle layers, the larger more muscular arteries, such as the aorta, 
have many highly organised layers separated by an elastic lamella, whereas less 
muscular arterioles have only one smooth muscle layer.
1.2 Pulmonary circulation and its structural organisation
The pulmonary circulation is a high flow, low pressure system. Its vascular bed 
resembles that of the systemic circulation though the walls of larger pulmonary arteries 
are only 30% of the thickness of those in the aorta and the smaller arteries have 
relatively little smooth muscle. Pulmonary circulation is essential to the maintenance of 
circulating O2 levels and when O2 levels are compromised (partial pressure of oxygen 
(P0 2 ) below 60 mmHg) it responds uniquely by constricting and diverting blood flow to 
the well ventilated areas (ventilation-perfusion matching), a phenomenon known as 
hypoxic pulmonary vasoconstriction (HPV), (Dumas et al., 1999). Conversely, the 
systemic circulation responds to low P0 2  by dilating to provide a better O2 supply to 
target organs (Wadsworth, 1994). Features of the pulmonary vasculature in the rat are 
similar to that in humans, thus making the rat a suitable model to study pulmonary 
related diseases (Hislop & Reid, 1978).
1
1.2.1 Pulmonary structural organisation
The main trunk of the pulmonary artery leaves the right ventricle and divides into two, 
the left and right pulmonary arteries. These arteries have a similar muscular media to 
the main trunk but contain three, instead of four, central laminae, the right supplies the 
four right lobes of the lung and the left a single lobe. The axial artery inside the lung 
looses one more layer of central laminae and as the arteries branch from this towards the 
periphery the central laminae continues to decrease as the wall thickness decreases 
(Hislop & Reid, 1978). A typical structure of a segment of the pulmonary arterial tree 
is shown in Fig. 1.1 A. There are three different models that have previously been used 
to label the arteries in the complex pulmonary artery tree. These are the Weibel model, 
the Strahler model, and the Diameter-Defined Strahler's system (Fig. 1.1).
The Weibel model (Fig. 1.1 B) labels the largest vessel as generation one and assumes a 
symmetrical dichotomy exists whereby at each bifurcation the generation increases by 
one. In humans this model predicts 28 orders of the PA tree (Weibel, 1963). The 
Strahler/Horsfield system (Fig 1.1 C) labels the smallest non-capillary blood vessel as 
order 1 and at the point where two vessels of order 1 meet an order 2  vessel forms and 
this pattern repeats (Singhal et al., 1973; Yen et al., 1984). The Diameter-Defined 
Strahler's system (Fig. 1.1 D) has an addition to the original Strahler model (Jiang et a l , 
1994): when a vessel of order n with diameter Dn meets another vessel of order n, the 
vessel formed is called a vessel of order n + 1 only if its diameter is larger than Dn + (Sn 
+ S„ +i) / 2, S„ and S„ +i represent the standard deviations for diameters of orders n and n 
+ 1. Using this model there are a total of 15 orders of the human (Huang et a l , 1996) 
and 11 orders of the rat PA tree (Jiang et a l , 1994). The Weibel model is the one most 
often referred to and possibly the simplest; it was therefore the preferred choice for 
labelling arteries throughout this thesis.
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Figure 1.1. Structural organisation of the pulmonary vascular tree. (A) The structure of a 
typical segment of the arterial tree. (B), (C) and (D) show the Weibel Model’ the 
‘Strahler model’ and the ‘Diameter-defined Strahler's system’ schemes, respectively, for 
labelling the complex artery structure. Reproduced from Mandegar et al. (2004).
1.3 Regulation o f  intracellular calcium concentration
The main function of pulmonary arteries is to regulate blood flow by changing vessel
diameter. The contractility of smooth muscle is reliant upon the intracellular calcium
2+ 2+concentration ([Ca" ] i ) .  At rest [Ca ]* is low (~100nM) creating a gradient greater than 
10000 fold with the extracellular level (~1.6mM, Himpens et al., 1992). The
2"F 2 “bfundamental systems co-ordinating to control [Ca" ]; are: 1) extracellular Ca entry via 
voltage operated calcium channels (VOCCs); 2) receptor operated cation channels
(ROCCs); 3) Ca release and sequestration from and into the sarcoplasmic reticulum
2_|_
(SR); 4) store-operated channels (SOCs) activated by depletion of the SR; 5) Ca -
3
ATPase and Na+-Ca2+ exchanger (NCE) responsible for plasmalemmal Ca2+ efflux and
9 +
6 ) mitochondrial Ca release and sequestration.
2_|_
Ca entry can be activated by changes in membrane potential, known as excitation- 
contraction coupling (E-C coupling), (Bauer & Sanders, 1985) or by neurotransmitter or 
hormonal stimulation of receptors, known as pharmacomechanical coupling (Somlyo & 
Somlyo, 1968). In E-C coupling VOCCs are activated when depolarisation surpasses a
9+threshold, just a few millivolts is sufficient to open VOCCs and allow Ca influx, 
causing contraction (Brayden & Nelson, 1992). In different vascular beds this threshold 
varies, possibly due to the voltage dependence and density of VOCCs and the type and 
density of K+ channels expressed in SMCs. Ionic concentration gradients determine the 
membrane potential in vascular SMCs (VSMCs). Activity of electrogenic ion 
exchangers, such as the NCE or the Na+-K+ ATPase, also affects membrane potential; 
for example, activation of the NCE hyperpolarises the membrane (Bolton, 1979).
9  .
Neurotransmitters increase the permeability to Ca via voltage independent ROCCs
9-4-and may stimulate Ca entry either directly by causing depolarisation and VOCC 
activation, or via the release of an intracellular messenger. The nature of the messenger
9  I
coupled receptor activation to Ca entry has not yet been fully elucidated, however the 
involvement of 3’5’-adenosine monophosphate (cAMP), 3’5’-guanosine 
monophosphate (cGMP), diacylglycerol (DAG) and protein kinase C (PKC) have been 
proposed in the activation of VOCCs, and ROCCs may open either directly or via 
second messengers such as inositol-1,4,5 trisphosphate (IP3) or inositol-1,3,4,5 
tetrakisphosphate (IP4) (van Breemen & Saida, 1989).
The SR is the major store of intracellular calcium ions (Ca2+i) and its effective 
permeability is determined by the relative rate of influx and efflux mechanisms. The
9  1 ^  .
sarcoplasmic/endoplasmic reticulum Ca ATPase (SERCA) serves to sequester Ca by
9  1
removing it from the cytoplasm and refilling the internal Ca stores; SERCA is also 
sensitive to thapsigargin (Treiman et a l , 1998). The levels of Ca2+i present are 
reflective of the filling state of the internal Ca2+ stores (Rueda et al., 2002). It has been 
suggested that an active SERCA pump is essential to obtain optimal Ca2+ release in 
SMCs (Gomez-Viquez et al., 2003). The predominant mechanism by which the SR can
9  1
be stimulated to release Ca is by IP3 acting upon IP3 receptors. IP3 is increased after 
agonist receptor activation causing phospholipase C (PLC) induced hydrolysis of
4
phosphatidylinositol bisphosphate (PIP2) to yield IP3 and DAG (Tasker et a l, 1999). 
When Ca2+ entry via ROCCs and VOCCs increases in [Ca2+]i to jliM  concentrations
94-further Ca release can be induced from the SR via interaction with ryanodine receptors 
(RyRs), a phenomenon known as calcium induced calcium release (CICR) (Lesh et al.,
94-1998). SOCs can also be activated to increase Ca entry, the mechanism by which this
9  .
happens is predominantly dependent on depletion of the intracellular Ca stores 
(Brueggemann et al., 2006).
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Additionally, the mitochondria are emerging as regulators of Ca i, having a capacity to 
effectively store/buffer sub-plasmalemmal Ca2+ (Parekh, 2003; Malli et al., 2003). It is,
9 1  9 4 -
therefore, suggested that mitochondrial Ca uptake occurs alongside Ca release via 
the mitochondrial NCE to contribute to ER Ca2+ refilling (Malli et al., 2003).
9  .
Additionally, SR release of Ca , via RyR or IP3 mediated mechanisms, increases
9  .
mitochondrial Ca in PASMCs (Drummond & Tuft, 1999). It is currently unknown to
94-what extent the mitochondria are involved in ER refilling and Ca homeostasis, though 
it is considered to be important (Ward et al., 2004). It is also possible that
94-mitochondrial regulation of Ca may have an important role in HPV, hypoxia has
9 .
indeed been shown to inhibit mitochondrial uptake of Ca (Kang et a l, 2002).
1.4 Membrane dependent ion transport mechanisms in the regulation o f  EC coupling in 
VSMCs.
Spanning the membrane of VSMCs are several types of ion channels, exchangers and
9  .
antiporters, all interacting to control vascular contractility via the regulation of [Ca ]i. 
Such channels include voltage-gated sodium and calcium channels, voltage independent 
calcium and non-selective cation channels, chloride channels and voltage- and ligand- 
gated K+ channels. Plasmalemmal Ca2+ and Na+-K+ ATPase are also present, alongside 
an array of exchangers: the NCE (Nabel et al., 1988), Na+-H+ (NHE), (Yun et al., 1995) 
and Na+-Mg2+ (NME), (Gunther, 1993). The development of cell isolation and 
electrophysiological (mainly patch clamp) techniques has enabled these channels to be 
studied comprehensively under normal and pathophysiological conditions (Jackson et 
al., 1997). The following sections will characterise briefly each of these ion transport 
mechanisms in PASMCs, with a more extensive discussion on the role of K+ channels 
and particularly Kv channels, reflecting the main interest of this work.
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1.4.1 Sodium channels
Okabe et a l (1988) were the first to describe a rapidly activating and inactivating 
inward current (Iin) in rabbit PASMCs that was dependent upon extracellular Na+. This 
current was also found to be present in other vascular tissues including; cultured human 
pulmonary (Platoshyn et a l,  2005), human aortic (Cox et a l, 1998), mesenteric (Berra- 
Romani et a l, 2005) and cultured human, rabbit and pig coronary (Choby et a l, 2000) 
SMCs. Na+ channels consist of four internally homologous subunits each containing six 
TM domains, the S5-S6 TM domains fold to create an internal pore. These subunits 
form a single principle subunit: the structural basis of this pore determines the 
selectivity and conductance properties of the channel and is described in detail (Marban 
et a l, 1998). The functional role of Na+ channels in the PA is not clear. Tetrodotoxin, 
a specific Na channel inhibitor, has no effect upon membrane potential, Ca i release or 
proliferation in PAs and, therefore, they are generally regarded as unimportant in the 
control of the normal function of these vessels (Platoshyn et a l, 2005). It is noteworthy 
that the occurrence of Ins in mesenteric SMCs was found to be dependent upon the 
enzymatic isolation conditions and this may account for discrepancies in the 
observations of In3 in VSMCs (Berra-Romani et a l, 2005).
1.4.2 Voltage operated calcium channels (VOCCs)
As mentioned above, VOCCs are integral to the maintenance of vascular tone and are 
ubiquitously expressed in VSMCs. VOCCs are formed as a complex of several different 
subunits: a l, a2, p, y, and 8 . Similar to Na+ channels, they consist of four domains each 
containing six TM regions. The a l subunit is essential for channel functioning, it forms
I
the Ca selective pore and contains the voltage sensor. Generally, six subtypes of 
VOCC have been identified (L-, N-, P-, Q-, R-and T-), of these the dihydropyridine- 
sensitive, high voltage-activated slowly inactivating L-type and the low voltage- 
activated rapidly inactivating T-type have predominantly been characterised in VSMCs. 
It has been proposed that R-type channels may be present in VSMC; recently R-type 
currents were up regulated in cerebral arteries during subarachnoid haemorrhage 
enhancing constriction (Ishiguro et a l, 2005). However, they are yet to be fully 
characterised using electrophysiological techniques. L-Type channels have a 
predominant role in the regulation of vascular tone; they are regulated by membrane
6
potential in VSMCs and are activated by depolarisation of the cell membrane. 
Additionally, vasoconstrictors also act, in part, by opening the L-type channels again 
through membrane depolarization or second messenger activation (Nelson et a l , 1990). 
Only the L-type have been substantially characterised in PASMCs and are thought to be 
important in elevating Ca i during hypoxia. Differences in Ca channel density and 
oxygen sensitivity were also observed along the PA tree in studies using specific VOCC 
inhibitors and direct measurement of VOCC currents (Franco-Obregon & Lopez- 
Bameo, 1996; McMurtry et al., 1976; Leach et al., 1994). Recent studies also suggest 
that the T-type are important in the proliferation of human PASMC (Rodman et al.,
2005).
1.4.3 Transient receptor potential channels (TRP): Molecular correlates fo r  SOC?
TRP channels belong to the superfamily of cation channels due to their 6 TM structure 
enclosed by N and C termini, with each subunit contributing to the channel pore 
(Hofmann et a l , 2002). The main TRP channel subtypes are: classical or canonical TRP 
(TRPC), vanilloid receptor related TRP (TRPV) and melastatin related TRP (TRPM) 
(Clapham et a l , 2001). In VSMCs more than 10 TRP isoforms have been detected; 
TRPC1 and 6  are ubiquitously expressed, TRPC4 is widely expressed and TRPC3, 5 
and 7 are also detected following injury (Beech, 2005). Briefly, TRP channel activity is 
suggested to be important in modulating vessel contractility, regulation of Ca i,
j
osmotic stress, Mg homeostasis and in the response to vascular injury (Beech, 2005). 
Additionally, VSMC proliferation and remodelling are likely to influence the expression 
of TRPC isoforms and thus may alter their function (Golovina et a l , 2001). Published 
data on TRPM and TRPV subtypes is scarce; TRPM 2-4 and 7-8 and TRPV 1-4 have 
been detected using RT-PCR in both de-endothelialised rat aorta and PA (Inoue et a l ,
2006). For an in-depth discussion of the properties and functional significance of TRP 
channels in the vasculature please refer to Dietrich et a l (2006).
SOCs are activated by the depletion of intracellular Ca stores and, due to varied 
experimental conditions, there is discrepancy over the involvement of capacitative 
calcium entry (CCE) in SOC currents (/soc) (Brueggemann et a l , 2005). Using the 
A7r5 cell line and freshly isolated MASMCs Brueggemann et a l (2005) showed, by 
measuring cytosolic Ca using fura-2 fluorescence and electrophysiological techniques,
7
that store depletion of Ca2+ activated CCE which corresponded to /soc suggesting an 
/soc/CCE pathway. Using small interfering RNA (siRNA) and infecting cells with an 
adenovirus expressing an anti-sense nucleotide sequence it has been proposed that the 
molecular correlate for this channel was likely to be TRPC1, an isoform of the TRP 
family of non-selective cation channels (Brueggemann et al., 2006). hoc  also associates 
to TRPC1 expression in cerebral arteries and internal mammary arteries (Bergdahl et 
a l , 2005). Expression of TRP1, a TRP gene proposed to encode the channels 
responsible for CCE and hoc, was also up regulated in proliferating PASMC. Moreover, 
Sweeney et a l (2002) demonstrated that TRPC1 resembled Isoc and, by regulating
o  i
CCE, had a crucial role in PASMC proliferation and regulating Ca i.
1.4.4 ATP dependent transporters 
Ca2+ ATPase
^ I
In addition to the SERCA described in section 1.3, a plasmalemmal Ca -ATPase 
(PMCA) which functions to remove Ca2+ from cells exists in VSMCs (Pande et a l ,
9-4-2006) and prevents overloading of the cytoplasm with Ca (Guerini et al., 2005). The 
PMC A is encoded by four genes (PMCA 1-4) of which the vascular smooth muscle 
expresses PMCA-4 and, to a lesser extent, the PMCA-1 (Pande et al., 2006). The 
PMCAs contain 10 TM domains, with C and N regions in the cytosol. The key 
regulatory domain is within the C- tail and contains a calmodulin-binding domain and 
the sites of phosphorylation by PKC and PKA (Guerini et a l , 2005). Functionally, the 
pump itself has not been studied in any great detail though, interestingly, PMCA 
activity has been shown to increase in the presence of H2O2 (1 mM) and matrix 
metalloprotease 2 (MMP-2) in PASMCs (Mandal et al., 2003).
Na+-K* ATPase
The Na+-K+ ATPase is the chief mechanism for Na+ extrusion, transporting both Na+ 
and K+ against their concentration gradients. It is a heterodimer formed from a catalytic 
a subunit and a glycosylated p subunit (Koster et al., 1995). The a subunit is 
functionally important conferring the binding sites for the physiological ligands (namely 
Na+, K+, Mg2+ and ATP) and for ouabain, a specific inhibitor which displays tissue
specific affinity for the pump (Juhaszova & Blaustein, 1997). The Na+-K+ ATPase 
utilises energy derived from ATP hydrolysis to undergo conformational changes to 
enable binding and release of Na+ and K+ (Skou & Esmann, 1992). The pump may also 
be regulated by phosphorylation, PKA and PKC are postulates to phosphorylate the a 
subunit (Blanco et al., 1998), and its structure and function is comprehensively 
reviewed in Skou (2004).
1.4.5 Sodium dependent exchangers
While Na+-K+ ATPase is mainly responsible for Na+ extrusion, Na+ could potentially 
enter the cell via several Na+ -dependent transport mechanisms, including the NCE, a 
potassium dependent NCX (NCKX), NHE and NME, such Na+ dependent mechanisms 
are functionally important in the vasculature as they have essential roles in both 
excitation contraction coupling and pH/ion homeostasis. All of these exchangers are 
important in the homeostasis of intracellular ions such as Ca2+, Na+, K+ and Mg2+, 
which could potentially affect the Kv channel activity. The physiological and 
pharmacological characteristics of these exchangers will be discussed in depth in 
Chapter 7, where their role in Kv channel regulation will be described.
1.4.6 Potassium channels
Potassium channels are the key regulators of cellular excitability and are fundamentally 
involved in the regulation of cellular resting membrane potential. The membrane 
topologies of the main classes of potassium channels (voltage-dependent K+ channels 
(Kv), large conductance Ca2+ activated K+ channels (BKca), ATP dependent K+ 
channels ( K a tp)  and two pore domain K+ channels (2PK)) are found in Fig. 1.2. 
Briefly, Kv channels are tetrameric 6 TM spanning proteins formed from symmetrically 
arranged potassium channel subunits, either in a homo or hetero multimeric 
combination (see Table 1.2), surrounding a central pore highly selective to the 
transportation of K+ ions across the cell membrane (MacKinnon, 1991a) (Fig. 1.2 A). 
In the voltage-gated potassium channels the S4 TM domain contains four Arg residues 
which are essential for depolarisation dependent opening of the channel (Aggarwal & 
MacKinnon, 1996). Selectivity to potassium ions is energetically favoured through a 
flexible pore lined by a backbone of carbonyl groups, a sequence highly conserved
9
between different K+ channels (Noskov & Roux, 2006; Noskov et al., 2004). BKca 
channels also form tetramers which consist of 4 a and 4 |3 subunits. The a subunit has 7 
TM domains and features extracellular N- and intracellular C- termini (Fig. 1.2 B) 
(Wallner et al., 1996). The channel is regulated by the p subunit which comprises of 
two membrane-spanning domains separated by an extracellular loop. As in Kv 
channels, the S4 region contains positively charged residues and confers voltage 
sensitivity of the channel. K atp  channels consist of an octameric complex of four pore- 
forming inward rectifier K+ (K ir)  channel subunits (K jr 6.1 or 6.2) (Fig. 1.2 C) and four 
sulphonyl urea receptors (SURs) (Aguilar-Bryan & Bryan, 1999). 2PK channels have 
four TM segments (denoted M1-M4), two pore forming domains (PI and P2), a short 
cytoplasmic N-terminal and a long cytoplasmic C-terminal. In addition, an extracellular 
loop exists between the Ml and PI regions (Lesage & Lazdunski, 2000) (Fig. 1.2 D). It 
is believed that two a subunits of 2PK are necessary to form functionally active 
channels.
1.4.6.1 Role o f l t  channels in VSMCs
Being expressed in all arteriolar SMC membranes, K+ channels are important in the 
regulation of cell membrane potential (Vm) (Yuan, 1995; Nelson & Quayle, 1995). In 
SMC the driving force for K+ ions is out of the cell, thus opening of K+ channels 
precedes K+ efflux and hyperpolarisation of the membrane. Closure or inhibition of K+ 
channels conversely instigates membrane depolarisation and subsequent opening of 
voltage-gated L-Type Ca2+ channels, increasing Ca2+i. Elevated Ca2+i, in turn, causes 
CICR from the SR further increasing Ca2+i concentration. Ca2+ activates the contractile
o  I
apparatus by binding calmodulin. The Ca -calmodulin complex (CaM) binds the CaM 
dependent myosin light chain kinase (MLCK), phosphorylates the myosin light chains 
(LC20), increases the activity of myosin ATPase and, ultimately, increases cross bridge 
cycling causing contraction (Horowitz et al., 1996).
10
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Figure 1.2. Putative topology of K+ channel subunits in VSMCs (a planar view). (A) 
Kv channel a subunit, (B) BKca channel a subunit, (C) K j r subunit of K Atp  channels and 
(D) 2PK channels. The pore forming loops are defined as P-Loops in A-C and PI and 
P2 in D. The transmembrane (TM) domains are indicated in each subunit.
Functional K+ channels expressed in VSMCs are listed in Table 1.1 and include: Kv, 
B K c a ,  K a t p ,  K j r and TASK channels. A basic overview of the key functional properties 
(activation, inactivation and exogenous blockers) of these channels in vascular smooth 
muscle are summarised in Table 1.2.
K+ channels, therefore, play a pivotal role in the regulation of vascular smooth muscle 
tone (Mandegar & Yuan, 2002; Mandegar et al., 2002). Decreased Kv channel activity 
and the subsequent rise in [Ca2+]j has been implicated in stimulating PASMC 
proliferation and could potentially be involved in pulmonary vascular medial 
hypertrophy in patients with pulmonary hypertension (Platoshyn et al., 2000). High 
circulating glucose levels associated with diabetes mellitus are shown to increase 
reactive oxygen species (ROS) by inducing super oxide (SO') production which impairs 
Kv channel activity (Liu et al., 2001; Liu & Gutterman, 2002b); although ROS may also 
decrease or leave Kv channels unaffected depending upon the oxidant species 
(Gutterman et al., 2005). BKca channels have also been linked to coronary 
atherosclerosis (Bolotina et al., 1991). Vascular remodelling is now associated with 
both promotion of SMC proliferation and attenuation of cell apoptosis where K+ efflux
11
also inhibits cytoplasmic caspases (Remillard & Yuan, 2004). This is well documented 
for altered K+ channel activity in the pulmonary vasculature in conditions where chronic 
hypoxia is prevalent (such as living at high altitude), (Remillard & Yuan, 2005), 
resulting in increased medial hypertrophy of the arterial walls and the ensuing 
pulmonary hypertension (PH). Consequentially, dysfunctional potassium channel 
regulation in blood vessels is thought to contribute to the development of major 
cardiovascular diseases and attention is being drawn to them as potential therapeutic 
drug targets (Mandegar & Yuan, 2002; Mandegar et al., 2002; Sobey, 2001).
Table 1.1. Functional K+ channels expressed in VSMCs.
K* Channel
Tissue Kv BKca K a t p K ir TASK KCNQ
Pulmonary Yuan, 1995; 
Peng et al., 
1996
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The functional characteristics and physiological roles of K+ channels in VSMCs have 
been extensively investigated over the past decade and a complete discussion is beyond 
the scope of this thesis. For a comprehensive overview of the role of potassium 
channels in the regulation of VSMC function refer to recent reviews (Sobey, 2001; Cox 
& Rusch, 2002; Korovkina & England, 2002; Jackson, 2000b). The structure and 
function of BKca, K a t p ,  Kv, KCNQ and TASK channels will be discussed further in 
relation to pulmonary circulation, focusing on Kv channels that are of specific interest 
to this study.
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Table 1.2. Properties of potassium channels in vascular smooth muscle (with particular focus on pulmonary circulation).
iC  Channel Subtvpe Accessory subunits Activated by .... Inhibited by... Antasonists
BKca Slo l or KCNMA1 (Orio et 
a l, 2002)
pi (Brenner et a l, 
2000; Cox & Aldrich, 
2000; Orio et a l , 
2002), P2, p 3, P4 
(Platoshyn et a l, 
20041)
PKG (Barman et a l , 
2003‘), NO (Bolotina 
e ta l,  1994;
Brakemeier et a l, 
2003), PKA (Carl et 
a l, 1991, EETs (Zhang 
et a l, 2001; Archer et 
a l, 2003), CO (Xi et 
a l, 2004; Wang et a l, 
1997), AA (Lu e ta l,  
2005), Depolarisation 
inc [Ca2+]j (Jackson, 
2000
PKC (Barman et a l , 
20041; Minami et al., 
1993), ROS (Tang et 
a l, 2004), dec pHj 
(Schubert et a l, 2001), 
Hyperpolarisation inc 
[Ca2+]i (Nelson & 
Quayle, 1995), c-Src 
(Alioua et al., 2002)
IbTX (Gao & Garcia, 
2003; Giangiacomo et 
a l, 1992), ChTX 
(Gao & Garcia,
2003), Paxilline 
(DeFarias e ta l,
1996; Tammaro et al.,
2004), lmM  TEA (Li 
& Aldrich, 2004),
Kv Kv 1.1-1.7&1.10, Kv2.1, 
Kv3.1b, 3.3&3.4, 
Kv4.1&4.1, Kv5.1, Kv 6.1- 
3^ K ^ .l& 3 ,K v l0 .1 ,v ll.l
t&rfciier 'et a l, 19981; 
Smirnov, 2002 8666 /id}1; 
fcopp&ck, 2001 8997 /id}1; 
Flatctehyn, 2004 10664 /id}1)
Kv pi, Kv 02, Kv P3
(Accili etal., 1997; 
Platoshyn et a l , 
20041)
Depolarisation
(Nelson & Quayle, 
19951), PKA (Aiello et 
a l, 1995; Son et a l, 
2006), dec pHj (Berger 
e ta l,  1998 )
Hyperpolarisation
(Nelson & Quayle, 
19951), PKC (Aiello et 
al., 1996), inc [Ca2+]i 
(Cox & Petrou, 1999), 
Rho kinase (Cachero 
e ta l,  1998)
4-AP (Osipenko et 







KCNO KCNQ1 (Ohyaef al, 2003; 





ERG1? (Ohya etal., 
2 0 0 2 )
Depolarisation
((Nelson & Quayle, 
19951)
Hyperpolarisation
(Nelson & Quayle, 
19951)
Linopirdine (Joshi et 
al, 20061; Ohya et 
al, 2003), XE991 
(Joshi et al, 20061; 
Yeung & Greenwood, 
2005), Ba2+ (Gibor et 
al, 2004)
K atp 6.1 (Cui et al., 20021; 
Teramoto, 2006), Kir 6.2 
(Isomoto etal., 1996)
SUR2B (Cui et a l , 
2 0 0 2 1;Isomoto et al., 
1996)
PKA (Sun eta l,  2006), 
CGRP (Wellmanetal, 
1998), decreased ATP 
(Clapp & Gurney, 
1992), PKG (Nelson & 
Quayle, 1995 ), 




al, 2004; Wilson et al, 
2000), Ca2+ activated 
PP2B (Wilson et al, 
2000), PKC 
(Chrissobolis & Sobey, 










TWIK-1&2 (Gurney eta l,  
20031; Gardener et al., 
20041)
Depolarisation and
inc pH0 (Gardener et 
al, 2004 ), PKA 
(Olschewski et al, 
20061)
Hyperpolarisation
and dec pH0 (Gardener 
et al, 2004*)
Zn2+ (Gurney et a l , 
2003 *), Anandamide
(Gurney et al, 2003J)
1 Pulmonary circulation
Arachidonic acid (AA); Carbon monoxide (CO); calcitonin gene related peptide (CGRP); Charybdotoxin (ChTX); epoxyeicosatrienoic acids 
(EETs); nitric oxide (NO); iberiotoxin (IbTX); Protein kinase A/C/G (PKA/C/G); protein phosphatase 2B (PP2B).
1.5 Hypoxic pulmonary vasoconstriction (HPV)
The pulmonary circulation responds uniquely to hypoxia by contracting and thus 
diverting blood flow from poorly ventilated regions to those with better oxygen supply 
and matching ventilation to perfusion, this phenomenon is widely known as hypoxic 
pulmonary vasoconstriction or HPV. Conversely, systemic circulation responds by 
dilating and maximising blood flow and oxygen supply to cells around the body. 
Exposure to acute hypoxia may result in HPV. If hypoxia is sustained vascular 
remodelling occurs and the more serious condition of pulmonary arterial hypertension 
(PAH) develops (Dumas et al., 1999). Despite extensive research the mechanisms of 
HPV are still to be fully elucidated. How O2 levels are detected in PASMCs, what 
interim signalling is involved and which components act as effectors remain debated.
1.5.1 Multiple mechanisms involved in HPV
There are many components proposed to be involved in the mechanism of HPV and 
currently there is no single mechanism that can entirely explain the phenomena 
(Weissmann et al., 2006b; Aaronson et al., 2006). Specific pathways will be discussed
1
in detail later. It is currently well accepted that elevated [Ca ]i is crucial to the 
development of HPV. One of the mechanisms proposed supports Ca entry via L- 
Type Ca channels (McMurtry et al., 1976), subsequent to inhibition of Kv channels 
and membrane depolarisation. Kv channel inhibition is controversially thought to 
involve ROS mediated by a decrease in H2O2, this is due to a reduction of SO" 
production by the mETC resultant of the decreased O2 supply (Weir & Archer, 1995; 
Archer & Michelakis, 2002). Alternatively, others have shown data supporting an
9 +increase in ROS (Waypa & Schumacker, 2006) and no significant role for Ca entry
1
via L-type channels (Robertson et al., 2000b). Ca from intracellular stores triggering
^ I
SOCC, the opening of Ca -permeable cation channels and sensitisation of the 
contractile apparatus to Ca involving Rho-kinase (ROK) are now increasingly 
postulated to be involved HPV (Robertson et al., 2000b). Furthermore, other groups 
dispute Kv channels being the key regulator of membrane potential and provide 
evidence for TASK being the initial trigger for depolarisation in PASMC in response to 
hypoxia (Gurney & Joshi, 2006).
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In isolated arteries HPV exhibits a biphasic profile (Fig. 1.3). An initial transient 
contraction, proposed to be predominantly due to SOC (Robertson et al., 2003) and a 
progressively increasing contractile response dependent upon the presence of an 
endothelium. Interestingly, the removal of the endothelium does not suppress the rise in 
[Ca2+]j during phase 2 further supporting an involvement of Ca2+ sensitisation in the 
SMCs.





Figure 1.3. Two phase response of PA to acute hypoxia. Above is the change in vessel 
tension and below changes in Ca2+ concentration. Reproduced with kind permission 
from Ward et a l,  (2004).
1.6. O2 sensors and mechanisms o f  O2 sensing
Currently there is little consensus over the mechanisms by which cells sense changes in 
oxygen tension despite it being a key function of tissues such as the carotid body and 
pulmonary vasculature. Mitochondria, being the major consumers of oxygen, have 
emerged at the forefront of current research into mechanisms of oxygen sensing in the 
pulmonary vasculature. Detection of anoxia would appear to be simple -  oxidative 
phosphorylation (OXPHOS) would cease to take place, though detection of changes in 
oxygen tension within a physiological range is much more complex. NADPH oxidase 
could be another candidate and will be discussed first.
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1.6.1 Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase
The presence of a unique cytochrome b-245 containing NADPH oxidase in calf 
PASMCs was demonstrated to increase production of effector superoxide (SO') in 
response to hypoxia, a process inhibited by NADPH inhibitor diphenyleneiodonium 
(DPI), but not mETC inhibitor myxothiazol (Marshall et al., 1996). However, when 
wild type and gp91phox knock out (KO) mice were exposed to hypoxia, HPV still 
occurred in whole lung preparations despite an attenuation of SO' production (Archer et 
al., 1999). However, in support of a role for NADPH oxidase, Weissmann et a l 
(2006c) found that p47phox KO mice did display a reduced acute hypoxic response, 
though CH-induced changes were maintained. Essentially this group supported an acute 
role for NADPH oxidase, but favoured a more prominent mechanism involving the 
mitochondria. Archer et a l (1999) concluded that NADPH does not have a prominent 
role in oxygen sensing leading to Kv channel inhibition and HPV, and postulated that, 
as inhibition of mETC complex I mimics hypoxia, inhibits Ik, reduces ROS production 
and causes vasoconstriction, the mitochondria might be involved in O2 sensing.
1.6.2 Mitochondria
The notion that redox status is involved in pulmonary vascular tone was first proposed 
by Weir et a l (1985) and then Archer et a l (1986) reinforced this concept. 
Surmounting evidence now postulates mitochondria as one of the most important O2 
sensors in the pulmonary vasculature. Due to the large O2 consumption by the 
mitochondria it makes sense that they also act as cellular oxygen sensors. In intact 
lungs and PASMCs, proximal mETC inhibitors are proven to prevent a rise in PA 
pressure and block contraction in response to hypoxia, thus attenuating HPV, whereas 
distal inhibitor antimycin itself caused constriction and did not abrogate HPV; 
pinpointing a functional significance of the mETC in the mechanisms underlying HPV 
(Waypa et a l , 2001). Even more convincing are studies using mutant cells lacking 
mitochondrial DNA derived from PASMCs (p° cells). These cells retain contractility 
(tested with thromboxame A2 analogue, U46619) but fail to respond to hypoxia (Waypa 
et a l , 2001). More specifically, Leach et a l (2001) described data supporting a 
fundamental role for the mETC in both the phase 1 and 2 parts of the response to 
hypoxia in PA rings. Any disparity with the mETC as the predominant O2 sensor may
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be explained by mitochondrial diversity between vascular beds, which has been 
proposed as an explanation for the difference in response to hypoxia in PA and systemic 
vasculature (Michelakis et al., 2002).
1.6.2.1 Mitochondrial oxidative phosphorylation
Mitochondria occupy a considerable proportion of the cells cytoplasm and are crucial to 
cellular respiration, enabling up to 15 times more ATP to be produced than glycolysis 
alone (Fig. 1.4). This chemiosmotic process, by which large amounts of energy 
harnessed in the inner mitochondrial membrane are used to drive the production of 
ATP, was first proposed by Mitchell (1961). Mitchell continued to propose that 
uncouplers of oxidative phosphorylation or OXPHOS acted as proton conductors 
through the mitochondrial membrane from the matrix (Reid et al., 1966). Wilkstrom 
furthered the hypothesis and his principles that oxidation of cytochrome c oxidase 
complex, catalysed by cytochrome c oxidase, is coupled to translocation of H+ ions 
across the mitochondrial membrane also apply to the subsequent respiratory chain 
complexes (Wikstrom & Saari, 1977).
This mechanism by which protons are transferred across the membrane has been the 
focus of many years of investigation and still remains controversial. Recently it was 
even proposed that proton pumping by cytochrome c oxidase is not mechanistically 
coupled to internal electron transfer, but instead to O2 at the catalytic site (Faxen et al.,
2005). However, the latest evidence has now demonstrated that electron transfer from 
haem a to the O2 reduction site initiates the proton pump mechanism by being 























Figure 1.4 Simplified diagrammatical representation of cellular respiration. Glucose 
undergoes glycolysis to produce pyruvate and a net of 2 ATP molecules. Pyruvate is 
converted to Acetyl CoA and during this process is transported by a pyruvate carrier 
into the mitochondrion. Acetyl CoA then enters the Krebs’ cycle. Here the acetyl group 
is further oxidised to generate NADH and ubiquinol. NADH acts as the reducing 
equivalent driving the mETC. Electrons are transported from complex I to III via 
coenzyme Q (Qe) and from complex III to IV via cytochrome c (cyte"). The 
electrochemical gradient (A,p) created by movement o f protons into the inter 
mitochondrial space drives H+ back across the membrane via the Fo/Fi ATP synthase, 
producing ATP which itself is transported out o f the mitochondrion by the ATP 
translocase in exchange for ADP. Adapted from Leach et al., (2002).
1.6.2.2 mETC
OXPHOS is the process by which a series of multi-subunit enzyme complexes interact 
passing electrons down a series of redox reactions and simultaneously storing energy as
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Figure 1.5. Simplified diagram of the mETC and its inhibition. NADH and FADH2 are
the reducing equivalents supplying complex I and II, respectively, the final electron 
acceptor in complex IV is molecular O2 , generating water. Superoxide (SO*) is known 
to be produced at both complexes I and III. The correct functioning of the mETC 
complexes maintains AT™. mETC inhibitors indicated are rotenone (inhibiting complex
I), myxothiazol (inhibiting complexes I and proximally in III) and antimycin (inhibiting 
distally in complex III). Additionally, cyanide inhibits at Complex IV. Adapted from 
Ward, (2003).
Complex I
NADH and FADH2 are high energy electron carriers generated by the Krebs’ cycle and 
transferred to the inner mitochondrial membrane. Here NADH acts as a reducing 
equivalent feeding complex I of the mETC. Complex I or the NADH dehydrogenase 
complex is the largest complex consisting of over 40 polypeptide chains and is reduced 
by accepting e' from NADH which looses a hydride ion to form NAD+. Electrons are
20
passed via flavin and several iron-sulphur centres to ubiquinone which transports the 
electron to complex III, itself becoming reduced to ubiquinol.
Complex II
Complex II, the cytochrome b-c complex or co-enzyme Q reductase, consists of 11 
polypeptide chains and is the only membrane bound complex in the chain. It passes the 
electron to cytochrome-c which transfers the electron down the mETC to complex III 
(cytochrome c reductase complex). Complex II functions to add additional electrons 
into the quinone pool by removing electrons from succinate and transferring them (via 
FAD+) to coenzyme Q, thus bypassing complex I.
Complex III
Complex III comprises 13 polypeptide chains and includes two cytochromes and two 
copper ions. In complex III a phenomenon known as the Q cycle occurs; two electrons 
from ubiquinol (QH2) are removed in a stepwise manner and accepted as single 
electrons sequentially by cytochrome ci from the Rieske protein. Concurrently, four 
protons move across the membrane, adding to the proton gradient initiated in complex I 
(Hunte et a l, 2003; Yu et a l, 1998). If the AT^ changes or inhibitors such as 
antimycin are present, then the electron transport is disrupted. This may conversely 
alter the production of superoxide in this complex (Fig. 3.3).
Complex IV
Four electrons are subsequently passed, in a series of one-electron steps, to the final 
electron acceptor, molecular oxygen, which is reduced to form a water molecule. This 
occurs in complex IV, the cytochrome oxidase. Generated Ap  drives the formation of 
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Figure 1.6. Detailed mechanisms of electron transport in complex III. Ubiquinol (QH2 )
binds at the Q0 site, located near the outer surface of the inner membrane Rieske iron- 
sulphur protein (the inhibitory site of proximal inhibitor myxothiazol) accepts a single 
electron and generating semiquinone, which reduces the first cytochrome b heme (b^ 
(Demin et al. 1998). The iron-sulphur group of the Rieske protein subsequently 
transfers the electron to cytochrome Cj. Concurrently, the second cytochrome b heme 
(bn) accepts the electron from bL and reduced uniquinone to form ubisemiquinone. This 
additional quinone reduction site is situated on the matrix side membrane (denoted Qi, 
for inner membrane). Electrons from cytochrome b are then transferred to regenerate 
ubiquinol. The bci complex is the inhibitory site of distal inhibitor antimycin (Bolgunas 
et a l , 2006).
Complex V
F0F 1 ATP synthase present in the mitochondrial inner membrane catalyses the synthesis 
of ATP from ADP and phosphate. The Fo part resides in the membrane whilst the Fj 
part protrudes above the membrane into the matrix. It serves an important function in 
catalysing the synthesis of ATP and is driven by a flow of protons across the membrane 
(Stock et al., 2000) (Fig. 1.6). An electrochemical gradient is created for protons during 
electron transfer in the mitochondrial inner membrane. This reaction is fully reversible
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with ATP hydrolysis, generating a change in the proton motive gradient. The F r  
ATPase part is primarily responsible for the synthesis, as well as hydrolysis, by 
application of external torque rotating the y subunit in reverse, of ATP (Itoh et al., 
2004). It is also proposed that there are different binding sites for the substrates of ATP 
synthesis (ADP and Pi) and hydrolysis (ATP) and for the products of these two 
processes (Gao et al., 2005). Two commonly used inhibitors of the ATP synthase are 
oligomycin, binding between the F0 and Fi subunits and dicyclohexylcarbodiimide 
(DCCD) binding in the F0 subunit (Matsuno-Yagi & Hatefi, 1993). The reaction for 
both ATP synthesis and hydrolysis by the FoFi ATPase is represented by [EQN1.1].
[E Q N l.l] A D P + P; + |H + <=> A TP + |H +
where |  H+ indicates high proton concentration and j,H+ indicates low proton 
concentration.
Situated in the inner mitochondrial membrane, the ATP translocase (ANT) facilitates 
the transport of ADP and ATP between the mitochondrion and the cytosol. ADP can 
only enter the mitochondrial matrix when it is directly coupled the exit of ATP. The 
reaction which is catalyzed by the translocase is represented in [EQN 1.2].
[EQN1.2] A D P3-cyt+ A T P 4 matnll --------------► A D P3 matnx + A T P4‘cyt
ATP and ADP (both devoid of Mg ) are bound with nearly the same affinity. 
Currently two different isoforms (ANTI and ANT2) have been identified in the rat, 
each comprising of two subunits (Brandolin et al., 1993). Interestingly, the levels of 
ANT transcription have been directly linked to the degree of OXPHOS with evidence 
for high levels of both isoforms present in energy demanding tissues such as the heart 
and muscle (Ning et al., 1998). It has, however, also been proposed that the expression 
of these subunits is coupled more to the tissues ability to proliferate (Domer et al.,
1999). If the mETC function is impaired, e.g. in the presence of inhibitors or 
uncouplers, the proton gradient will be reduced, but respiration will proceed. However, 
the ATP synthase will be active in the reverse mode culminating in ATP hydrolysis, not 
synthesis. In addition, ATP has a 10 fold higher affinity for Mg than ADP and also
^ I
acts as one of the main buffers of intracellular Mg . Therefore, changes in the
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o  I
ADP/ATP ratio will cause changes in the Mg concentration (Kun, 1976). The 
translocation of ATP or ADP can be blocked by Mg2+, because MgATP/MgADP 
complexes cannot be transported by the ANT (Gropp et al., 1999). Mg2+, however, is 
suggested to be very important in ATP synthesis, where it helps to bring the p- 

























Figure 1.6. A diagrammatical representation of ATP synthesis and transport. Electron 
transport through the mETC, H+ leaves the matrix creating a proton gradient (Ap) and 
generating a that is negative to the matrix. This provides the driving force for the 
F]F0 ATP synthase to synthesise ATP. The ANT is an antiporter that catalyses the 
exchange of ADP for ATP across the inner mitochondrial membrane.
1.6.2.3 Mitochondrial ROS production
ROS production occurs with a single electron reduction of O2 . Leaks in electron 
transport tend to arise at complexes I and III giving rise to superoxide production 
(Turrens, 1997). The mechanism of superoxide production at complex III is most 
extensively understood (Turrens et al., 1985). Changes in ROS during hypoxia are well 
established and there is currently support for the involvement of the mETC in oxygen
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sensing in PASMCs (Moudgil et al., 2005; Waypa & Schumacker, 2005). H2O2 is the 
main and most stable intracellular oxidant formed by dismutation (by superoxide 
dismutase 2, SOD2) of SO' in the mitochondria. There are three human forms of SOD 
(SOD 1-3); in the mitochondria the SOD2 isoform with a manganese centre is present. 
Production of ROS has been shown to be sensitive to cyanide and particularly antimycin 
and is thus likely to involve a component of complex III. In addition, factors such as 
myxothiazol (by preventing the formation of ubisemiquinone) also reduced the 
production of H2O2 . Cytochrome b was not involved in this mechanism as it remained 
reduced throughout (Turrens et a l , 1985), therefore leaving ubiquinone as the only 
reduced electron carrier capable of converting O2 to O2’. The mechanism at complex I 
is currently thought to involve a single electron reduction of O2 the source of which is 
now proposed to be an iron sulphur cluster (either the Nla, Kushnareva et a l (2002) or 
the N2, Genova et a l (2001) and not ubisemiquinone as has subsequently been shown 
(Lambert & Brand, 2004). Despite these advances the physiological relevance of ROS 
generation by Complex I still remains unclear (Lenaz et a l , 2006).
1.7 Transduction mechanisms
Currently and controversially cellular redox state and ROS are thought to represent the 
predominant transduction pathway in response to hypoxic conditions. In addition, 
pathways involving ATP and the cellular phosphorylation state are speculated to be 
involved. Both are discussed below.
1.7.1 Intracellular redox state
The role of intracellular redox state in the cellular response to hypoxia is widely 
recognised, however there is a difference in opinion, either siding for a paradoxical 
increase in ROS and activation of oxidant dependent signalling mechanisms to inhibit 
K+ channels (Waypa et al., 2001; Waypa & Schumacker, 2002; Ward et al., 2006) or 
that decreased ROS production occurs with an associated change in redox couples 
inhibiting redox-sensitive K+ channels (Archer et al., 1993; Archer & Michelakis, 
2002). An interesting, and entertaining, point:counterpoint article was recently 
published in the Journal of Applied Physiology between two groups of researchers, JP
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Ward and SL Archer, at the forefront of this debate arguing the evidence for both 
hypothesis (Ward et a l , 2006;Weir & Archer, 2006a; Weir & Archer, 2006b).
1.7.1.1 Hypoxia and ROS
An increase in ROS in response to hypoxia in PASMC is thought to activate the release 
of Ca2+ from intracellular stores. RyR activation by ROS has been shown to have an 
important role in the sustained contraction in response to hypoxia (Du et al., 2005). In 
turn Ca channels in the plasma membrane will be recruited and contraction initiated. 
Using proximal (rotenone and myxothiazol) and distal (antimycin and cyanide) 
inhibitors Schumacker and colleagues concluded that proximal ROS act as second 
messengers to increase Ca2+ release in PASMCs during'hypoxia (Waypa et a l , 2002). 
Further supporting this, proximal inhibitors abolished HPV but PAs still responded to 
vasoconstrictors, whereas HPV was maintained in the presence of distal inhibitors 
(Waypa et a l , 2001). Evidence obtained by other groups also supports the increase in 
ROS under hypoxic conditions; in isolated perfused rabbit lungs (Weissmann et a l , 
2006a), in porcine distal PAs (Liu et a l , 2003), in rat PAs (Wang et a l , 2006) and in 
vascular walls of murine lung sections (Paddenberg et a l , 2003). In direct contrast, 
Archer and colleagues postulate that a decrease in ROS is responsible for 
vasoconstriction via inhibition of K+ channels, which are demonstrated to be responsive 
to changes in cellular redox state (Weir & Archer, 1995). Such involvement of ROS in 
K+ channel regulation during hypoxia is discussed in detail later in this chapter.
It is noteworthy that a number of other mechanisms have also been proposed to play a 
role in the regulation of ROS in response to hypoxia, in particular when hypoxia 
becomes more sustained (Wolin et a l , 2005; Waypa & Schumacker, 2005; Ward et a l ,
2006). Complexes I and III of the mitochondrial ETC (discussed above) are believed to 
be the major sources of ROS production (Guzy et a l , 2005). ROS from complex III 
apparently essential for the stabilisation of hypoxia inducible factor la  (HIF-la) under 
sustained hypoxia (BelAiba et a l , 2004; Mansfield et a l , 2005; Chandel et a l , 2000). 
Controversially, Paddenbergs’ group have suggested that complexes I and III regulate 
ROS only under normoxic conditions and that it is actually complex II that is 
responsible for the increase in ROS under hypoxic conditions and necessary for the 
development of HPV (Paddenberg et a l , 2003). They proposed that a change in the
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catalytic activity of complex II from succinate dehydrogenase to fumarate reductase is 
principally responsible for this. Another group suggest that hypoxia induced increases 
in SO' anions can increase endothelin 1 (ET-1) release and down regulate endothelin B 
(ET-B) receptors in SMCs (Wang et al., 2006). In PASMCs, an increase in ROS can 
also increase vascular endothelial growth factor mRNA, thus a more reduced redox state 
may be a possible treatment for the remodelling that occurs in pulmonary hypertension 
(BelAiba et al., 2004).
1.8 HPV effector components
As previously mentioned there are several effector components in HPV proposed. Most 
recently proposed is a role for AMP-activated protein kinase (AMPK) dependent, cADP 
ribose activated, Ca release from the SR via RyR. Additionally, an increase in 
RhoA/ROK has been shown to increase myosin light chain phosphorylation and
9+possibly be involved in Ca sensitisation of the contractile apparatus.
1.8.1 AMP-activated protein kinase (AMPK)
Evans et al (2005, 2006a&b) have proposed a novel effector mechanism in PASMCs 
which may be particularly sensitive to the metabolic stresses induced by hypoxia. They 
report that hypoxia induced an increase in the AMP/ATP ratio with an ensuing AMPK 
dependent cADP-ribose activated Ca2+ release from the SR via RyRs Four AMPK 
isoforms are currently identified in PASMC with the a ip iy l  isoform most prevalent 
and at higher expression levels than in systemic vasculature (Evans et al., 2005). It is 
also worth noting that hypoxia has recently been shown to activate AMPK via increased 
ROS production, independent of the above-mentioned change in nucleotide ratio 
(Quintero et al., 2006).
1.8.2 RhoA kinase and Ca sensitisation
The ROK inhibitor Y27632 has recently been used to study the involvement of RhoA 
and its downstream effector ROK in the signalling pathways activated by hypoxia. 
Studies have demonstrated that cGMP effects RhoA/ROK directed Ca2+ sensitisation of 
the contractile apparatus in arteries (Sauzeau et al., 2000). Ca2+ sensitisation was first
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described by Leach et al (1994) in the PA who, while seeking an explanation for the
ry, j
lack of further increases in Ca j during the 2 , endothelium dependent, phase of HPV
9-Fproposed a possible Ca -sensitisation of the contractile apparatus in PA (Robertson et 
al., 1995; Leach et a l , 1994). RhoA/ROK have previously been shown to be central
o  I
components of Ca sensitisation in guinea-pig ileum smooth muscle (Sward et a l ,
2000). This has since been proven to have a role in both acute and chronic hypoxia 
(McMurtry et a l , 2003). Hypoxia has been shown to increase RhoA/ROK leading to an 
increase in myosin light chain phosphorylation (Wang et a l , 2001; Wang et a l , 2003). 
In addition, inhibition of ROK blocks both the sustained phase of HPV in PA and 
inhibits HPV development in perfused rat (Robertson et a l ,2000a) and mouse (Fagan et 
a l , 2004) lungs. How RhoA/ROK is activated by hypoxia is currently unclear. It is
9 +speculated that either hypoxia induced elevation of Ca itself (Sakurada et a l , 2003) or 
the hypoxia driven increase in ROS (Waypa et a l , 2001) activate the RhoA dependent
9  i
Ca sensitisation. After further experiments it is now concluded that a PKC and ET-1
9  i
independent Ca sensitisation is responsible for the sustained response to acute hypoxia 
and that this is intrinsically reliant upon an intact endothelium (Aaronson et a l , 2002; 
Robertson et a l, 2003). This lead to the current hypothesis over the involvement of 
RhoA/ROK activation by an endothelium derived constrictor factor. It is noteworthy 
that inhaled Rho kinase inhibitors may possibly be useful as vasodilators in patients 
with PH (Nagaoka et a l, 2005).
1.8.3 K* channels
In PASMCs, as in other types of VSMCs, potassium channels play a crucial role in the 
maintenance of negative resting membrane potential (-60 to -50mV). Functional K+ 
channels expressed in PASMCs include the Kv channels (Yuan, 1995), KCNQ (Kv7) 
(Joshi et al., 2006 ;Yeung & Greenwood, 2005; Peng et al., 1996), BKca (Peng et al., 
1996; Barman et al., 2003), K atp (Clapp & Gurney, 1992) and 2PK (Gurney & Joshi, 
2006; Gurney et al., 2003; Olschewski et al., 2006).
BKca channels are ubiquitously expressed in VSMC and are activated by both 
membrane potential and intracellular Ca2+ contributing to the control of membrane 
potential and consequently vascular tone (Korovkina & England, 2002). These
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channels may act as a negative feedback mechanism in response to depolarisation and
o  I
increased [Ca ]i during vasoconstriction, and could be a target for the action of 
vasoactive substances (Brayden, 1996). Cox & Rusch, (2002) showed that inhibition of 
Ca efflux decreased the BKca current and increased the Kv current, indicating that
^ j
cytosolic Ca levels are critical regulators of these channels. BKca channels are 
expressed in PASMCs, though the relative contribution to the whole cell current has 
species diversity and varies in different PA tree regions (Mandegar et al., 2002). Recent 
reports indicate an attenuation of BKca currents during acute hypoxia via an inhibition 
of cAMP/PKA dependent pathway (Barman et al., 2005). A role for BKca channels in 
HPV is currently controversial.
Recently, 2PK have been identified in PASMCs having a non-inactivating current, 
denoted Ik n , which is characterised by having no time or voltage dependency (Evans et 
al., 1996). In rat and rabbit PASMC (Gurney et al., 2003) and, most recently in human 
PASMC (Olschewski et al., 2006), it has been shown that the pharmacological profile 
of Ik n  matches the TASK-1 (TWIK related Acid Sensitive K+ channel, (Patel & Honore,
9 +2001) subtype of 2PK, being insensitive to glybenclamide, TEA and Ca channel 
blockers and having a high sensitivity to external pH but not Ca2+i. Reverse 
transcription polymerase chain reactin (RT-PCR) analysis has shown both TASK-1 and 
TASK-2 channels to be present in rat MA- and PA-SMCs (Gardener et al., 2004). 
TASK-1, in particular, is able to regulate membrane potential by 10 mV in both a 
hyperpolarising and depolarising direction and as such is strongly implicated as being a 
predominant factor in regulating resting membrane potential, and thus vascular tone, in 
PASMCs (Olschewski et al., 2006). It is also worth noting that TASK-1 exhibits 
sensitivity to hypoxia (Olschewski et al., 2006) and, as such, these channels may be 
functionally important in mechanisms underlying HPV. There is no evidence yet to 
suggest a direct role of TASK in HPV. Additionally, there is no link shown between 
either BKca or TASK channels, and the proposed ROS-dependent transduction 
mechanism, discussed previously.
K atp  is another ubiquitous class of K + channels, which show little or no voltage 
dependence. It is believed that under basal conditions the open probability of K Atp is 
low (Jackson, 2000a). Co-expression of SUR subunit 2B with Kir 6.lor 6.2 produces
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channels with characteristics of two distinct K atp families, K n d p  (named reflecting a 
primary role for various nucleotide diphosphates in their activation) and K Atp 
(predominantly sensitive to ATP), respectively (Beech et a l , 1993). K Atp channels are 
shown to be present in PASMC and activated under metabolic deprivation (Clapp & 
Gurney, 1993). The expression of K jr 6.1 with SUR2B has been detected in human 
PASMCs (Cui et a l , 2001). Some evidence suggests they may contribute to resting 
membrane potential in PASMCs, although the regulatory mechanisms are still to be 
elucidated (Cui et a l , 2002). Additionally, there is no proposed role in HPV, Robertson 
et a l (1992) suggested that K Atp channels are normally closed in the pulmonary arteries 
and are not activated by the levels of hypoxia that cause a constriction.
KCNQ (previously KVLQT1, Kv7 family) channels were first identified in cardiac cells 
where mutations in a chromosomal loci on the KVLQT1 gene encode for an inherited 
form of long QT syndrome (LQT) (Wang et a l , 1996). Since their discovery isoforms 
KCNQ 1-5 have been identified. They have been widely studied in neurones, where 
KCNQ2 associates with KCNQ3 or KCNQ4, and KCNQ3 associates with KCNQ5 
(Robbins, 2001). KCNQ2 are the proposed molecular correlates for a slowly activating 
and slowly deactivating K+ M-current ( I k(M)) that shows no inactivation (Tinel et a l, 
2000 (heart); Robbins, 2001). KCNQ channels encode a “shaker like” 6 TM spanning 
channel with a single pore domain (Fig. 1.2A). In the vasculature, KCNQ1 channels 
have recently been identified and are thought to play an important role in the 
contractility of both rat portal veins (Ohya et a l, 2003; Yeung & Greenwood, 2005) and 
in mouse and rat PAs (Joshi et a l, 2006). Linopiridine and XE991, KCNQ blockers, 
were demonstrated to be potent and selective PA constrictors and data suggests that 
KCNQ channels could contribute to the regulation of resting membrane potential in the 
PAs (Joshi et a l, 2006). Again, a role in HPV is currently not established.
1.9 Kv channels
The Kv channels are the most diverse group of K+ channels ubiquitously expressed in 
VSMCs. The variety of Kv channel subtypes and their regulatory components found in 
the vasculature are summarised in Table 1.2. Kv channels, similar to BKca, are 
composed of a tetramer of Kv a subunits (pictured in Fig 1.2A) which come together to
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form a pore selective to the conduction of K+ ions. Accessory p subunits have been 
shown to alter the kinetic properties of associated Kvl a subunits (Accili et a l , 1997). 
Kv channels are activated by depolarisation (Beech & Bolton, 1989) and are central to 
the regulation of resting membrane potential throughout the vasculature; aortic 
(Tammaro et a l , 2004), mesenteric (Kharkhun et a l , 2000), cerebral (Knot & Nelson, 
1995) and pulmonary (Yuan, 1995) SMCs.
A prominent voltage-gated K+ current (Ik v) which plays an important role in the 
regulation of the resting membrane potential is present in freshly isolated rat PASMCs 
(Yuan, 1995; Smirnov et a l , 2003; Smirnov & Aaronson, 1994). A heterogeneity of Kv 
channel currents in conduit PASMCs has been described (Archer et a l,  1996, Smirnov 
et a l, 2002). Firstly, Archer et a l (1996) identified a differential expression of a Kca 
current; in larger elongated cells a low current density and sensitivity to TEA and ChTX 
was predominantly found, whereas in smaller cells a high current density and sensitivity 
to 4-aminopyridine (4-AP, a delayed rectifier K+ current inhibitor) existed. The Kca 
was the representative current in the conduit arteries whereas the K d r  was more 
prominent in the resistance. Smirnov et a l (2002) furthered this work by focusing on 
Kv channels and Kv channel currents in conduit arteries, termed Ikvi and IkV2- Ikvi 
constituted 67% of the population and demonstrated large, rapidly activating Ikv 
inhibited by 4-AP but insensitive to TEA. The remaining 33% of cells expressed IkV2, a 
smaller and slower activating current, which, in contrast, was more sensitive to TEA 
than to 4-AP. Resistance arteries were found to demonstrate a third uniform Ik vr  
subtype with a large current resembling that of Ikvi but distinguished by a higher current 
density, a significantly larger time constant for activation and I r v activation and 
inactivation were 7 mV more negative than IrvI- Notably, I r vr  was also more sensitive 
to 4-AP that Irvi (Smirnov et a l, 2002).
Post et a l (1992) first demonstrated that Irv in PASMCs is diminished by hypoxia and it 
has since been proposed that it may contribute to HPV. Yuan et a l (1993a) showed that 
the inhibition of Irv amplitude is specific for PA since it was not observed in MA. The 
importance of Kv channels in the regulation of pulmonary vascular tone has been 
further supported by Smirnov et a l (1994) who showed that chronic hypoxia (P0 2  30-35 
mmHg) was associated with a marked (40-50%) reduction in the Irv amplitude. Similar 
to acute hypoxic episodes, chronically hypoxic animals had a PASMC resting
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membrane potential that was significantly more positive (-43.5±2 mV) than that 
observed in PASMCs from normoxic animals (-54.3±2 mV) (Smirnov et a l , 1994). 
Application of 1 mM 4-AP mimicked this depolarisation. Platoshyn et a l (2001) 
provided evidence for decreased mRNA expression and attenuated protein expression of 
the Kv channel a -subunits (K vl.l, Kvl.5, Kv2.1, Kv4.3, and Kv9.3) in primary 
cultured PA- but not in MA- SMCs. This work has been supported by work from other 
groups; Wang et a l (2005) in rat distal PASMCs and Hong et a l (2004) under sub­
acute hypoxic conditions. Furthermore, in chronic hypoxia, it has been proposed that 
hypoxia-induced down regulation of Ik n  would subsequently promote Kv channel 
opening and it was thus suggested that there is a switch during chronic hypoxia in the 
K+ current determining resting potential from Ikn to Ikv (Osipenko et al., 1998).
Several attempts to identify the molecular components of native PASMC O2 sensitive 
Kv channel currents have been carried out (Patel et a l , 1997; Archer et a l , 1996). All 
studies verify a potential role for the Kv a subunits Kv1.2, Kv1.5, Kv2.1, Kv3.1b and 
Kv9.3 which display similar hypoxic inhibition and are all slowly inactivating voltage- 
gated channels sensitive to 4-AP but not ChTX. Several P subunits are expressed in 
PASMCs and may possibly interact with the KV1 family as oxidoreductase enzymes and 
can function as redox sensors (MacKinnon, 1991b; Yuan, 2001). p subunits may have a 
significant role in O2 response as the Kv1.2p subunit demonstrates O2 sensitivity on the 
Kv4.2a subunit (Archer et a l , 1999). Co-expression of any of the P subunits with one 
of the O2 sensitive a subunits affects the time and voltage dependant properties of the 
resulting current, suggesting that the a subunits may not be the only O2 sensors and 
further implicating a role for the p subunit in O2 sensing in PAs (Coppock & Tamkun, 
2001).
Archer and colleagues (1993) were the first group to propose a redox based O2 sensor as 
a regulatory point in the response of pulmonary vasculature to hypoxia and also 
suggested that a decrease in ROS is responsible for vasoconstriction via inhibition of K+ 
channels, which were demonstrated to be responsive to changes in cell redox state (Weir 
& Archer, 1995). Since this initial observation this group has continued extensive 
research in support of this hypothesis. They progressed to show opposing effects of 
oxidants (increasing) and antioxidants (decreasing) whole cell potassium channel
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currents (Reeve et a l , 1995). Archers’ group now postulates that, the high basal levels 
of H2O2 in PA may actually activate K+ channels and therefore in hypoxia a decrease in 
mitochondrial H2O2 production would block them (Michelakis et a l , 2004). Inhibition 
of Ikv by mETC inhibitors, particularly those acting at complexes I and III (being most 
responsible for ROS generation, Archer et a l (1993), supports this concept. Conversely, 
mitochondrial uncouplers, which decrease mitochondrial membrane potential (ATm) 
(Yuan et a l , 1996), and metabolic inhibition of PASMCs with 2-deoxyglucose (Yuan et 
a l , 1994) also inhibited Ikv, suggesting the presence of multiple, presently 
undetermined, mitochondria-dependent mechanisms which affect Ikv in PASMCs. 
Notably, these studies were only focused on the inhibition of Ikv amplitude, which does 
not allow for discrimination between mitochondria-specific and non-specific actions of 
inhibitors (Searle et a l , 2002). Enhancement of Ikv at negative voltages and inhibition 
at positive voltages was observed, but mostly ignored, by number of researchers in both 
canine (Post et a l , 1992) and rat (Archer et a l , 1993; Turner & Kozlowski, 1997) 
PASMCs. Furthermore, it is unknown whether and how changes in mitochondrial 
function affect Kv channel activation and inactivation, two other important voltage- 
dependent characteristics. These characteristics determine the proportion of available 
Kv channels in the physiological range of membrane potentials (Nelson & Quayle, 
1995) and understanding of the mechanism of their regulation should provide an 
invaluable insight into the Kv channel function in the pulmonary circulation.
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1.10 Aims and objectives
The mechanism by which the pulmonary arteries sense O2 and constrict in response to 
hypoxic levels remains highly controversial and currently unknown. The interaction 
between the mitochondria, as a sensor for O2, and Kv channels, as an effector, has been 
proposed; however the two phenomena have not been studied in detail. Furthermore, 
agreement over evidence for an involvement of ROS in Kv channel regulation is yet to 
be sought.
Therefore, the main aim of this thesis was to comprehensively investigate the 
mechanisms of interaction between Kv channel function and the mitochondria in rat 
PASMCs and to determine a potential physiological significance of such an interaction. 
To determine specificity to the pulmonary circulation, the key observations will also be 
compared in mesenteric arterial SMCs, as a representative of the systemic circulation.
Thus, the initial objectives were set as follows:
1) To identify and characterise the role of mitochondria and individual mETC 
complexes in the regulation of Kv channels in PASMCs using the whole cell 
and perforated patch clamp techniques.
2) To assess a role of intracellular redox state in the mitochondria dependent 
regulation of Kv channels in PASMCs.
3) To determine tissue specificity of the mitochondria-dependent modulation of 
Kv channels by comparing the results obtained in PASMCs to those in 
MASMCs, as a model of systemic circulation.
4) To determine the potential relevance of the interactions between 
mitochondria and Kv channels to HPV.
5) As a result of my investigation, the involvement of Na+ dependent extrusion 
mechanisms and in particular the NME became apparent. These were 
therefore characterised in the last chapter of this thesis.
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The experiments were performed using the whole cell and perforated patch clamp 
techniques, confocal imaging microscopy and small vessel wire myography in PA- and 
MA-SMCs and whole vessels isolated from the rat.
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C h a p t e r  2
MATERIALS AND METHODS
2.1 Solutions
Table 2.1 Composition of solutions for cell isolation
Table 2.2 Composition of extracellular solutions for electrophysiological recordings
Table 2.3 Composition of intracellular solutions for electrophysiological recordings
Table 2.4 Composition of solutions for wire myography and solutions for confocal 
imaging
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Table 2.1. Solutions for cell isolation (in mM)







pH 7.2 adjusted with NaOH NaOH
PSS -  Physiological saline solution





NaCl 110 0 0 0 0
KC1 5 5 140 5 5
MgCl2 1.2 1.2 1.2 1.2 1.2
CaCl2 1.5 1.5 1.5 1.5 1.5
HEPES 10 10 10 10 10




pH 7.2 adjusted with NaOH HC1 KOH KOH KOH
PSS -  Physiological saline solution
All extracellular solutions contained 1 pM paxilline and 10 pM glybenclamide to inhibit 
B K c a  and K atp  channels respectively.
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Table 2.3. Intracellular electrophysiology solutions (in mM)
Composition Standard 
pipette soluion
5 MgCl2 5 Na2ATP 5 MgATP 5 EDTA 1 GSH Perforated
Patch
KC1 140 140 140 140 140 140 140
MgCl2 0.5 5 0.5 0.5
CaCl2 0.5 0.5 0.5 0.5 0.5 0.5
HEPES 1 0 1 0 1 0 1 0 1 0 1 0 1 0





Amphotericin B 1 0 0  pg/ml
pH 7.2 adjusted with
---- j------------
KOH KOH KOH KOH KOH KOH KOH




1 0  MgCl2 High CaCl2 
(220nM)
10 EDTA BAPTA HEPES
KC1 140 140 140 140 140 30
MgCl2 0.5 1 0 0.5 0.5 0.5
CaCl2 0.5 0.5 5.67 0.5 0.5
HEPES 1 0 1 0 1 0 1 0 1 0
EGTA 1 0 1 0 1 0 1 0
K-HEPES 1 1 0
BAPTA 1 0
EDTA 1 0  "
pH 7.2 adjusted with KOH KOH KOH KOH KOH KOH







MgS0 4 1 1
NaH2P 0 4 0.5 0.5
KC1 4 80
Glucose 11 11
CaCl2 1 . 8 1 . 8
For the Krebs solutions (Table 2.5) pH was stabilised by continuous gassing with either 
air, 95 % (V 5 % CO2 . For dose dependent response curves to KC1 concentrations of 
10, 15, 20, 40, 80 and 100 mM K+ were studied. Changes in osmolarity were 
compensated by respective reductions in the NaCl concentration.
Solutions fo r  confocal imaging
For cell and tissue imaging PSS (Table 2.1) and Krebs (Table 2.5) were used,
9-4-respectively, whereas Ca free PSS (Table 2.1) also contained ImM EGTA.
94- 9  IThe free [Ca ] (10 nM and 220 nM) and [Mg ] in the pipette solution was calculated 
using Maxchelator software (Stanford University, USA). Different Mg2+i 
concentrations were achieved by adding corresponding amounts of MgCl2 to the pipette
9  ,
solution giving free [Mg ] of 350 pM, 3.55 mM and 7.4 mM for 0.5 mM, 5 mM and 
10 mM MgCl2 , respectively.
The pH of the pipette solution was adjusted to 7.2 using KOH, the total K+ was adjusted 
as necessary to be 140 mM with KC1.
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2.2 Materials and Reagents
Basic chemicals were purchased from BDH Merck (UK) or Fisher (UK). Enzymes for 
cell isolation, channel and exchanger inhibitors, ETC inhibitors and fluorescent imaging 
probes were purchased from Sigma (UK) or Roche (UK). The stainless steel wire was 
provided by DMT A/S (DEN).
2.3 Tissue preparation
2.3.1 Rat vasculature
Preparation for cell isolation
Male Wistar rats (weight 225-300 g) were killed by cervical dislocation in accordance 
with UK Home Office guidelines. The heart and lungs were removed en bloc after 
opening of the chest cavity from the diaphragm and cutting the rib cage. Subsequently, 
the abdominal area was opened midline and the whole mesenteric bed was removed. 
All tissues were placed in 30ml of PSS solution and maintained on ice for micro 
dissection. Small intra pulmonary arteries (<500 pm external diameter, 3rd to 5th order) 
and 3rd to 4th order mesenteric arteries were micro-dissected, cleaned of connective 
tissue, cut into sections ~3mm wide and used for enzymatic cell isolation.
Preparation fo r  wire myography
Tissues were removed as above; micro dissected and cleaned of connective tissue whilst 
remaining intact in the organ. 40pm diameter stainless steel wire (DMT/AS) was 
carefully inserted through a 2 mm length of artery, which was subsequently freed before 
mounting into the wire myograph.
All of the above procedures were carried out using a stereo-microscope (Leica, zoom 
2000 or Meiji, Optech scientific instruments) and KL 1500 LCD light source 
(Olympus).
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2.3.2 Isolation o f single VSMCs
PA sections bathed in normal physiological salt solution (PSS, Table 2.2) were left on
I
ice for 30 min followed by incubation in Ca -free PSS for 10 min at 37°C. Tissue was
SJl
then transferred into pre-warmed nominally Ca -free PSS (2 ml, Table 2.1) containing 
1 mg/ml collagenase (Type XI or, in the most recent experiments Collagenase P 
(Roche) was used yielding a better quantity of PASMCs), 0.5 mg/ml papain and 1 mM 
dithiothreitol (a reducing agent used to activate the papain) and incubated for 2 0  min at 
37°C. Also, 10 pl/ml PSS was added to Ca2+ free PSS to elevate Ca2+ concentration and 
thus increase collagenase activity. Digested tissue was transferred into pre-warmed
9-4-Ca -free PSS and cooled on ice for 5 minutes. The tissue pieces were then triturated to 
remove the surface layers of the tissue {tunica intima and tunica adventizia), mainly 
containing non-smooth muscle cell types with a wide bore Pasteur pipette (to avoid
9-4-bubbles in the solution) in 2 ml Ca -free PSS. This was repeated and the resulting two
9-4-volumes of Ca -free PSS containing dispersed cells were combined and filtered
9  .
through 95pm nylon mesh. Cells were stored at +4°C in the presence of Ca . It is 
worth mentioning that under these conditions cells tend to contract partially with time, 
similar to those shown in Fig. 3.17. Only elongated cells were used in experiments
Cells from MAs were isolated using the same procedure except using 2 and 1 mg/ml 
collagenase and papain, respectively. Also, the tissue incubation time in enzyme was 
increased to 30 min.
2.4 Wire myography
Small PA and MA obtained from the same rat and threaded onto 40pm stainless steel 
wire were carefully mounted into a two vessel Mulvany-Halpem myograph (model 
400A; Danish Myotechnology) at room temperature. The temperature was increased to 
37°C and gassed with 5% CO2 balanced with O2 . At 37°C the tissue was equilibrated to 
a resting tension of 30 mmHg (pulmonary) or 100 mmHg (mesenteric) and internal 
vessel diameter was estimated using a normalisation program. Following a 20 minute 
stabilisation period the vessels were contracted using 80mM Krebs (Table 2.5) for 2
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minutes, only vessels developing a tension of >3mN were used for recording. The 
endothelium was removed using a hair to gently rub the intimal surface of the vessel, 
lOpM ACh was used to verify successful removal. Four to six 80mM KPSS 
applications were performed to establish a steady maximal contraction.
2.5 Confocal Microscopy
y I y I
2.5.1 Confocal Imaging o f Mg z and Ca z
2.5.1.1 Individual smooth muscle cells
o  I
Changes in free Mg i were measured using a membrane-permeable fluorescent 
indicator MagFluo-4-AM (Molecular Probes) and an Olympus FV300-SU laser 
scanning confocal microscope. A drop of cell suspension was placed on a microscope 
coverslip and loaded with 5 pM MagFluo-4-AM for 45-60 min in the dark at room 
temperature. The loading solution also contained 50 pM BAPTA-AM (Molecular 
Probes) to suppress possible changes in MagFluo-4 fluorescence due to increases in 
Ca2+i and 20% (w/v) Pluronic F-127, (vortexed thoroughly). After loading, PASMCs 
were continually superfused with PSS (2 ml/min) for 10-30 min to allow de- 
esterification of both agents. Integral MagFluo-4 fluorescence was measured by using 
excitation and emission wave lengths of 488 and 505 nm respectively. Images were 
acquired at 0.33Hz using Fluoview software (Olympus, USA). Measurements were 
performed in Ca -free PSS containing 1 mM EGTA to inhibit Ca influx. Data were
analysed off-line with MetaMorph v.6.1 (Universal Instruments), corrected for
photobleaching, occurring at this acquisition rate under control conditions, using a 
monoexponential decay function [EQN 2.1], and expressed as a relative intensity 
normalised to the maximal fluorescence observed in the presence of 1 pM A23187, 
added at the end of experiment.
[EQN 2.1] y = y0 + Ae'x/t
where yo = y offset, A = amplitude and t = the decay constant.
Ca i fluorescence imaging in PASMCs was performed in a similar manner to Mg j. 
Fluo-4 loading solution was prepared by a dispersion of the AM ester Fluo-4 AM ester 
in 4ml PSS containing 20% (w/v) Pluronic F-127, which was vortexed thoroughly.
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Cells were plated on a glass coverslip and incubated with the loading solution for 45-60 
min at room temperature in which the final concentration of Fluo-4 was 12.5 pg/ml. As 
for Mg2+, cells were then superfused with PSS for 10-30 min before commencing 
fluorescence measurements. Fluorescent intensity was corrected as described above for
9 +Mg measurements, and expressed as the relative intensity normalised to the maximal 
fluorescence observed in the presence of ionomycin (1 pM) added at the end of 
experiment.
2.5.1.2 Isolated vessels
Whole vessels were mounted on a single channel wire myograph (described in 2.4) and 
loaded with MagFluo-4 AM (as previously described in 2.5.1.1) except the bath volume 
was 5 ml. To maximise loading of the smooth muscle cells the connective tissue was 
partly digested with 0.5-1 mg/ml of papain and collagenase and DTT (for 3-10 mins). 
The enzymes were removed by washing every 5 minutes for 30 minutes before loading. 
The vessel was then loaded with MagFluo-4AM for 90 minutes, replacing the dye after 
45 minutes. After successful loading, monitored by observation of changes in the 
fluorescence every 5 minutes, the dye was washed for a further 30 minutes before any 
recording and lOpM wortmannin was added to prevent tissue contraction and thus 
movement which subsequent data analysis (Hong & Chang, 1998). Wortmannin, 
preventing contraction by inhibiting myosin light chain kinase, was present throughout 
all subsequent measurements.
2.6 Electrophysiological recordings
2.6.1 Patch clamp set up and electrical recordings
Neher & Sakmann (1976) were the first to describe the patch clamp technique and its 
use in the study of ion channel distribution and characteristics. The technique was later 
refined by Hamill and coworkers in 1981. A successful patch clamp set up requires 
mechanical stability and shielding from electrical noise (Neher & Sakmann, 1976). The 
latter is achieved by shielding with a Faraday cage and connecting items capable of 
electrical conductivity to a ground point thus preventing current passage between parts 
of the set up. An anti-vibration table was used to mount the inverted microscope 
(Nikon, Japan), the recording chamber and the micromanipulator (Sutter Instruments,
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UK). The micromaniopulator is used to control the movement of the patch pipette. The 
chamber for the cell suspension is sealed with a cover slip over the bottom, to facilitate 
a visual control over the approach of the pipette to the cell. Membrane currents were 
measured using an Axopatch 200B amplifier (Axon Instruments) and data acquisition 
was controlled by a personal computer using pClamp 6  software (Axon Instruments, 
Foster city, CA).
2.6.2 Pipette fabrication
Pipettes were fabricated from hard borosilicate glass capillaries (Sutter Instruments); 
internal diameter 0.86mm, external diameter 1.5mm. Thick glass wall capillaries were 
used to reduce electrical noise between the pipette and bath solutions via the glass. 
Pipettes were cut to size and the ends gently smoothed in a Bunsen flame to prevent 
damage to the electrode and the rubber seal in the pipette holder. A Narishige (Japan) 
PC-10 two stage pipette puller was used to pull the pipettes. To facilitate the formation 
of the gigaohm seal to the cell the pipette tips were fire polished by a hot platinum wire 
mounted on a Micro forge MF-830, Narishige (Japan) under observation, at a 
magnification of 45x. Patch pipettes were produced on the day of use and stored in a 
sealed container. Both the pipette and reference electrode were formed from silver wire 
(Ag) 0.25mm diameter coated with silver chloride, according to the reaction Cl" + Ag 
~  AgCl + e’ under a constant electrical current for ~10 minutes. Pipettes had a 
resistance of 4-6 MO when filled with the pipette solutions (for whole cell and 
perforated patch recordings). Pipette resistance was calculated from the following 
equation (Ohms Law) using a 10 mV step protocol: V=IR, where V = voltage in volts, I 
= current in amps, and R = pipette resistance in Ohms.). At the start of each experiment 
the liquid-junction potential between the two electrodes, caused by differences in the 
composition of the bath and pipette solutions, was compensated (Neher, 1992).
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Figure 2.1. Photograph of the Patch clamp rig. On the right is a home made 6 barrel 
pipette perfusion system. Centre inverted microscope with head stage. On the left are 
the amplifier, digitizer and computer. All is surrounded by a faraday cage.
2.6.3 Whole cell recordings from VSMCs
Cells were placed in a chamber (100-200 pi) and left for 5 minutes to adhere to the glass 
cover. Throughout the experiment the cells were superfused (~1 ml/min) with either 
PSS or the test solutions via a 6 barrel pipette perfusion system. After breakthrough 
into the whole-cell mode cells were left to equilibrate with the pipette solution for 5 min 
preceding any recordings (Hille, 2001). Capacitance transients were routinely measured 
during this period in response to a 1 OmV hyperpolarising step (filtered at 10 kHz and 
sampled at 200 kHz). The area under the transient capacitance divided by lOmV (size 
of the depolarising step) was used to calculate the cell capacitance (CIT1). The mean Cm 
recorded in different pipette solutions was similar and equal to: 12.3±0.36 pF (n=94, 
standard pipette solution); 11.6±0.5 pF (n=43, ImM GSH); 11±0.45 pF (n=61, PP) and 
13.4±1.3 pF (n=8, 5mM Mg2+). The holding potential was -80mV unless otherwise 
stated. All electrophysiological experiments were performed at room temperature.
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Whole cell voltage-gated K+ channel currents (Ikv) (sampled at 10 kHz and filtered at 2 
kHz) were recorded using the standard patch-clamp technique using the protocols 
described in 2.6.4. Series resistance was measured to be: 11.8±0.42 m'Q (n=94, 
standard pipette solution); 13.3±0.65 m'Q (n=43, 1 mM GSH); 14.3±0.6 mD (n=61, PP) 
and 10.9±1.46 m'Q (n=8 , 5 mM Mg2+).
2.6.4 Electrophysiological stimulation protocols
To study and compare the voltage dependent characteristics of Ikv under a variety of 
conditions and in different cell types, a set of standard voltage protocols were designed 
using PCLAMP 6  software, which are detailed below and will subsequently be referred 
back to in the text, avoiding unnecessary repetition.
2.6.4.1 Measurement o f the Ikv activation - I - V  step protocol
The peak Ikv amplitude and tail currents were recorded using a 200 ms step 
depolarisation applied from -100 mV to +50 mV in 10 mV increments every 10 s, 
followed by a 160 ms step to -20 mV (Fig 2.2 A). Due to inactivation of the current 
with time and in particularl at more positive potentials the peak Ikv was measured from 
the onset of membrane depolarisation by fitting to a monoexponential function 
(indicated by the red line in Fig. 2.2 A).
[EQN 2.2] f(t) = A exp (-t/x) + C
where f(t) is the current as a function of time (t), x is the time constant of activation, A is 
a scaling factor and C is an asymptotic value used as evaluation of Ikv peak. The ratio 
of the Ikv peak measured at +50 mV in the presence and absence of inhibitors (Ikv 
Block) was used to evaluate Ikv inhibition (Smirnov et al., 2002).
The current was leak-corrected, where I(ieak) was calculated from the fit of the current 
measured in the negative range of -90mV to -50mV (where there was negligible 
activation of Ikv), with a linear regression function to obtain the slope resistance (a) and 
intercept on the Vm axis (b) ([EQN 2.3]);
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[EQN 2.3] I(Leak)(V m) aV m+b
The leak-subtracted current at each membrane potential was subsequently calculated 
([EQN 2.4]);
[EQN 2.4] IKv ( V m)  =  r Kv( V m)  -  I (Leak)(V m) ,
and divided by Cm to derive current density. I’kv is the non-leak subtracted Ikv
2.6.4.2 Measurement o f the steady state activation: Ixv-tail current protocol
Tail currents were measured at -20 mV following 200 ms depolarising steps between - 
100 and +50 mV. They were measured 2-3ms after the step to minimise contamination 
from capacitance transients. The amplitude of the tail current, corrected for the 
minimum tail current amplitude (I(min)) measured between -60 and -100 mV ([EQN 
2.5]), was normalised to its maximal value and plotted against Vm.
[EQN 2.5] Normalised iKv(tail) (I(tail)“I(m in))/(I(max)“I(min))
The instantaneous I-V relationship value that is thus derived is proportional to the 
number of channels open at each Vm. The resulting dependence was then fitted to the 
Boltzmann function.
[EQN 2.6] 7 = 1
1 + exp W a- V J l k a) 








Figure 2.2. Measurements of Ikv peak and Ikv steady-state tail activation with tail 
current protocols. A; representative current traces recorded with the I-V protocol shown 
above in control conditions (Cm =14.6 pF). The red lines represent the 
monoexponential fit of the peak current ([EQN 2.2]). B; the dependence of the 
normalised Ikv tail on Vm, recorded from the cell shown in A, fitted with the Boltzmann 
function ([EQN 2.6], solid line).
2.6.4.3 Measurement o f  Ikv activation -  Ramp protocol
In experiments described in chapter 7, Ikv was recorded using 2s voltage ramp protocol 
between -lOOmV and +100mV from a holding potential of -80mV and applied every 
20s. This protocol allows to rapidly record I-V relationships under various 
experimental conditions. To quantitatively analyse the changes in IKv activation the last 
3 ramp episodes in any particular condition were averaged. A minimum of 5 traces 
were always recorded to establish a stable control for comparison.
The IKv was leak-corrected in the same manner as described for the I-V protocol in 
section 2.6.4.2. The I-V relationship was then fitted to the following equation ([EQN 
2.7];
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[EON 2.71 gKyn  -
/G -  l + [exp (Vm- V a) l{ -k a)}
Where Gmax, Va and ka are the maximal whole-cell 7kv conductance, the half-activation 
potential (where 50% of the channels are open) and the slope factor, respectively; and 
gKv is /kv conductance at each membrane potential (Vm) derived as a ratio of the peak 7kv 
over the difference between the test Vm and the K+ equilibrium potential ([EQN 2.8]).
[EQN 2.8] g = lKv/(Vm-Ek)
The Ek was calculated to be equal to -83 mV according to the Nemst equation ([EQN 
2.9]);
R T . [ K \ ]  '
[EQN 2.9] Et = — In
zF
Where R = gas constant (1.987 cal mol’1 K '1, T = room temperature in Kelvin, z = 
valance of ion, F = Faraday constant (9.6485* 104 C mol’1) and [K+] 0 = extracellular K+ 
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Fig. 2.3. The voltage ramp protocol. A; the voltage protocol with a representative trace 
below from a PASMC with Cm = 9.68 pF. B; the leak subtracted I-V relationship from - 
lOOmV to + lOOmV for the representative cell shown in A fitted with the Boltzmann 
function (EQN 2.7], solid line). Note that the quality o f fit was better at positive 
potentials than at negative Vm. A justification of this protocol and possible explanation 
of the differences between real data and the theoretical fit are given in chapter 7.
2.6.4.4 Measurement o f  steady state inactivation - Availability protocol
Ikv inactivation was recorded using a two pulse protocol. A 200ms test pulse to +60mV 
was applied subsequent to a 10 s conditioning pre-pulse in 10 mV increments from 
-lOOmV to + 40mV, every 30s. The second pulse, to + 60mV, measures the degree of 
Ikv inactivation. Ikv measured at the end of the second pulse was normalised to its 











Fig. 2.4. Steady state Ikv inactivation -  availability protocol. (A); Ikv traces recorded 
with the availability protocol in a representative PASMC, Cm = 8.67 pF. The solid line 
at the end of the pulse indicates where the inactivation was measured. (B); normalised 
steady state Ikv inactivation dependence for the cell shown in A. The data at each 
potential was normalised to the average of the data between -80 and -lOOmV where 
there was minimal channel inactivation. A represents the non-inactivating component.
[EQN 2.10] I - A
1 + exp ((Vc -V„) /kh)
+ A
where Vh is the half-inactivation potential, kh is the slope factor of inactivation and A is 
the non-inactivating component of the current.
2.6.4.5 Measurement o f membrane potential -  current clamp protocol
Vm was measured in the current-clamp mode acquired at 100 Hz for 300 s by applying a
4.5 ms pulse every Is. The drug was applied for 300 s after a stable resting membrane 
potential was achieved (~ 60 s).
2.7 Comparison o f the changes in Ikv activation and inactivation
Only relative changes in the half-activation ( V a)  and half-inactivation ( V h )  potentials 
(calculated at the absolute V a/V h  in test conditions minus absolute V a/V h  in control 
conditions and defined as A V a and A V h  respectively) were compared, to take into 
consideration individual variation in the Ikv voltage-dependent parameters. Absolute 
values of V a and V h , as well as ka, and A, are given in the corresponding tables.
2.8 Variability in Ikv Parameters
The relative changes in the voltage dependent characteristics of Va, Vh, ka, kh and Ikv 
block were compared in paired cells due to variability in the parameters. Variations in 
IKv parameters were observed in PASMCs either dialysed with the control pipette 
solution (whole-cell recording) or non-dialysed (perforated-patch recording). For 
example, the Va ranged between -35 and +24 mV with a mean o f -13.2+0.6 mV, n=184, 
in the whole-cell mode, and between -32 and +7 mV with a mean of -9.6+1 mV, n=63, 
in the perforated-patch configuration (Fig 2.5 A&B, respectively). Similar variations in 
Vh (whole-cell recording) were also seen (ranged between -47 and +2 mV with a mean 
of -23.7+1.1 mV, n=69). All the conditions are represented by a normalised distribution 
as indicated by the histogram analysis of Va parameters (Fig 2.5 A&B). Analysis of the 
correlation between Cm, which is proportional to cell surface area, and the Ikv amplitude 
at +50 mV and also between cell surface area and Va (Fig. 2.5 C&D) showed no 
relationship between either Cm and IkV(50) or Va (the regression co-efficient, R, were 
equal to 0.095 and 0.155, respectively).
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Figure 2.5. Normal distribution o f Ikv voltage-dependent parameters, V a  and V h .  (A) Ikv 
was recorded in PASMCs either dialysed with the control pipette solution (WC) or in 
perforated-patch mode (PP) and bathed in PSS. Solid lines represent the Gaussian 
model fit with the mean Va values of -12 (WC) and -7 mV (PP) (A) and Vh value of -20 
mV (B). (C and D) Correlation between the cell membrane capacitance and Ikv 
amplitude at +50 mV in pA (A) and Va values (B) measured in the same cell (n=184) in 
the WC mode. R is the regression coefficient.
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2.9 Data analysis, presentation and statistics
All data analysis, curve fitting and graphical representation of the results were 
performed using Clampfit 8.02 (Axon Instruments, Foster City, CA, USA) and Origin
6.0 (Microcal Software, Northampton, MA, USA) software. The data are presented as 
mean ± s.e.m (standard error of the mean). Statistical comparisons were performed
ii jt a a a a a
using a paired(*) or non-paired() two-tail J-test with ’ p<0.05, ’ /?<0.01, ’ /?<0.001
j|C3|gj|Cj|( I f  I I  If  II
and ’ /K0.0001 deemed significant unless stated otherwise. A paired t-test was
used to compare the difference in parameters obtained in control (which could be either 
PSS or pre-treatment with another inhibitor) and test conditions in the same cell, 
whereas a non-paired t-test was used to compare differences between two groups of 
cells. Additionally when Va or Vh were compared in control in the different 




INVOLVEMENT OF MITOCHONDRIAL DEPENDENT MECHANISMS IN 
THE REGULATION OF I k v
To assess how Ikv is regulated by mitochondrial dependent mechanisms this chapter 
investigates the interaction between Kv channels and mitochondria using changes in Ikv 
activation, inactivation and Ikv block as the indicators of Kv channel activity, and 
specific mitochondrial inhibitors to alter mitochondrial function under a variety of 
extracellular and intracellular conditions.
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3.1 Results
3.1.1 Effect o f mitochondrial uncoupling on Ikv
The effect of mitochondrial uncoupling on Ikv was investigated using 2 pM CCCP, a 
widely used mitochondrial uncoupler (Kadenbach, 2003; Kang et al., 2002). Incubation 
of PASMCs with CCCP for 5 minutes caused a parallel leftward shift in both Ikv 
activation (AVa=-8.1±1.4 mV, n=20, p<0.00001) and inactivation (AVh=-6.8±2.4 mV, 
n=12,£><0.018) dependencies (Fig. 3.1). A small, but consistent, Ikv peak inhibition was 
also observed at positive voltages (I kv(50) block = 22±4.8 %, n=2 0 , p<0.006, Fig. 3.1 C). 
There was, however, no significant effect of CCCP upon the slope of the steady state 
activation or inactivation dependencies (Table 3.1). These results suggest that 
uncoupling of the mitochondria with CCCP, which should lead to a significant decrease 
in mitochondrial membrane potential (ATm), caused significant effects on the properties 
of IKv in PASMCs.
Additionally, acceleration of the current decay was evident (observed in traces in Fig.
3.1 A&D), resulting in a significant reduction of the non-inactivating component of Ikv 
from 0.32±0.05 (control) to 0.18±0.02 (CCCP) (n=12, p<0.001). Two processes could 
be possible for such acceleration 1 ) more channels become inactivated, 2 ) direct 
blocking effect of the drug on open channel. The data providing evidence for both 
possibilities, at least for some of the mitochondrial inhibitors, will be addressed later in 
this chapter.
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Figure 3.1. Effect of mitochondrial uncoupling with CCCP on IKv activation, 
inactivation and block. A-C, Modulation of Irv activation. (A) Voltage protocol and 
original current traces recorded from a representative PASMC 5 min after pre­
incubation with the mitochondrial uncoupler CCCP (2 pM). Traces in grey in A 
correspond to a Vm = -30mV. (B) Comparison of CCCP-induced changes in the peak Ikv 
measured from a single exponential fit of the current activation at each Vm, and 
normalised tail currents (upper and lower panel respectively). (C) The mean absolute 
(Va) and relative (AVa) changes in IKv activation. D-F, Effect on IKv inactivation. (D) 
Current traces recorded with the availability protocol (shown at the top of the panel) in 
the absence and presence of CCCP from a representative PASMC. (E) CCCP-induced 
changes in the normalised Ikv measured with the availability protocol. (F) Compares 
the mean absolute (Vh) and relative (AVh) changes in Ikv inactivation. A and D were 
obtained from different cells with Cm=14.6 and 8.7 pF, respectively. Lines in B were 
drawn with Va=-17 and -28.9 mV (dashed lines) and ka=8.9 and 7.7 mV, for control and 
CCCP respectively. Lines in E were drawn with Vh=-12.9 and -22.9 mV (dashed lines) 
and kh=8.1 and 5.7 mV and the non-inactivating component equal to 0.39 and 0.16 in 
control and CCCP-containing solutions respectively.
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S. 1.2 Role o f the mETC in Ikv modulation
Since the mitochondrial membrane potential (ATm) is maintained by the mETC, a 
putative involvement of individual mETC complexes in the mitochondrial dependent 
modulation of Ikv was further investigated with widely used mETC inhibitors: rotenone 
(inhibiting at complex I), myxothiazol and antimycin (inhibiting at complex III) (all at 1 
pM) and NaCN (inhibiting at complex IV, 1 mM).
Figure 3.2 summarises the effects of mETC inhibitors on AVa, AVh and Ik v block. A 
significant negative shift in the Ikv activation and increased Ikv block was observed with 
all mETC inhibitors (Table 3.1), mimicking those caused by CCCP. Interestingly, a 
noticeable larger shift in Ikv activation and block was observed with distal mETC 
inhibitors (antimycin and cyanide) in comparison to the proximal inhibitors (rotenone, 
and myxothiazol) with the effects caused by antimycin were most pronounced ( I kv(50) 
block = 39.6±8.8, AVa = -13.6±2 mV, n=9, /?<0.011) (Fig. 3.2 A-C). A significant 
decrease in Ikv block for antimycin was observed at all potentials from 10 to 50 mV 
(Fig. 3.2 D). It is also worth noting that the slope of the steady-state activation 
dependencies was significantly increased in the presence of myxothiazol and antimycin 
(acting at complex III, Table 3.1). Similar to Ikv activation, all mETC inhibitors, except 
myxothiazol, induced significant changes in AVh,, again antimycin had the most 
pronounced effects (AVh = -15.6±2.1 mV, n=8 , /?<0 .0 0 0 2 ). Furthermore, antimycin, 
12.6±0.8 to 8±0.8 p<0.006, and rotenone, 11.8±1.2 to 8.6±1.1 p<0.0024, increased the 
slope of the steady state Ikv inactivation dependencies (Table 3.1). It is also worth 
noting that there was a substantial decrease in the non-inactivating component for all 
inhibitors, with all but rotenone being significant; for antimycin this was decreased from 
0.31±0.03 to 0.08±0.02, p<0.0005, n=8 . Therefore, for characterisation of the 
mechanisms involved in the interaction between mitochondria and Ikv, antimycin was 
chosen as the main modulatory agent of mitochondrial function.
It is noteworthy that changes in the IkV(50) block under different conditions were similar 
to those calculated for the maximal whole-cell conductance determined from the 
conductance-voltage relationships (for example; antimycin 47.6±5.9 %, n=9, rotenone 
44.7±9.9 %, n= 6  and myxothiazol 56.7±4.9 %, n=7, in comparison to IkV(50) in Table 
3.1).
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TABLE 3.1. Effect of CCCP and mitochondrial ETC inhibitors on voltage-dependent parameters of Ikv-




















-2 1  ± 2
(/?<0.00005)
9.9±0.7





















































-1 0 .6 ±1.1
-24.2±1.9









(/?<0 .0 0 0 2 )



















{ p < 0.023)




(^<0 .0 0 0 2 )
-7.2±2.6 10
Here a^d in subsequent Tables p  values show significant differences between the values measured in control conditions and in the presence of the tested 
inhibitor obtained in the same PASMCs (paired two-tail /-test) unless indicated otherwise.
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Figure 3.2. Effect of the mETC inhibition on the 7kv characteristics: activation (A), 
inactivation (B) and Ikv(5 0) block (C). (D) Comparison of antimycin-induced changes in 
the peak Ikv measured from a single exponential fit of the current activation at each 
potential.
3.1.3 Specificity o f the Ikv modulation to the mETC
One common feature for antimycin and the other mitochondrial inhibitors is their 
modulation of AT™ by reducing the proton gradient across the inner mitochondrial 
membrane. If the inhibitors are specifically targeting the mETC, and therefore A'Fm 
then, using antimycin as the test inhibitor, it would be expected that the antimycin- 
induced effects should be attenuated either: 1) in the presence of CCCP (by collapsing 
A^m), and 2) after pre-treatment with the proximal mETC inhibitors, such as rotenone 
or myxothiazol (by reducing electron flow proximally to the mETC complex III). It 
could also be expected that enhancing the drive of the mETC, by increasing electron 
flow to distal regions with Complex II substrate succinate would augment the effects of
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antimycin. All of these conditions were investigated. Cells were pre-incubated for 5 
minutes in CCCP or a proximal inhibitor (rotenone or myxothiazol) prior to any 
recording of the control parameters and antimycin was then added in addition to the pre- 
incubated drug and equilibrated for 5 minutes before recording the test Ikv parameters. 
Succinate was dialysed into cells and again equilibrated for 5 minutes before 
commencing recording using the Ikv protocols.
Although pre-incubation of PASMCs with CCCP did not alter the antimycin-mediated 
Ikv inhibition (44.4±7.1 %, n=8 , /K0.007) (Fig 3.3 B), the antimycin-induced shift in 
both Ikv activation (from -13.6±2 mV, n=9 to -3.1±1 mV, n= 8  (p<0.0004)) and 
inactivation dependencies (from -15.6±2.1 mV, n=9 to -2.7±1.9 mV, n=10 (p<0.005)) 
were significantly reduced (Fig. 3.3 A). Additionally, antimycin caused an increase, 
instead of decrease, in the slope of Ikv activation following pre-treatment with CCCP 
(Table 3.2). Conversely, despite the complete inhibition of AVh (from -15.6±2.1 mV to 
-2.7±1.0 mV, ;?<0.005) (Fig. 3.3 A), the non-inactivating component of Ikv was still 
significantly reduced by antimycin, indicating a possible direct open channel block 
during the prolonged membrane depolarisation. The antimycin-mediated increase in the 
slope of Ikv inactivation from 11.8±1.2 mV to 8.8±1.1 mV (p<0.0007) is also consistent 
with this concept (Table 3.2). Similarly to antimycin, CCCP also attenuated, but not 
significantly, the effect of inhibition of complex I by rotenone on Ikv activation. In 
contrast to antimycin the effect of rotenone on Ikv inactivation was not affected by 
CCCP (Fig. 3.3 D).
Similar to CCCP, cell pre-treatment with myxothiazol and rotenone, significantly 
attenuated the antimycin-induced changes in Ikv activation and inactivation (Fig. 3.3 C). 
Consequently, no significant changes in ka were found in the presence of both proximal 
inhibitors (Table 3.3). It is noteworthy that, although it was not possible to record Ikv 
availability in the presence of antimycin with myxothiazol or rotenone since prolonged 
exposure to both inhibitors often caused cell blebbing and deterioration, the absolute 
value of Vh obtained in myxothiazol and antimycin (-32.1±3.6 mV, n=6 ) was 
comparable to that measured in antimycin alone (-32±2.6 mV, n=8 ), suggesting that the 
effects of these agents on AVh were also not additive. Significant potentiation of the 
antimycin-induced IkV(50) block was observed with myxothiazol, but not with rotenone 
(Fig. 3.3 C).
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TABLE 3.2. Effect of the cell pre-treatment with the mitochondrial uncoupler CCCP (2 pM) on antimycin (1 pM) induced changes of Ikv characteristics.
















CCCP -19.4±1.4 10.5±1.1 -27.8±3.6 1 1 .8±1 .2 0.21±0.03
Antimycin -22.5±1.5 12.1±1.4 -3.1±1 44.4±7.1 8 -30.5±4.2 8 .8± 1.1 0 .1±0 . 0 2 -2.7±1.9 1 0
+ CCCP O<0.015) (/?<0.03)b A o o o o Co A o o o (p<0.0007) (p<0.005)a
CCCP -22.3±3.1 10.3±1.5 -28.4±3 9.5±0.6 0.19±0.03
Rotenone -24.5±2.9 12.2±1.4 -2.2±1.9 25..9±3.7 11 -33.7±2.5 7.6±0.6 0.16±0.01 -5.3±1.2 11
+ CCCP (p<0.04) (/K0.008) {p<0 .0 0 2 ) (/?<0 .0 2 )
a Compares the mean values obtained in this condition and those measured in the presence of antimycin A alone (Table 3.1) (non-paired two-tail f-test). Cells 
were incubated with CCCP for 5 min prior to commencing recordings. 
b Denotes significant differences only with the one-tail f-test.
TABLE 3.3. Effect of the proximal mETC inhibitors rotenone and myxothiazol on the effects of the distal ETC inhibitor antimycin (all at 1 pM).
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a Compares the mean values obtained in these conditions and those measured in the presence of antimycin alone (Table 3.1) (non-paired two-tail r-test). Cells 
were incubated with rotenone or myxothiazol for 5 min before Ikv characteristics were recorded. 
b Denotes a significant difference only with the one-tail Mest.
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Figure 3.3. Specificity of the antimycin-induced effects on the mETC. A, Effect of the 
mitochondria uncoupler CCCP (2 pM) on antimycin-induced changes in Ikv activation 
and inactivation. B-C, Effect of the proximal mETC inhibitors rotenone and 
myxothiazol (all at 1 pM) on the antimycin-induced changes in Ikv activation (B) and 
block (C). (D) Effect of CCCP on rotenone-inducted changes in Ikv activation and 
inactivation. Black bars on the right of each panel show the effect of antimycin or 
rotenone, respectively, alone for comparison. Cells were pre-incubated with each drug 
for at least 5 min before recording Ikv-
If the effects of rotenone are specific to the mETC, increased supply of substrate to 
mETC via complex II would be expected to block rotenone dependent changes in Ikv- It 
has previously been shown that rotenone and antimycin have direct actions on ion
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channels including Kv channels (Lopez-Bameo et al., 2001; Mason et al., 2004). 
Dialysing cells with a Na succinate containing pipette solution (Table 2.3) an exogenous 
substrate for the mETC complex II, could enhance transfer of electrons from FADH2 
(reduced ubiquinone) to FAD+ (oxidised ubiquinol) to the Reiske Fe-S protein in 
complex III. The changes in AVa and AVh induced by rotenone remained unaltered (Fig 
3.4).
E
~  -4 
<
-8
-1 2  J
Figure 3.4. Effects of cell dialysis with 5 mM Na succinate (Table 2.3) on rotenone- 
induced changes in Ikv activation and inactivation. Black bars on the right of each panel 
show the effect of rotenone alone for comparison. Cells were pre-incubated with each 
drug for at least 5 min before recording Ikv
3.1.4 Effect o f  mETC inhibition on membrane potential.
Antimycin caused a reversible membrane depolarisation in PASMCs (AVm= 31.2±10.3 
mV, n=2). CCCP also caused a small, but significant and reversible, depolarisation 
(AVm = 4.7±1.5, n=5,/?<0.05) in dialysed cells. It was interesting to note that when the 
cell was more depolarised the effect of CCCP was much more substantial, this is 
particularly evident in the representative trace in Fig. 3.5 D, after the second application 
of CCCP. In this cell, when RMP was on average -39 mV, CCCP caused a 4.6 mV 
depolarisation and, subsequent to the first application when RMP had changed to -33 
mV, the effect of CCCP was much more substantial with a 29 mV depolarisation. This 
was similar to the depolarisations in response to antimycin (Fig. 3.5 A).
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Figure 3.5. Effect of antimycin and CCCP on PASMC membrane potential. (A-B) 
Depolarisation and recovery after perfusion with antimycin in WC configuration 
(change in membrane potential, AVm). (C-D) Depolarisation induced by CCCP in WC. 
(B and D) Representative traces from separate cells showing the effects of antimycin 
(Cm = 12.3 pF) and CCCP (Cm = 10 pF), respectively. The dashed lines in B and D 
indicate average resting membrane potential in that cell.
3.1.5 Effect o f mETC on Ikv activation in intact PASMCs
To address a potential influence of cell dialysis on Ikv activation the WC mode patch 
clamp was compared to non-dialysed cells using the perforated patch clamp (Table 2.3) 
in PASMCs. The effects of the mETC inhibitors in whole cell mode were mimicked by 
antimycin, but not rotenone, in intact cells causing a significant leftward shift in Ikv 
activation (Fig. 3.4). Notably, the antimycin-induced shift in Va measured in the 
perforated-patch mode was significantly smaller than that recorded in the whole-cell 
configuration (AVa = -4.6±1.6 mV, n=8 in perforated patch compared to -13.6±2 mV, 
n=9 in whole cell configuration, ^<0.004), suggesting a possible presence of an 
additional factor(s) or influence of other process’s that are altered by or lost during cell
2 jiM C C C P  2 C C C P
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dialysis. No significant effect on Ikv amplitude was observed for rotenone, though with 
antimycin a significant, 30.2±11.2 % IKv block was evident (Table 3.5). No notable 
changes in the slope of Ikv activation were recorded (Table 3.5). The significant 
leftward shift in AVh still occurred shifting the dependence by -8±1.6 mV (n=7, 
/?<0.003). It is also worth noting that the non-inactivating component is still 
significantly decreased from 0.28±0.05 mV to 0.11±0.03 mV (n=7, p<0.036). 
However, the antimycin induced increase in the steady state inactivation dependencies 
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Figure 3.6. Effect of mETC inhibition in intact PASMCs. Comparison of the effect of 
rotenone (complex I) on Ikv activation and antimycin (distally in complex III) on Ikv 
activation and inactivation in non-dialysed PASMCs. All experiments were performed 
in the perforated-patch mode using 100 pg/ml amphotericin B (Table 2.3).
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TABLE 3.4. Effect of mETC inhibitors and ROS on IKv activation recorded in perforated-patch mode.
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Concentration of rotenone, antimycin and oligomycin was 1 pM, concentration of H20 2 was 300 pM.
aCompares the mean values between perforated-patch and control (In: 0.5 mM MgCl2) whole-cell modes (Table 3.5) (non-paired f-test). 
b Compares the mean values obtained in these conditions and those measured in the presence of antimycin and oligomycin alone (Tables 1 and 5 respectively) 
(non-fJaired r-test) . 0 Denotes a significant difference only with paired one-tail f-test.
3.1.6 Dependence ofljcv on intracellular redox state
The results presented so far strongly support a specific mitochondria-mediated action of 
antimycin on Ikv in PASMCs. One of the possible contributing mechanisms could be 
associated changes in cellular redox state (Archer et a l , 1993; Waypa et a l , 2001). 
Indeed, inhibition of the mETC could alter Ap and thus change ATm and, as the rate of 
ROS production is highly influence by both Ap and ATm (Demin et a l , 1998), it is 
necessary to assess the involvement of ROS in the mitochondria-dependent regulation 
of Ikv Therefore, the consequences of changing cellular redox state on Ikv were studied 
in cells pre-incubated for 5 mins in 300 pM H2O2, applied in the extracellular solution, 
or cells dialysed for 5 mins with reduced glutathione (GSH, 1 mM in the pipette) to 
either decrease or increase cellular redox state, respectively. The effects of redox 
modulation by 300 pM H2O2 and 1 mM GSH on the shifts in V a and V h  induced by 
antimycin were investigated in PASMCs. In addition, the effects of H2O2 and the cell 
permeable activator of SO', menadione, were assessed in intact PASMCs.
In dialysed PASMCs, 300 pM H2O2 alone caused a small, but consistent, decrease in 
the Ikv(50) peak (9.5±4.2 %, n=28,/?<0.0008; Fig. 3.7 A) and a significant leftward shift 
in IKv activation (-5.1±1.3 mV, /K0.0007; Fig. 3.7 B), thus mimicking the effect of the 
mETC inhibitors (Fig. 3.5). Although a small difference was also observed in A V h , the 
effect was not significant (Fig. 3.7 B). As expected, in cells dialysed with 1 mM GSH 
(5 min dialysis in GSH to enable equilibration prior to any recording), the H2 0 2 -induced 
changes in A V a were virtually eliminated (Fig. 3.7 C) and, although not significantly 
different from the effects of H2O2 alone, caused a small reversal of the shift in Vh to 
+4.5± 3.6 mV, n=7 (p<0.041, one tailed Mest).
It is worth noting that cell dialysis with 1 mM GSH alone had a significant effect upon 
Ikv activation (Va = -15.2±0.7 mV (GSH) and -13.1±0.6 mV (control), /?<0.03), 
resembling the shifts observed with the oxidant H2O2 . There were, however, no effects 
in cells dialysed with GSH alone upon inactivation (Table 3.5). Notably, both 
parameters (Va and Vh) measured in PASMCs were normally distributed (Fig. 3.8 
A&B), similarly to those measured under control conditions, supporting the previously 
made statement of a relatively homogenous population of Ikv in resistance PASMCs.
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In agreement with the effects of H2 O2 on Ikv activation, 300 pM H2 O2 had no effect 
upon membrane potential in both dialysed (AVm = -1.6±1.5 mV, n=7) (Fig. 3.9) and 



















Figure 3.7. Effect of cellular redox state on Ikv activation and inactivation. Effect of 
300 pM H2 O2 on Ikv characteristics in PASMCs dialysed with the control solution (A & 
B) or with 1 mM GSH added to the pipette solution ([GSH]P) (A & C).
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Statistical comparison was performed using all pooled data for the IKv recorded in PASMCs bathed in PSS and dialysed with a specified pipette solution (one 
way ANOVA).
Figure 3.8. Comparison of the distribution of Ikv voltage-dependent parameters, Va (A) 
and Vh (B) in cells dialysed with control and 1 mM GSH containing pipette solutions. 
IKv was recorded in PASMCs either dialysed with either the control pipette solution or 
pipette solution containing 1 mM GSH and bathed in PSS containing paxilline and 
glybenclamide. Solid lines represent the Gaussian model fit with mean Va values of -12 
mV (control) and -14 mV (GSH) (A) and mean Vh values o f -20 mV (control) and -22 
mV (GSH) (B).
Control 300 jiM HjOj AMP
300 nM H20 2300 |iM H O
Figure 3.9. Effect of 300 pM H2 O2 on membrane potential. (A) Change in membrane 
potential (AVm) induced by H2 O2 in whole cell patch clamp mode. (B) A representative 
recording from a cell with Cm = 12.6 pF.
S. 1.7 Effects o f cellular redox state on antimycin induced changes in Ikv
Antimycin-mediated changes in Ikv activation and inactivation were not significantly 
affected by pre incubation of cells in 300 pM H2O2 (Fig. 3.10 A&B). Interestingly, 
similar to data where cells were preincubated in myxothiazol (Fig. 3.3), the antimycin- 
induced IKv block was also enhanced by H2O2 from 39.6±8.8 % (n=9) to 64.6±6.8 %, 
n=8 , /?<0.05 (Fig. 3.10 C). Conversely, cell dialysis with GSH caused a significant 
decrease in the antimycin-dependent changes in Va from -13.6±2 mV, n=9 (antimycin 
alone), to -4±1.8 mV, n=15,/?<0.003 (antimycin in the presence of GSH), and Vh from 
-15.6±2.1 mV, n=9 (antimycin alone) to -8.7±2.5 mV, n=14, /?<0.033 (antimycin in the 
presence of GSH) (Fig. 3.10 B&C) without affecting the IkV(50) block (Fig. 3.10 A). 
This data suggests a potential link between the antimycin-dependent modulation of the 
voltage-dependent characteristics of Ikv (activation in particular) and intracellular redox 
state. The lack of an inhibitory effect of H2O2 on the antimycin-induced Ikv(50) block 
might suggest that Kv channels are already oxidized (as proposed by Archer et a l , 
1993; Michelakis et a l , 2004). This, however, seems unlikely since cell dialysis with 
GSH caused a significant leftward shift in Ikv activation in the absence of any inhibitors 
(Fig. 3.8 and Table 3.5), mimicking the effect of H2O2. Additionally, H2O2 had no 
effect upon membrane potential as shown in Fig. 3.9, which suggests against an 
additional effect of an oxidised cellular redox state in the regulation of Kv channels in 
PASMCs.
Interestingly, cell dialysis with 1 mM GSH did, although not significantly compared to 
the control, reduce the rotenone induced shifts in Ikv- In this, more reduced, cellular 
redox state rotenone caused very small and non-significant shifts in both Va, -2.7±2.1 
mV (n=13) and AVh, -2.7±2 mV (n=l 1). In addition, no significant effects on the slope 
of the steady state activation dependencies or the Ikv block were now evident (Table 
3.6). Despite this, the slope of the inactivation dependency was still increased from 
10.8±0.4 mV (n= 11 in control) to 8.2±0.5 mV (n= 11 in rotenone lpM), /K0.0013.
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Figure 3.10. Effect of cellular redox state on the modulation of Ikv by antimycin. 
Effect of H2 O2 and [GSH]P on antimycin-mediated changes in IKv AVa(A), AVh(B) and 
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Figure 3.11. Effect H2 O2 and menadione on Ikv activation in non-dialysed PASMCs. 
All experiments were performed in the perforated-patch mode (with 100 pg/ml 
amphotericin B in the pipette).
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TABLE 3.6. Modulation of the IKv characteristics by extracellular hydrogen peroxide (H20 2, 300 jiM) and its effect in the presence of intracellular reduced 
glutathione (GSH, 1 mM) and antimycin and rotenone (both at 1 pM) induced changes in the presence of H20 2 and GSH.
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8 Compares the mean values obtained in the specified condition and those measured in the presence of antimycin alone (Table 3.1) (non-paired two-tail r-test). 
b Coiwpares the mean Va, ka, Vh and kh values obtained in PASMCs dialysed either with the control pipette solution or with solution containing 1 mM GSH in 
the absence of any inhibitors (non-paired two-tail ttest).
S. 1.8 Effect o f H2 O2 and menadione on Ikv activation in non-dialysed cells.
Again it was important to assess a potential influence of cell dialysis on Ikv activation 
the WC mode patch clamp and this was done by compared to non-dialysed cells using 
the perforated patch clamp technique. 100 pg/ml amphotericin B was included in the 
pipette solution to gain electrical access to the cell (Table 2.3). In contrast to dialysed 
cells, modulation of cellular redox state by H2O2 had no significant effects upon Ikv 
activation nor the slope of the steady state activation dependencies and there was no Ikv 
block (2.2±16.5 %, n=6 ) in non-dialysed cells. In addition to 300 pM H2O2, cells were 
perfused with the membrane permeable activator of superoxide, menadione, at 1 0  and 
1 0 0  pM. Both concentrations caused a small, but not significant, rightward shift in IKv 
activation, opposite to the shifts in dialysed cells (Fig. 3.11). Additionally no changes 
in the slope of the steady state activation of the Ikv block were observed with either 
menadione concentration. This could suggest that an anti-oxidative cellular mechanism 
for the maintenance of cellular redox levels is sufficient to counteract of externally 
applied oxidants like H2O2 and intracellular increases in superoxide production which 
might be induced by menadione. This data therefore advocates against a major role for 
cellular redox levels in the mitochondria-dependent regulation of Ikv
3.1.9 Involvement o f  the Fo/FjATP synthase
Inhibition of the mETC could reduce F0/F1 ATP synthase activity, thus decreasing local 
ATP levels. If ATP synthase is involved, then its inhibition with the selective inhibitor 
oligomycin should mimic the effects of the mETC inhibitors on Ikv-
3.1.10 Inhibition o f  the Fo/F]ATP synthase
Oligomycin (lpM), a potent inhibitor of mitochondrial ATPase, was applied to 
PASMCs for 5 minutes after recording Ikv control parameters. Figure 3.12 shows that 
changes in Ikv block (A) Va (C) and Vh (E) caused by oligomycin were indeed 
comparable to those induced by antimycin. There was a substantial leftward shift in 
both Va (AVa = -11.4±1.9 mV, n=12, ^<0.00007) and Vh (AVh = -14.8±2.5 mV, n = ll, 
p<0.0002). In addition the Ikv block was reduced by 29.6±1.8 % and there was 
significant increases in the dependencies of both the steady state Ikv activation (9.9±0.5
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mV to 8.8±0.6 mV, n=12, p<0.039) and inactivation (12.2±1.3mV to 9±0.7 mV, n = ll, 
/?<0.00001). Additionally, a significant decrease in the non-inactivating component was 
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Figure 3.12. Effect of F0/F1ATP synthase inhibitor oligomycin (1 jiM) on Ikv- A-B, 
Effect of olgomycin on current density to highlight Ikv block at potentials up to +50 
mV. Effect of oligomycin on Ikv activation (C&D) and inactivation (E&F) measured 
and normalised to the maximal current using tail currents and Ikv availability protocols 
(as described in chapter 2.6) in the absence (C&E) and presence (D&F) of 5 mM 
Na2ATP. G&H compares the AVa and AVh also in the absence (G) and presence (H) of 
5 mM Na2ATP. ^Compares the mean values in (G) and (H). The controls had 0 mM 
Na2ATP (as shown in Fig. 3.1).
Similarity between the effects of antimycin and oligomycin could suggest that local 
changes in ATP concentration are important in IKv modulation by the inhibitors. Cell 
dialysis with 5 mM Na2ATP, increasing intracellular ATP levels, practically abolished 
the effect of oligomycin on AVa and AVh (Fig. 3.12). An attenuation of the effects of 
oligomycin by dialysis with an elevated ATP concentration is clearly shown in the 
figures comparing; 1) Ikv current densities where the current block at and above 0 mV is 
now not significant (Fig. 3.12 A, control vs. B 5 mM Na2ATP); 2) normalised tail 
current densities where the leftward shift in Va is practically abolished (AVa = -2.2+0.9 
mV, n=6,/?<0.004 impaired t-test shown in Fig 3.12 (C), control vs. (D) 5 mM Na2ATP) 
and 3) the shift in Ikv inactivation is significantly blocked (p<0.003, non-paired t-test to 
oligomycin in control conditions, Fig. 3.12 E, control and F, 5 mM Na2ATP). It is 
interesting to note that in the presence of Na2ATP there is rectification of the current 
positive to +30 mV, shown in Fig. 3.12 D. It is also worth noting that the changes in the 
slopes of the steady state Ikv activation dependencies caused by oligomycin alone were 
completely blocked by Na2ATP (Table 3.7) and, despite having an insignificant smaller 
18.9+7.2 % (n=6 ) reduction in Ikv block, there was no significant difference to the 
oligomycin in control condition. Additionally, there was no effect upon the slope of the 
steady state dependencies of Ikv inactivation, however, despite being significantly 
reduced from 0.38+0.04 mV to 0.28+0.01 (n=6 , p<0.035) a significant block of the 
effects of oligomycin on the non-inactivating component was nevertheless evident 
(p<0.00001, non-paired /-test) (Table 3.7).
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TABLE 3.7. Effect of Fi/F0 ATP Synthase inhibitor oigomycin (1 pM) on IKv
Steady-state IKv activation and IKv(soi block IKv inactivation
Va ka AVa Ikv(50) ft 
(mV) (mV) (mV) block (%)




Oligomycin -26.1±1.9 8.8±0.6 -11.4±1.9 29.6±1.8 12 
(p<0.00007) (p<0.039) (pO.OOOl)
-25.2±3.5 12.2±1.3 0.25±0.01




Oligomycin -12.4±1.7 7±0.7 -2.2±0.9 18.9±7.2 6  
(p< 0.03 l)b (p<0.004)*
-12*2.9 11.3*2.3 0.38±0.04
-13.8*2.6 9.4*1.3 0.28*0.01 -1.9±1.5 6
(p<0.035) (p<0.003)a
(p<0 .0 0 0 0 1 )a
IMgCl2Ip-0.5 mM
Antimycin -21.8±2 6.3±0.5
Antimycin + -30.5±3.9 7.2±0.7 -8.7±2.2 44±6.3 7 
Oligomycin (/K0.008) (p<0.045)b (p<0.017)
0?<0.033)a,b
-33.6±2.1 8.9*1.1 0.04*0.01
-41.9*2.6 7.7*1.2 0.1*0.01 -8.3±2 7 
(p<0.007) (p<0.011) (p<0.041)a,b
Concentration of antimycin was 1 pM; cells were pre-treated for 5 min before commencing IKv recording.
“Compares the mean values obtained in the specified condition and those measured in the presence of oligomycin alone (non-paired two-tail t-test). 
b Denotes a significant difference only with the one-tail t-test.
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Figure 3.13. Effect of antimycin on the oligomycin induced shift in Ikv parameters. (A) 
Cell pre-treatment with antimycin (1 pM) does not block the effect of oligomycin on Ikv 
activation or inactivation. (B), Ikv(5 0) block in oligomycin (control and 5 mM Na2ATP 
pipette solutions) and in the additional presence of antimycin when dialysed with 
control pipette solution. Grey bars indicate effect of oligomycin alone for comparison.
3.1.11 Effects o f  intracellular ATP on the antimycin dependent changes in Ikv
The effects of oligomycin on IKv essentially mimic those of antimycin raising the 
possibility of a similar mechanism of action. Pre-treatment o f PASMCs with antimycin 
however, despite reducing, did not prevent the subsequent effects of oligomycin on AVa 
and AVh (Fig. 3.13 A&B), suggesting an additive action of these inhibitors. 
Conversely, the oligomycin-induced reduction in ka was reversed (from 6.3±0.5 mV in 
antimycin to 7.2±0.7 mV in both inhibitors, /?<0.045, n=7) and changes in were 
blocked in the presence of antimycin (Table 3.7), thus indicating a possible cross-talk 
between the mETC and the ATP synthase. It is also interesting to note an increase of 
the non-inactivating component in the additional presence of oligomycin (from 
0.04±0.01 to 0.1±0.01,/K0.011, n=7, Table 3.7). In contrast, oligomycin and antimycin 
had an additive effect on Ikv amplitude, Ikv block was enhanced in the presence of both 
drugs to 44±6.3 %, p<0.017 (paired to antimycin alone) and /?<0.033 (unpaired to 
oligomycin alone) (Fig. 3.13 B)
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TABLE 3.8. Effect of intracellular ATP, EDTA and Mg2+ on antimycin-induced changes in the IKv characteristics.
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1 0 .2 ±2 .1 -6.7±1
(p<0.005)a
58.5±6.9













a Compares the mean values obtained in these conditions and those measured in the presence of antimycin alone (Table 3.1) (non-paired two-tail t-test). 
b Denotes a significant difference only with the one-tail Mest.
The similarity between the changes in the Ikv characteristics caused by the complex V  
(ATP synthase) and complex III inhibitors could, nevertheless, advocate that an ATP- 
dependent process could be involved in the action of antimycin. To verify this notion, 
the effects of antimycin were also studied in cells dialysed with 5 mM Na2ATP. Fig. 
3.14 C&D demonstrates that, like oligomycin, the effect of antimycin on both Ikv 
activation ( A V a = -3±1.1 m V ,  /?<0.0005, n=8 ) and inactivation ( A V h  = -9.1±2.8 m V ,  
/K0.037 one-tailed t-test, n=7) was indeed significantly reduced, although changes in 
Ikv inactivation appeared to be less sensitive. The example traces in Fig. 3.14 B also 
indicate an increase in the slope dependency of the steady state inactivation (13.8±1.6 
m V  to 7.8±0.8 m V ,  /?<0.0004, n=7), changes for activation were blocked (see Table 
3.8). Also, the antimycin-induced Ikv(50) block was virtually abolished by Na2ATP 
(Table 3.8), with only a small decrease (11.6 %) evident in the traces from a 
representative cell in the absence and presence of Na2ATP (Fig. 3.14 B). It is worth 
mentioning that a similar decrease in the non-inactivating component from 0.4±0.04 to 
0.12±0.02, p<0.0002, n=7 was still observed as seen with antimycin in control 
conditions, suggesting that the effects of antimycin on the non-inactivating component 
are independent of changes in V a and V h  and probably reflect a direct effect of the 
inhibitor on Ikv.
Interestingly, cell dialysis with 5 mM MgATP, a condition that would be expected to 
favour protein phosphorylation, partly recovered antimycin-mediated effects on at least 
Ikv (Fig. 3.14 C & D). More notable were changes on Ikv activation parameters with a 
partial recovery of AVa increasing to -6 .9 ± 1 .1  mV, n=9, p<0.09 when compared to 
Na2ATP. IKv block was also increased to 26.2±4.5 %, /?<0.0005 and the slope of the 
steady state activation dependency increased from 9.5±1 to 7.8±0.8,/?<0.031 (one tailed 
t-test) in comparison to the Na2ATP and thus reflecting the antimycin induced shifts. 
However, inactivation parameters were not dissimilar from those dialysed with Na2ATP
One possible explanation of the differences between the two ATP salts could be the
94-Mg -chelating property of ATP. To account for this possibility the effect of equimolar
I
replacement of 5 mM EGTA with EDTA (a much more potent chelator of Mg ) in the 
pipette was examined (Table 2.3 in methods). Cell dialysis with the increased buffering
^  I
capacity for Mg significantly attenuated antimycin-induced changes in both AVa 
(-3.3±1 mV, n=8 , /K0.0005) and AVh (-4.4±2.6 mV, n=8 , ;?<0.003) and reduced its
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Ikv(50) block by an average of 17.7 % (Table 3.8), thus mimicking the effect of Na2ATP 
(Fig. 3.14 C-E). Furthermore, the increase in the dependency of Ikv activation as seen 
with antimycin under control intracellular conditions was completely blocked when 
cells were dialysed with increased EDTA, akin to Na2ATP (Table 3.8). It is also 
noteworthy that the mean V a and V h  values obtained in cells dialysed with Na2ATP and 
EDTA, but not with MgATP, in the absence of any inhibitors were significantly more 
positive when compared to those in cells dialysed with the control pipette solution 
(Table 3.8).
3.1.12 Direct effect o f antimycin on Ikv
Notably, although significantly reducing A V h , these conditions did not change the effect 
of antimycin on the non-inactivating component strongly suggesting a possible direct 
effect of antimycin. To investigate this possibility the following analysis was 
performed. This non-specific effect is most clearly demonstrated by comparison of the 
effects of antimycin and oligomycin on Ikv kinetics under conditions (5 mM EDTA for 
antimycin and 5 mM Na2ATP for oligomycin) when changes in Ikv inactivation ( A V h )  
were eliminated (Fig. 3.12). The effect of antimycin on the Ikv decay measured during 
the 10 sec conditioning pre-pulse was practically unchanged by cell dialysis with 5 mM 
EDTA (Fig. 3.15 A&B), which virtually eliminated the antimycin-induced leftward 
shift in the Ikv inactivation dependency (Fig. 3.15 C). In contrast, cell dialysis with 
Na2ATP significantly reversed both the oligomycin-mediated shift and the inhibition of 
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Figure 3.14. Dependence of Ikv modulation on Mg2+j. A & B are representative Ikv 
traces from two PASMCs in control (left) and in lpM  antimycin (right); (A) dialysed 
with control pipette solution (Cm = 12.3 pF, AVa = -20.8 mV and Ikv(50)=  63.6 %.) and 
(B) dialysed with 5 mM Na2ATP (Cm = 17.8 pF, AVa = -1.3 mV and Ikv(5 0 ) = 11.6%). 
Comparison of the effect of intracellular (pipette) Na2ATP, MgATP and EDTA (no 
MgCb was added to the pipette solutions) on antimycin-induced changes in IKv 
activation (C), inactivation (D) and Ikv(5 0) block (E). Black bars show the effect of 
antimycin alone for comparison. a in C and D denotes significant difference with one- 
tail non-paired /-test.
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Figure 3.15. Demonstration of the direct block of Irv by antimycin. Comparison of the 
kinetics of Ikv inactivation induced by antimycin (A-C) and oligomycin (D-F) (both at 1 
pM) in PASMCs dialysed with control (A, D), EDTA (B) or Na2ATP (E) containing
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pipette solutions. G and H, changes in the time constant of inactivation calculated from 
a mono-exponential fit of the Ikv elicited by a 10 s conditioning pre-pulse at 0 mV 
(availability protocol) for antimycin in control and EDTA (G) and oligomycin in control 
and Na2ATP (B). Ikv was normalised to its peak amplitude and averaged (solid lines). 
Symbols and error bars represent mean and s.e.m. for 8  (A and B), 11 (D) and 6  (E) 
PASMCs. *indicates the level of significance between data obtained in the presence and 
absence of an inhibitor using the paired Mest, while indicates a significant difference 
between oligomycin-induced changes in cells dialysed with Na2ATP and those recorded 
with the control pipette solution. Note that no significant difference in the antimycin- 
induced Ikv decrease was observed, although EDTA significantly inhibited the shift in 
the Ikv inactivation dependency (C). Conversely, the reduction in the oligomycin- 
mediated effect was well correlated with AVa changes (F).
3.1.13 Dependence o f  antimycin- mediated effects on Mg ;
If Mg2+i is involved in the effect of the mitochondrial inhibitors on Ikv activation and
• 2 “binactivation, then it would be expected that cell dialysis with elevated Mg i should 1) 
mimic their effect and 2) attenuate the effect of antimycin. This was assessed by 
increasing [MgCl2] in the pipette solution from 0.5 to 5 mM. Although the change in 
[Mg2+]i alone did not affect Ikv activation (Table 3.5), the inactivation dependency was 
significantly shifted to the left, Vh = -23.7±1.1 mV, n=69 (control) compared to - 
30.7±12.8, n=12 (5 mM MgCl2),p<0 .0 2 , in the absence of any inhibitors (Fig. 3.16 A). 
Elevated Mg2+ also significantly decreased the non-inactivating component from 
0.28±0.01 to 0.12±0.02, p<0.035, possibly via a direct effect on the Kv channel that 
might occur at positive potentials. Nevertheless, antimycin-induced changes in both 
AVa from -13.6±2 mV, n=14, (control) to -6.7±1 mV (5 mM MgCh), and AVh from - 
15.6±2. mV, n=9, (control) to -8.2±2.7 mV, n=6 , (5 mM MgCk), were significantly 
reduced when compared to those in low [Mg2+] (p<0.005 and ^<0.043, respectively, 
Fig. 3.16 B). Only the steady state dependencies of inactivation were increased 
significantly from 10.7± 0.8 mV to 7.4±0.7 mV (n=6 , p<0.032). Consequently 
supporting a role for a mitochondria-mediated increase in [Mg2+]j in the regulation of 
Kv channels. Interestingly, the antimycin-dependent Ikv(50) block was markedly 
enhanced in the elevated [Mg2+]i (Fig. 3.14 E), a similar potentiation of the antimycin
induced block to that occurring with H2 O2 (Fig. 3.10 C). Similarly to other conditions 
antimycin induced a significant decrease in the non-inactivating component from 
0.22±0.04 to 0.06±0.02, /?<0.002, n=6.
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Figure 3.16. Comparison of the effect of increased pipette MgCl2 ([MgCl2 ]p) on Ikv 
characteristics. (A) Effects of 0.5 and 5 mM [MgC^Jp on Va and Vh in the absence of 
inhibitors (non-paired t-test). (B) Increased [MgCbJp significantly attenuates the 
antimycin-induced shifts in Ikv activation and inactivation.
3.1.14 Confocal imaging o f Mg2+, and Ca2+i in single PASMCs
An increase in Ca2+j and Mg2+j in response to mitochondrial inhibition has previously 
been demonstrated in cardiac myocytes (Leyssens et al., 1996), but not in pulmonary 
arteries. Therefore, confocal imaging of PASMCs loaded with Mg2+-sensitive dye, 
MagFluo-4-AM, was carried out in order to study the effect of CCCP and antimycin on 
Mg2+j concentration and to verify a possible role for Mg2+ in the mitochondrial 
dependent regulation of Ikv- The Mg2+ imaging was investigated in the presence of 
BAPTA-AM and Ca2+ free Krebs (Table 2.4) to minimise Ca2Ydependent 
contamination of the fluorescent signal which also occurs in response to these 
inhibitors, as demonstrated in (Fig. 3.18). CCCP caused a significant increase in Mg2+j 
in PASMCs. The images in Fig. 3.17 A show two individual PASMCs (a and b) under 
optical light and showing MagFluo-4-AM fluorescence taken at 0, 5 and 10 minutes 
after application of 2 pM CCCP. The final panel shows maximal fluorescence after
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stimulation with A23187. In Fig. 3.17 B these images are converted to a normalised 
MagFluo-4-AM expressed as a percentage of the maximal response to A23187 and 
shows the CCCP induced increase in MagFluo-4-AM fluorescence over a 10 minute 
period. Similar significant increases in MagFluo-4-AM intensity were also observed for 
antimycin (Fig. 3.17 C&D).
To confirm that the increased intensity of MagFluo-4-AM was attributed to a change in 
Mg2+ concentration and not Ca2+ concentration, changes in Ca2+ intensity were also 
measured in a separate set of experiments using Fluo-4, a dye more selective for Ca . 
Note that there is a relatively small level of control fluorescence after the correction 
procedure (less then 0.5 %. Fig. 3.18 B). As shown in Fig. 3.18 a significant increase in 
Ca2+j did also occur in response to both C C C P and antimycin. These changes in Ca2+i
^  i
were abolished in cells pre-incubated with 50 pM BAPTA, conditions that the Mg 
measurements were recorded in, completely blocking Fluo-4 fluorescent signals (n=7,
I
data not shown). Additionally, cell dialysis with 220 nM Ca alone caused a 
significant rightward shift in Ikv activation (from Va = -13.1±0.6 mV (control, n=184) to 
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Figure 3.17 mETC inhibition induces increases in Mg2+i. CCCP- (A-C) and antimycin-
^  i
(D) induced increases in Mg i in single PASMCs. (A) Images from two representative 
individual freshly isolated PASMCs (a and b). (B) Normalised MagFluo-4 intensity for 
the representative cells in (A). (C) & (D) Mean normalised intensities in 8 cells with 
CCCP and 8 cells with antimycin. Intensities were normalised to the peak MagFluo-4 
fluorescence measured in A23187 and compared using paired /-test. Dr. Kathryn Yuill 
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Figure 3.18. Effects of CCCP (2 pM, A) and antimycin (1 pM, B) on Ca2+i in PASMCs. 
Experiments were performed at room temperature with the cells were bathed in PSS. 
aDenotes one-tail paired /-test. Dr. Kathryn Yuill contributed to this figure.
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3.2 Discussion
Mitochondria in the regulation o f  Kv channels
The major findings in this chapter reveal the existence of a potent mitochondria- 
mediated regulatory pathway in the Kv channel activity in PASMCs. The 
mitochondrial uncoupler CCCP, and mETC inhibitors, rotenone, antimycin and cyanide 
induced similar changes in all three Ikv parameters. Antimycin-induced effects (the 
most pronounced) were studied in detail. It was found that these effects 1) cannot be 
entirely explained by changes in cellular redox state, 2) are mimicked by the ATP 
synthase inhibitor oligomycin, 3) were significantly inhibited by cell dialysis with 5 
mM Na2ATP, EDTA or with increased, 5 (instead of 0.5) mM, MgCl2, whereas 
intracellular MgATP partially reversed this effect and 4) both CCCP and antimycin
94-caused a significant increase in Mg i. Collectively, these findings suggest the presence 
of a novel mitochondrial-mediated Mg j-dependent mechanism in the regulation of Kv 
channels in PASMCs.
3.2.1 Variability in Ikvparameters
A wide variation in the absolute Va and Vh values under control conditions existed in 
PASMCs which was consistent with a normalised distribution. Variability may be 
representative of different populations of cells present. Differences in the intracellular 
micro-environment close to the Kv channel mouth (e.g. variations in local divalent 
cation concentration (Gelband et al., 1993), different heteromultimeric composition, 
and/or the presence of multiple Kv channel isoforms (Davies & Kozlowski, 2001; 
Archer et ah, 1998)) in PASMCs could potentially contribute to such variability. It is 
noteworthy, however, that histogram analysis of Va and Vh showed a normal Gaussian 
distribution of the parameters (Fig. 3.4 A&B), arguing against the presence of separate 
sub-types of PASMCs expressing different types of Ikv with distinctive voltage- 
dependent characteristics as has previously been demonstrated in conduit PAs (Smimov 
et ah, 2002). Also, in contrast to conduit PASMCs (Smimov et ah, 2002), no correlation 
between the maximal Ikv amplitude and the cell membrane capacitance was observed 
(Fig. 3.3 C). Similarly, no correlation was found between the cell size and Va (Fig. 3.4
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D). Thus, this analysis strongly supports the presence of a relatively homogenous 
population of the whole-cell Ikv in small PASMCs.
3.2.2 Specificity o f the effects o f mitochondrial inhibitors
It has been demonstrated that other specific protein kinase inhibitors can directly affect 
Kv channels in PASMCs (Smimov & Aaronson, 1996). It was therefore important to 
show that the mETC inhibitors act via modulation of the mitochondrial function and not 
directly on Ikv- Although a reversal of the effects of inhibitors was not possible to 
assess under my experimental conditions (designed to study their action at equilibrium) 
full reversibility of the inhibitor-mediated inhibition of Ikv has been previously 
demonstrated during acute application of higher concentrations of inhibitors in this cell 
type (Yuan et al., 1996; Yuan et al., 1995). Furthermore, the usage of relatively low 
concentrations of mitochondrial inhibitors (1-2 pM) in this study ensured minimisation 
of possible non-specific actions. Importantly, the inhibition of antimycin-mediated 
changes in Ikv by CCCP and by the proximal mETC inhibitors, rotenone and 
myxothiazol strongly suggest that the inhibitor-mediated effects on Ikv are due to 
modulation of mitochondrial function. It is interesting to note that CCCP had no 
significant effect on the rotenone induced shift in both Ikv activation and inactivation. 
In addition, the lack of attenuation of the rotenone induced shifts in Ikv by cellular 
dialysis with Na succinate, acting as a substrate for mETC complex II, suggests either 
towards a non mETC specific effect of rotenone on Ikv in PASMCs, or to other yet 
unknown factors which may influence its specific action on complex I. Nevertheless, 
the direct effect of inhibitors particularly at the prolonged depolarisations, cannot be 
excluded.
Conversely, the absence of such correlation for antimycin-induced effects strongly 
suggests that the inactivation-dependent effect is masked by another process which is 
likely to represent an open channel block. In favour of this, the peak Ikv amplitude 
during Vc did not reduce much suggesting that the channel has to be opened first. 
Correlation between the inhibition of the oligomycin-mediated acceleration in the 
current decay and the shift in Va by cell dialysis with Na2ATP suggests that the effect of 
oligomycin on Ikv kinetics is predominantly due to changes in channel inactivation.
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This effect of antimycin resembles the direct block of Kv channels by specific protein 
kinase inhibitors staurosporine (Park et a l, 2005) and bisindolylmaleimide (Choi et a l, 
2000). It is also worth noting that antimycin did induce a similar block independent of 
the conditions. An inhibitor-mediated open channel block however is unlikely to 
significantly interfere with measurements of Ikv activation, since it develops over much 
longer membrane depolarisations than those used for the activation protocol. Due to 
difficulties in separation of mitochondria-mediated changes in Ikv inactivation from a 
non-specific Ikv block by inhibitors, changes in the non-inactivating Ikv component are 
difficult to interpret.
3.2.3 Role o f AWm
Incubation of PASMCs with the mitochondrial uncoupler CCCP, which should 
significantly reduce ATm, caused a significant effect on all three measured 
characteristics of Ikv; Va, Vh and Ikv(50) block (Fig 3.5). These effects of CCCP were 
mimicked by rotenone, myxothiazol (on activation only), antimycin and cyanide, 
inhibitors of the mETC complexes I, III and IV, respectively (Fig.3.6). Since ATm is 
predominantly maintained by the activity of the mETC complexes I, III and IV which 
create an electrochemical proton gradient (Ap) across the inner mitochondrial 
membrane, it is likely that inhibitor-induced decreases in Ap  and thus in ATm are 
primarily responsible for their effects on Ikv. The ability of CCCP and the proximal 
mETC inhibitors rotenone and myxothiazol to block the antimycin-dependent relative 
shifts in activation and inactivation (Fig. 3.7) strongly supports this conclusion. 
Furthermore, depolarisation induced by antimycin and CCCP reflects that observed in 
response to 4-AP (Yuan, 1995), a known blocker of Kv channels in PASMCs.
ATm and Ap provide the electrochemical driving force for three fundamental cellular 
processes, ROS generation by mETC complexes I and III, ATP synthesis by complex V 
(ATP synthase) and ion transport across the inner mitochondrial membrane (the latter is 
crucial for maintenance of mitochondrial integrity and regulation of mitochondrial 
function). Therefore, mETC inhibitor-induced changes in ATm are likely to affect any 
of these processes alone or in combination. It is highly possible that inhibition of the 
mETC by antimycin would increase ROS production by this complex due to its increase 
in the lifetime of the electron donor, ubisemiquinone (Turrens et al., 1985).
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3.2.4 Role o f ROS
Antimycin acts at complex III, which is the main proposed site of electron leak and 
ROS production in the mETC (Chen et al., 2003). A putative involvement of ROS was 
therefore assessed using variety of experimental approaches. It was found that 1) 
extracellular H2O2 mimicked the effect of the mETC inhibitors only on activation, and 
failed to attenuate the antimycin-induced effects on AVa and AVh in dialysed PASMCs, 
2) cell dialysis with GSH alone had an effect on the Ikv activation, but not inactivation, 
and significantly reduced the antimycin-induced changes in A V a and A V h , 3) in dialysed 
cells H2O2 had no effect upon cell resting membrane potential, 4) in non-dialysed 
PASMCs neither H2O2 nor menadione had significant effect on Ikv activation and 
preliminary data also indicates no effect upon resting membrane potential.
Overall, these results demonstrate that Ikv activation is more susceptible to the changes 
in cellular redox state than Ikv inactivation is. The H2 0 2 -mediated leftward shift in Ikv 
activation should lead to an increase in the Kv channel activity in the physiological 
range of membrane voltages, as previously proposed (Archer et al., 1993; Michelakis et 
al., 2004). However, a similar shift in cells dialysed with GSH (which should increase 
the reduced state of Kv channels) and failure of H2O2 to alter the antimycin-dependent 
effects argue against the direct involvement of H2O2 in Ikv modulation by the 
mitochondrial inhibitors. Furthermore, the lack of the effect of H2O2 and the pro­
oxidant menadione (10-100 pM) on IKv activation in non-dialysed PASMCs (Fig. 4.5) 
suggests the presence of effective anti-oxidant mechanisms in intact PASMCs (Smith et 
al., 2005).
Additionally, this data only adds to the current controversies regarding the regulation of 
ROS in hypoxia and does not divulge a putative role for ROS in the regulation of Ikv in 
PASMCs. Contribution of neither a decrease nor an increase (debated extensively in 
Ward et al., 2006) in mitochondrial derived ROS in the regulation of Ikv is fully 
supported by the data in this chapter. An increase in ROS acting on Kv channels is 
implicated in the whole cell recordings; however in intact cells this is not evident. 
Nevertheless, increasing cellular redox state through dialysis with ImM GSH does 
modulate Ikv directly and attenuate the effects of antimycin, mainly on activation. A 
predominant role for mitochondrial derived ROS in the regulation of Ikv may not be
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supported, however changes in the Ikv activation do occur in the presence of increased 
ROS and, therefore, there is an involvement of ROS in Kv channel regulation in 
PASMCs (Fig. 3.7 & 3.9-10). Changes in intracellular ROS are not easy to confirm 
because dyes such as dichlorofluorescein (DCF), luminol and lucigenin are generally 
deemed as unreliable fluorescent indicators of ROS, for example they may detect 
extracellular NADPH oxidise induced ROS instead of intracellular changes (Wolin et 
al., 2005). However a, perhaps more reliable, FRET-based intracellular sensor has 
recently shown a hypoxia induced increase in ROS (Guzy et a l , 2005). This increase in 
ROS is unlikely to act directly on Kv channels, but may influence their activity or 
expression indirectly via increasing ET-1 (Wang et a l, 2006) or stabilising HIF-la 
(BelAiba et a l, 2004; Mansfield et a l, 2005; Chandel et a l, 2000).
3.2.5 Role o f  FqF i ATP Synthase
As changes in ROS cannot solely account for the changes in the mitochondrial 
dependent regulation of Ikv in PASMCs then it is possible that, by changing the proton 
gradient and ATm, the FoFi ATP synthase activity may be altered. Selective inhibition 
of ATP synthase with oligomycin affected Ikv similarly to other mitochondrial 
inhibitors in spite of the fact that their effect on mETC electron flow is different. CCCP 
increases electron transport by increasing the permeability to H+, uncoupling OXPHOS 
at ATm >140mV and driving electron flow (Kadenbach, 2003) and mETC inhibitors 
block the transport of electrons to more distal ETC complexes. A block of the ATP 
synthase, however, has no direct effect on the electron flow but may indirectly alter it 
due to an increased H+ gradient (Andersson et a l, 1987). In addition, a reversal of the 
ATP synthase block by intracellular dialysis with Na2ATP (Fig. 3.12 G&H) implies that 
changes in ATP levels are important in mitochondria-dependent regulation of Ikv- 
Conversely, the lack of a complete reversal of the oligomycin-induced effects by the 
inhibition of the mETC with antimycin suggests that they might act synergistically. The 
experimental data presented here does not allow this question to be directly answered. 
It is, however, entirely possible that antimycin would be expected to reduce the 
synthesis of ATP and, through reversal of the ATP synthase, accelerate its consumption 
secondary to mitochondrial depolarization. On the other hand oligomycin, by binding 
to the ATP synthase blocking the proton channel, has no direct effect on the electron 
chemiosmotic gradient and thus has no effect on state 4 respiration. Although the exact
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to the ATP synthase blocking the proton channel, has no direct effect on the electron 
chemiosmotic gradient and thus has no effect on state 4 respiration. Although the exact 
mechanism is still unclear, a switch from state 3 (active respiration utilising substrate 
ADP) to state 4 (controlled after an increase in conversion of ADP to ATP) respiration 
as a result of intracellular ATP being elevated (Nicholls, 2004) might be responsible for 
a combined effect of the inhibitors. Such effects on mitochondrial ATP levels/synthesis 
have additionally been proposed to possibly alter the production of an unknown 
signalling molecule in rat carotid body type 1 cells which is involved in the regulation of 
ion channel function (TASK channels in this particular investigation) (Wyatt & Buckler,
2004).
2H"3.2.6 Mg i as a mitochondrial mediator
The ATP-dependence of the oligomycin-induced shifts in both Ikv activation and 
inactivation might indicate the involvement of a phosphorylation-mediated process as 
the end point of the mitochondria-mediated regulation of the Kv channels. However, my 
findings in this and previous chapters, showing that: i) Na2ATP has a greater ability to 
reverse the effect of antimycin on Ikv activation and Ikv(50) block compared to MgATP,
sj I
ii) EDTA, a more potent chelator of Mg than EGTA, inhibits of antimycin-induced
9-1-effects on Ikv voltage dependent characteristics iii) elevation of Mg i (Fig. 3.16), 
significant attenuates the antimycin induced effects and iv) CCCP and antimycin
94-significantly increase Mg i (Fig. 3.15), strongly suggest that mitochondria-mediated
9 .
changes in Mg i play a pivotal role in the regulation of Kv channels in PASMCs, 
possibly in addition and/or subsequent to changes in the ATP/ADP ratio. Additionally, 
in PSS, both Na2ATP and EDTA strongly buffering Mg2+i shifted Va to more positive 
potentials (-9.6±1.6 mV, n=21, /K0.0006 and -8.1±1 mV, n=22, p<0.002, respectively) 
and shifted Vh to more positive potentials (only significant for Na2ATP, Table 3.8); the
9 .
significant negative shift in Vh when Mg is elevated (Fig. 3.16) is also supportive.
94-A lack of effect of increased Mg alone on Va may either indicate that the control (0.5
94-mM M gC y was sufficient Mg i to maximise effects on Ikv or that 5 mM MgCl2 was
94-insufficient to change Mg j or that there may be an additional factor which contributes
9  I
to modulation of Ikv activation, but is suppressed in high Mg . This factor could be of 
mitochondrial origin (e.g. ROS or ATP production) or represent an unknown cellular
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intermediate. There is very little known in the pulmonary circulation regarding
•ji
intracellular Mg regulation, however, the conclusions above are supported by the 
observations of the effect of mitochondrial depolarisation or inhibition of oxidative
94-phosphorylation on Mg i in cardiac myocytes (Leyssens et a l , 1996) and in PC 12 cells
9-4-(Kubota et al., 2005). In particular, both studies surmised an increase in [Mg ]j in
9 .
response to FCCP to be associated with the release of Mg i following ATP hydrolysis 
by the mitochondrial FiFo-ATPase. Importantly, with respect to Kv channels, Tammaro 
et al (2005) have also shown increases in MgCl2 in the pipette solution significantly 
shifted the activation of Kvl.5 and Kv2.1 channels (known to be expressed in PASMCs 
and potentially involved in HPV, (Archer et a l , 1998; Hogg et a l , 2002; Pozeg et a l , 
2003), expressed in Xenopus oocytes, to more negative potentials (Tammaro et a l ,
2005).
9  i
Changes in Ca i, which would also occur under these conditions (Fig. 3.18) (Kubota et 
a l , 2005; Wyatt & Buckler, 2004), are unlikely to contribute to the observed effects
94-because: 1) data were obtained from cells where free [Ca ]i was strongly buffered with
94-EGTA (~10 nM); 2) cell dialysis with 220 nM Ca alone caused a significant rightward 
shift in IKv activation, opposite to that caused by the mitochondrial inhibitors.
The results presented so far provide, for the first time, evidence for the existence of a 
novel mitochondria-dependent mechanism of Kv channel regulation, occurring via local
O j
changes in Mg * homeostasis. This hypothesis is summarised in Fig 3.19. As shown in
94-this figure a primary factor influencing Mg i is the change in the ATm upon inhibition 
of the mETC leading to local changes in the ATP-to-ADP ratio. Furthermore, reduction
9 .
in ATm itself would reduce the electrophoretic diffusion force which drives Mg i into
94-mitochondria causing a further increase in [Mg ]i. Resulting increases in the local
94-concentration of Mg ions are known to act on Kv channels changing their voltage-
94-dependency (Tammaro et a l , 2004; Lopatin & Nichols, 1994). Additionally, Mg can 
directly block Kv channels by interfering with K+ efflux from the cytosol (Tammaro et 
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Figure 3.19 Hypothetical mechanism of mitochondrial-mediated regulation of Kv 
channels in PASMCs. Sites of action of inhibitors and reagents used in this study are 
shown in grey. Dashed lines indicate possible, yet to be confirmed, ways of interaction.
Influenced by both cellular redox state and by the ATP-to-ADP ratio this mechanism 
might serve as an important link between redox state (Archer et al., 1993) Kv channels 
(Michelakis et al., 2004) and ATP-dependent phosphorylation (Yuan et a l , 1995). 
Although, a direct affect of ROS on Kv channels unlikely under physiological 
conditions, the results with GSH could indicate an indirect modulatory role. The 
current findings do not allow for this to be completely answered, however, increased 
ROS production at complex III in the presence of antimycin, which leads to rapid ATm 
reduction, ATP depletion and rigor contraction of cardiac myocytes, could be one 
possible explanation (Hudman et al., 2002). If this occurs in PASMCs, it could lead to 
a greater increase in Mg2+i and might be responsible for a greater effect of antimycin 
than that of other mETC inhibitors (Fig. 3.2) and its attenuation in the presence of GSH 
(Fig. 3.7).
Additive effects o f antimycin and oligomycin (Fig. 3.13) and significant differences 
between the control antimycin-mediated effects and those in cells dialysed with MgATP
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(Fig. 3.14) do not rule out a potential involvement of phosphorylation or 
dephosphorylation mediated process in Ikv modulation as previously suggested (Yuan et 
al., 1995). A simple mechanism could involve a direct phosphorylation of the channel 
protein causing changes in the number of negative surface charges, thus leading to the
94-alteration of static Mg interactions and thus Kv channel gating (Perozo & Bezanilla, 
1990). Conversely, more complex interactions involving the actin cytoskeleton 
organization also cannot be excluded and has been demonstrated for the Kvl.5 channels 
in Xenopus laevis oocytes (Mason et al., 2002). An alternative possibility is that
o  I
antimycin and oligomycin could influence Mg \ via different pathways. Antimycin 
could impose a stronger influence over A'Fm and the, non-specified, uptake and release
o  I
mechanisms of Mg by the mitochondria, oligomycin could exert a stronger influence 
over ATP hydrolysis, decreasing ATP-to-ADP ratio and thus decreasing the binding 
affinity for Mg2+ (Leyssens et al., 1996).
94-Despite the substantial evidence presented here favouring an involvement of Mg i it is
9  i
not possible to determine the exact contribution of ATP and Mg i to the changes in Ikv 
as modulation of the concentrations of these components in the vicinity of the channels 
is not easily achievable. It has been previously proposed a limited diffusion space exists 
close to Kv channels in PASMCs (Smimov & Aaronson, 1994). Complete inhibition of 
the H2O2 mediated shifts in Ikv by cell dialysis with GSH and a significant attenuation 
of the antimycin induced shifts by EDTA and GSH suggests that in the dialysed cells 
this compartment is relatively well controlled under conditions when the pipette 
solution is equilibrated with the cell interior. It is possible that there may be either an 
under or over estimation of the potential effects on Ikv, as seen with the perforated patch 
technique with maintained cellular integrity, where a significant decrease in the effects 
of antimycin was evident, compared to those in WC recordings.
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Chapter 4
EFFECT OF HYPOXIA ON I k v  ACTIVATION AND INTRACELLULAR Mg2+ 
IN PASMCS
4.1 Introduction
Kv channels have been proposed to have an important, yet controversial, physiological 
role in the cellular response to hypoxia. Despite being proposed to be molecular 
correlates for O2 sensing in PASMCs (Lopez-Bameo, 1994) it is more generally 
accepted that their function in altered by a factor stimulated by hypoxia causing
9+inhibition of the channel, membrane depolarisation and subsequent Ca entry through 
L-type VDCC. Kv channel inhibition was proposed reflecting data that showed a 
decreased Ikv amplitude and membrane depolarisation in response to acute hypoxia in 
both rat and mouse PASMCs (Archer et al., 1993; Archer et al., 2001; Yuan et al., 
1993; Turner & Kozlowski, 1997; Archer et al., 2004). Additionally, effects on 
amplitude were often only compared at more positive potentials, outside a physiological 
range, and therefore investigating the kinetics and parameters of channel activation and 
inactivation may provide a more accurate picture of Kv channel regulation in PASMC 
during hypoxia. For these reasons, the effects of acute (25-40 mmHg) hypoxia was 
investigated on the channel characteristics and comparisons were made to those 
observed for mitochondrial inhibition described in the previous chapter.
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4.2 Results
4.2.1 Measurements o f hypoxia levels in the electrophysiological recording chamber
Due to the small size of the experimental chamber (100-200 pi) it was not possible to 
simultaneously measure changes in O2 level and current recordings. Therefore, the level 
of hypoxia was measured separately using an ISO2 oxygen meter (WPI Incorporation, 
USA) under the same conditions as for electrophysiological recordings. A mean level of 
hypoxia of 30±3 mm Hg (n=6, with variation ranging from 22 and 40 mm Hg) was 
achieved 5 min after the perfusion (~1 ml/min) of the recording chamber with PSS 
saturated with 100% N2 (Fig. 4.1). The control PSS was bubbled with air.
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Figure 4.1. Oxygen level changes in the electrophysiological recording chamber during 
hypoxia. Each symbol represents the mean of 6 separate measurements. The position of 
the oxygen electrode, the perfusion tube and the suction outlet was altered during each 
measurement to account for possible variations in O2 levels during electrophysiological 
recordings.
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4.2.2 Effect o f acute hypoxia on Ikv activation in intact PASMCs
To address a potential relevance of the mitochondrial dependent changes in Ikv to HPV 
and its specificity to PASMCs, Ikv activation was compared during acute hypoxia in 
non-dialysed PASMCs and MASMCs. Hypoxia caused a significant enhancement in 
IKv in PASMCs at negative potentials (Fig. 4.2 A) associated with a significant leftward 
shift in the activation dependency in PASMCs, but not in MASMCs (Fig. 4.2 B). 
Additionally, a significant increase in the dependency of the steady state activation was 
observed only in PASMCs shifting it from 8.7+0.8 mV to 7.4+0.6 mV (n=6 , ;?<0.018) 
reflecting changes observed for antimycin in intact cells (Fig. 3.6). The effect on the 
peak IKv amplitude was not significant in either tissue at this level of hypoxia at any 
membrane potential (Table 4.1).
It is noteworthy that, although the data does not show a significant hypoxia-mediated 
inhibition of the peak Kv current as other researchers have suggested (Post et a l, 1992; 
Hogg et al., 2002; Archer et al., 2004), if the block is calculated at the end of pulse to 
+50 mV a small 8 .4+7.1 % (n=6 ) but significant (p<0.05, one-tail t-test) decrease was 
observed. Also, to monitor the cell state and the development of the effect, the ramp 
protocol was applied every 20 sec between recording the I-Vs with the step protocol. 
By ramping the voltage between -100 and +100 mV a wider voltage range was used to 
measure the tail currents. Analysis of the ramp data demonstrated both significant 
activation of the Ikv in the negative voltage range and a small (5-8 %) but significant 
(0.02<p<0.05, paired two-tailed Mest) hypoxia inhibition of the whole cell Kv current 
between +45 and +100 mV in 12 cells studied. The difference in the cell number is 
because some cells died before the recording of the second I-V was completed. 
Importantly, inhibition of the current was only obvious at positive, non-physiological, 
membrane potentials and, although it may help to elucidate the mechanisms involved, it 
is unlikely to have a major impact on cell excitability under these conditions.
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TABLE 4.1. Effect of hypoxia on IKv activation recorded in perforated-patch mode in PASMCs and MASMCs arterial smooth muscle cells.
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Fig 4.2 Comparison of the effect of acute hypoxia on Ikv I-Vs (A) and AVa (B) in 
PASMCs and MASMCs. All experiments were performed in the perforated-patch 
mode.
4.2.3 Hypoxia causes an increase in free Mg2+t
The results described in chapter 3 strongly suggest that Mg2+j is involved in the 
regulation of Ikv- Currently, Ca2+j has been shown to be elevated in hypoxia, however, 
direct measurements of changes in Mg2+i during hypoxia have not been performed in 
PASMCs. Mg2+ has been measured in hepatocytes where it increased from 0.63±0.05 
to 1.42±0.11 mM during hypoxia (Brecht & De Groot, 1994). Furthermore, increase in 
Ca2+i and Mg2+j in response to mitochondrial inhibition has previously been 
demonstrated in cardiac myocytes (Leyssens et al., 1996), but not in pulmonary arteries. 
Therefore, the effect of hypoxia was investigated in intact PAs and PASMCs loaded
^  i
with Mg -sensitive dye, MagFluo-4-AM.
A 20 min exposure of whole PAs to hypoxia (25-40 mmHg) caused a significant
A*
increase in free Mg i which reaches its peak within 4-5 min and then slowly recovers
_ 0-4-
following re-oxygenation (Fig. 4.3 A). The specificity of Mg * measurement with 
MagFluo-4-AM was confirmed by the lack of response to 80 mM KC1 (Fig. 4.3 B), that
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Figure 4.3. Hypoxia-induced increase in free Mg j (n=7) (A). (B) Lack of effect of 
KCI on Mg2+i (n=13). (A) and (B) were measured in endothelium-denuded whole PAs 
in the presence o f 10 pM wortmannin. Intensities were normalised to the peak 
MagFluo-4 fluorescence measured in A23187 and compared using paired /-test. Dr. 
Kathryn Yuill contributed to this figure.
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4.3 Discussion
4.3.1 Effect o f hypoxia on Ikv activation
The main observation in this chapter was that hypoxia causes activation of Ikv at 
negative membrane potentials in intact PASMCs. This effect was not observed in 
MASMCs. Although this observation is apparently against the current opinion that 
hypoxia should inhibit Kv channels, activation of the whole cell K+ currents by hypoxia 
was previously observed in canine (Post et al., 1992) and rat (Archer et al., 2004) 
PASMCs. This was, however, ignored and not discussed by the researchers.
The similarity between the effects of hypoxia on Ikv activation to that of antimycin, as 
discussed in chapter 3, may reflect a mitochondrial dependent component serving a 
protective role in the response of PASMCs to the early stages of the detection of 
hypoxia. It is therefore entirely possible that the observations of cell depolarisation in 
response to hypoxia reported previously (Archer et al., 1998) could initially be induced 
by another mechanism such as inhibition of TASK channels (observed in rat PAs 
(Gurney & Joshi, 2006), human PAs (Olschewski et al., 2006) and rat carotid body type 
1 cells (Wyatt & Buckler, 2004)) and/or Ca2+ entry via activation of SOCC and ROCC 
channels, for which the molecular correlates are proposed to be TRP channels 
(Kunichika et al., 2004). Additionally, inhibition of Ikv amplitude may occur once the 
cell becomes more depolarised enhancing, rather than initiating depolarisation and 
contraction, which may explain the initial lack of effect of hypoxia on Kvl .5 channels 
(Archer et a l, 1998) and why only poor attenuation of HPV in whole lung preparations 
after treatment with 5 mM 4-aminopyridine and 10 mM TEA was seen (Hasunuma et 
al., 1991). Increased Ca can cause activation of Ca activated chloride channels also 
causing membrane depolarisation (Pacaud et al., 1989). Additionally, at P0 2  of 60-80 
mmHg there is a lack of depolarisation and Kv channel inhibition (Olschewski et al.,
^  I
2002), though HPV is still triggered. The proposed role of M g * in the regulation of Kv 
channels by hypoxia is further supported by hypoxia-induced increases in M g * in 
intact arteries. This is the first observation of this kind in the PA, although it has 
previously been demonstrated in hepatocytes (Brecht & De Groot, 1994; Gasbarrini et 
al., 1992) and cardiac myocytes (Silverman et al., 1994) that anoxia also causes 
increased M g2+i.
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4.3.2. Effect o f hypoxia on Ikv block
Interestingly, 20-40 mmHg used in these experiments did not cause a decrease in Ikv 
amplitude as previously observed by other groups (Archer et al., 2004; Hogg et al., 
2002; Yuan et al., 1993; Turner & Kozlowski, 1997; Archer et al., 1996). In fact, a 
significant inhibition of the whole-cell K+ currents in rat PASMCs over the negative 
range of membrane potentials was actually only reported by two groups, Hogg et al., 
(2002) and Olschewski et al., (2002). The majority of workers, who originally studied 
the effect of acute hypoxia on the whole-cell K+ currents in both rat and mouse 
PASMCs (Archer et al., 1993; Archer et al., 2001; Archer et al., 2004), have observed a 
significant inhibition only at membrane potentials positive +50 mV (the most positive 
membrane potential we have used in our study), whilst Patel et al., (1997) reported the 
inhibitory effect of hypoxia only at +30 mV in cultured PASMCs, but failed to mention 
whether the effects were significant. Notably, Turner & Kozlowski, (1997), who did 
show a decrease of the current by hypoxia (20-30 mmHg) in PASMCs over the same 
range of membrane potentials, did not report any significance of the effect in either 
dialysed or non-dialysed cells. Therefore, the data presented in this chapter does not 
principally contradict the majority of the reports where the effect on the whole cell K+ 
current was studied.
Differences may be due to the use of different experimental conditions; for example 
whole cell versus perforated patch. In general, experiments using the whole cell patch 
clamp technique observed greater inhibition of Ikv (50-70 %), (Archer et al., 2004; 
Hogg et al., 2002). Additionally, a differential expression of Kv channel subtypes may 
affect the response to hypoxia; expression studies of Kv subunits, known to be 
expressed in PASMCs, in mouse L cells have shown that homomeric channels Kvl .2 
and Kv2.1, but not K vl.5 are reversibly inhibited by hypoxia; heteromeric channels 
composed of Kvl.2/Kvl.5 and Kv2.1/Kv9.3 are O2 sensitive and reversibly inhibited by 
hypoxia in the physiological voltage range (Hulme et al., 1999). It is worth noting that 
a recently reported finding that overexpression of the Kvl .5 a-subunit, one of the main 
components of the Kv channel in PASMCs, induced a hypoxia-sensitive Kv current 
only when the same channel was overexpressed in pulmonary, but not mesenteric 
arterial SMCs or HEK-293 or COS-7 cell lines (Platoshyn et al., 2006), suggesting that 
hypoxia-sensitivity of Kv channels may be cell specific and not subunit-type specific.
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Chapter 5
MITOCHONDRIAL DEPENDENT REGULATION OF I k v  IN MASMCS
5.1 Mesenteric circulation and hypoxia
In the early 1990s researchers, using mesenteric arteries directly compared the effects 
of hypoxia in systemic and pulmonary circulation in an attempt to try to elucidate the 
complex mechanisms involved in the phenomenon of HPV. In contrast to pulmonary 
circulation, no increase in artery tension (Yuan et al., 1990) alongside a decrease in 
arterial pressure and increase in vascular conductance was observed in mesenteric 
arteries in response to hypoxic exposure (Langdown & Marshall, 1995). However, a 
transient and small initial contraction was observed in some experiments (Leach et a l , 
1994). Additionally, hypoxia failed to attenuate Ikv and caused little or no 
depolarisation in isolated MASMCs (Yuan et a l , 1993a). Figure 7.1, reproduced with 
kind permission of Prof. J.P. Ward, shows a typical example of the differences 
observed in the two phase response to hypoxia in PA and MAs (Leach et a l, 1994). 
A brief and much smaller contraction is initially observed followed by a sustained 
relaxation of MA pre-constricted with prostaglandin F2Q (PGF2a). It was therefore 
concluded that different mechanisms must exist in response to hypoxia that are 
inherent to particular smooth muscle types. With respect to Kv channels this 
conclusion was recently supported by the observation that the hypoxic sensitivity of 
the K vl.5 channel is only seen in PAs and not in MAs (Platoshyn et a l, 2006).
As such tissue specificity exists to hypoxia it is therefore physiologically important to
o  I
determine if the postulated mechanism of mitochondrial mediated increased Mg i in 
the regulation of Ikv is specific to the pulmonary circulation. Comparisons were 
therefore made for the effects of mETC inhibitors, ROS and ATP on Ikv using cells 
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Fig 5.1 Different responses to hypoxia in pulmonary and mesenteric, large and small 
arteries. Pre-constriction with 10 pM PGF2 tt followed by 50 minutes hypoxia in (A) 




The effects of H2O2, mitochondrial uncoupler CCCP and inhibitors antimycin and 
oligomycin, targeting the most pronounced effects in the PASMCs were compared in 
the MASMCs to assess the specificity of the mitochondrial dependent mechanism to 
the pulmonary circulation.
5.2.1 Effect o f external H2 O2
Similar to PAMSCs, 300 pM H2O2 was used to decrease intracellular redox state. In 
MASMCs, H2O2 caused a significant shift to more negative potentials in both the 
activation and inactivation dependencies. Notably the shift in activation was 5.2 mV 
larger than that in PASMCs with AVa = -10.3+3.8 mV,p<0.05 and, more importantly 
V h  also shifted significantly with A V h  = -5.2±1.8 mV, p<0.04 (Fig. 5.2 A, B&D). 
Also, unlike in PASMCs no significant effect on the current amplitude was observed 
(Fig. 5.2 C).
5.2.2 Effect o f  mitochondrial uncoupling and mETC Inhibition on Ikv
Incubation of MASMCs with 2  pM CCCP caused a parallel leftward shift in both Ikv 
activation ( A V a= - 9 . 9 ± 3  m V ,  n=8 , ^ < 0 . 0 2 )  and inactivation ( A V h = - 5 . 9 ± 1 . 4  m V ,  n=8 , 
/ ? < 0 . 0 0 4 )  dependencies (Fig. 5 . 3 ) .  No effect was observed on A*, but Ah decreased 
from 8 . 5 ± 0 . 6  m V  to 7 . 1 ± 0 . 4  m V  (n=8 , p<0.03). A small but significant Ikv peak 
inhibition was also observed at + 5 0  m V  ( 1 3 . 6 + 4 . 5  %, n=8 , p<0.02, Fig. 5 .3  C). No 
acceleration of the current decay (shown in traces in Fig. 5 .3  A&D) and therefore no 
significant effects upon the non-inactivating component were observed. These 
results, despite some differences, show that generally mitochondrial uncoupling also 
affects Ikv in MASMCs in a similar way to those in PASMCs. Therefore, to 
investigate if any specific differences are observed between the two cell types the 
effects of complex III and ATP synthase inhibition by antimycin and oligomycin were 













Figure 5.2. Effect of H2O2 on MASMCs. (A&B) Normalised average IKv activation 
and inactivation curves in the presence and absence of 300 pM H2O2. Cells were 
equilibrated for 5 minutes in H2O2 prior to recording. The dotted lines indicate Va (A) 
and Vh (B). (C) Comparison of H2C>2-induced changes in the peak Ikv measured from 
a single exponential fit of the current activation at each Vm. (D) AVa and AVh for 
H2O2 in MASMCs.
As antimycin gave the most pronounced effects in PASMCs and was used for all 
subsequent studies, its effects were also compared in MASMCs. A significant effects 
on both activation and inactivation dependencies was still observed, with AVa = - 
8±2.5 mV (n=12, /?<0.008) and AVh = -4.6±1.6 mV, (n=9, p<0.02); however the 
effect of inactivation was significantly smaller than that observed for the PASMCs 
(p<0.0007, see Fig. 5.4 A). An equivalent decrease in Ikv block for antimycin to that 
in PASMCs was observed (32.9±5.3 %, n=12, /?<0.002). Nevertheless, no effect
O  C o n t r o l  
♦  3 0 0  11M H O
A  C o n t r o l  
A  3 0 0  p M  H  O
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upon the slope of the steady state activation or inactivation dependencies nor the non­
inactivating component was observed in MASMCs (Fig 5.4 C). In addition the non­
inactivating component was significantly smaller under control conditions in 
MASMCs (Fig. 5.4 B) when compared to the larger non-inactivating component 
observed in PASMCs.
C o n tro l 2 mM CCCP AV(
— ^ - C o n t r o l
2 mM CCCP
C o n tro l
C on tro l 2 »M C CCP AV
O  C o n tro l 
♦  2 uM C CCP
C on tro l
Figure 5.3. Effect of mitochondrial uncoupling with CCCP. A-C, Modulation of Ikv 
activation. (A) Voltage protocol and original current traces recorded 5 min after pre­
incubation of MASMCs with the mitochondrial uncoupler CCCP (2 pM). Note an 
enhancement of Ikv amplitude at negative membrane potentials (compare the Ikv 
traces at -30 mV shown in grey in panel A). (B) Comparison of CCCP-induced 
changes in the peak Ikv measured from a single exponential fit of the current 
activation at each Vm, and normalised tail currents (upper and lower panel 
respectively). (C) The mean absolute (Va) and relative (AVa) changes in Ikv activation 
(the latter was subsequently used for comparison). D-F, Effect on Ikv inactivation. (D) 
Availability protocol and current traces recorded in the absence and presence of 
CCCP from a representative MASMC. (E) CCCP-induced changes in the normalised
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Ikv measured with the availability protocol. (F) The mean absolute (Vh) and relative 
(AVh) changes in Ikv inactivation. A and D were obtained from different cells with 
Cm=17.7 and 10.9 pF, respectively. Lines in B were drawn with Va= 3.3 and -11.1 mV 
(dashed lines) and ^=8.2 and 6.8 mV, for control and CCCP respectively. Lines in E 
were drawn with Vh=-37.6 and -43.2 mV (dashed lines) and 9.8 and 7.7 mV and 
the non-inactivating component equal to 0.16 and 0.15 in control and CCCP- 
containing solutions respectively.
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Figure 5.4. Comparison of the effects of antimycin on Ikv in rat PA and MA SMCs. 
(A) Changes in activation and inactivation for MASMCs (black) and PASMCs 
(dotted). Normalised average Ikv inactivation in PASMCs (B) and MASMCs (C). 
The dotted lines in (B) and (C) represent the absolute mean Va and Vh values in the 
presence and absence of antimycin.
5.2.3 Effect o f  oligomycin on Ikv in MASMCs
The inhibitor of ATP synthase oligomycin, which in PASMCs caused a shift 
comparable to that in antimycin, failed to significantly alter Ikv activation in 
MASMCs. The effect in MASMC was significantly smaller than that in PASMCs 
AVa = -3.6±3.6 mV (n=9, p<0.027, one tailed f-test to PASMC) (Fig 5.5 A&C). 
There was still, however, a significant reduction in Ikv amplitude of 30.8±4.1 %, n=9,
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/KO.Ol. Furthermore, this was significantly reduced in comparison to the PASMCs 
(p<0.01) (Fig. 5.5 C). Again, there was no effect upon the slope of the steady state 
inactivation dependency or the non-inactivating component (Fig. 5.5 B).
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Figure 5.5. Effect o f oligomycin on Ikv in MASMCs. (A&B) mean normalised 
activation and inactivation dependencies fitted to the Boltzmann equation. The dotted 
lines indicate the Va and Vh in the absence and presence of oligomycin (1 pM). (C) 
Relative changes in Va and Vh for MASMCs (black bars) and PASMCs (shown as 
dotted bars for comparison).
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TABLE 5.1. Effect of CCCP, antimycin, H2O2 and oligomycin on the voltage-dependent parameters of Ikv





















(p<0 .0 2 )
9.5±0.7
11.2±0.9 -6 .6±2 .2 13.6±4.5





























































0 .1±0 .0 2 -6.3±1.2
(p<0 .0 1 ) 8
9
Here and in subsequent Tables p  values show significant differences between the values measured in control conditions and in the presence of the tested 
inhibitor obtained in the same MASMCs (paired two-tail /-test) unless indicated otherwise.
8 represents significant difference in comparison to the same condition in PASMCs. 
b represents significance with a paired one-tail /-test.
5.3 Discussion
Although there were similarities, particularly with CCCP, the data in this chapter 
serves to highlight substantial differences in the mETC mediated regulation of Ikv. 
Such differences include: 1) H2O2 induced larger shifts in AVa and caused a 
significant negative shift in AVh in MASMCs (an effect not observed in PASMCs); 
2 ) antimycin had a much smaller effect on both parameters, with AVh being 
significantly reduced in comparison to PASMCs; 3) oligomycin had virtually no 
significant effect on the steady-state activation of Ikv in MASMCs, although a small 
shift in AVh, which was significantly smaller than that in PASMCs, was observed. 
Interestingly, the block of Ikv at +50mV observed in all conditions, except H2O2 in 
MASMCs, mimicked that observed in the PASMCs (Fig. 5.2).
In conclusion, although mETC inhibition caused an effect on Ikv, there are significant 
differences between the two preparations, indicating that either different mechanisms 
or a differential association between the mitochondria and Kv channels in MASMCs. 
In addition, there was a lack of the effect of hypoxia in MASMCs, described in 
chapter 4. Hypoxia has recently been shown to have little effect on 7kv in MASMCs 
in a study which suggested that differential expression of the Kvl .5 channel could 
account for the hypoxia-sensitive mechanism essential for inhibition of channel 
activity exclusively in PASMCs (Platoshyn et al., 2006).
Since a detailed investigation of the mechanism of mETC inhibitions has not been 
performed to the same degree as in PASMCs, it is difficult to comment on the 
mechanisms of the observed differences. Indeed, unpublished observations from our
94-lab indicate that the effects of Mg i on IkV2 in conduit PASMCs and on Ikv in aortic 
SMCs (both assumed to be Kv2.1 mediated currents) (Tammaro et a l , 2005; Smimov 
et al., 2 0 0 2 ) were also different, suggesting that possible variations in the channel 
structural organisation could be an important factor in determination of tissue
1
specificity of Mg i-mediated effects. A possible involvement of other channel 
subtypes is supported, though indirectly, by the lack of non-inactivation component in 
MASMCs under control conditions.
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The understanding of these differences between the Kv channel structure and Mg i 
represent an interesting and challenging task and remain to be fully elucidated using 
the approaches described in this thesis. Additionally, to assess the contribution of 
H2O2 to the mitochondrial dependent regulation of Ikv in MASMCs further 
experiments, reflecting those characterising the effect in PASMCs in chapter 3, are 




FUNCTIONAL RELEVANCE OF THE MITOCHONDRIAL DEPENDENT 
REGULATION OF Ikv-
6.1 Introduction
The processes of activation and inactivation of Ikv can be used to describe the 
dependence of the whole cell open probability of Kv channels on membrane potential 
(Leblanc et a l , 1994). Data can be compared by deriving “whole cell open channel 
probability” (whole cell PQ) as a product of the average Ikv activation and availability in 
each condition. The “window current” is represented by the area under the curves and 
defines the range of Vm where ion channels should always be open. Analysis of the 
“window currents” can be used to create predictive models illustrated in Fig. 6.1
Since mitochondrial inhibition affected Ikv in both cell types, although to a different 
degree, it is important to evaluate whether changes in the Ikv voltage dependent 
characteristics (with CCCP, antimycin, oligomycin or H2O2) observed in PASMCs 
would have the same impact on the theoretical window currents as in MASMCs.
In PASMCs the mitochondrial uncoupler, CCCP, had a dual effect on the predicted 
window currents. At membrane potentials negative to -20 mV there is a marked 
enhancement of the whole cell PG, whereas above this potential the whole cell PQ 
decreases (Fig. 6.1 A). However, in MASMCs, in the physiological range of membrane 
potentials there is an only an increase in whole cell P0 in the presence of CCCP (Fig 6.1 
B).
Antimycin and oligomycin mimicked the dual effects on whole cell PG that were 
predicted for CCCP in PASMCs (Fig. 6.1 C&E) Again, in MASMCs the predicted 
whole cell P0 for CCCP was mimicked by antimycin (Fig 6.1 D). With oligomycin a 
small reduction in whole cell P0 was predicted at membrane potentials above -30mV 
(Fig 6.1 F).
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Interestingly, H2O2 mimicked the effects of CCCP in both PA and MA SMCs. In 
PASMCs it had the most pronounced increase in P0 in the negative range of membrane 
potentials, at potentials above 0 mV there was some reduction in P0. The predicted 
window current for H2O2 in MASMCs show a relatively small reduction in the P0 for 
Kv channels below -50 mV, above this there is a predicted increase in P0 (Fig. 6.2).
This theoretical consideration, despite some similarity in the action of mETC inhibitors 
in PA and MA SMCs nevertheless suggest that the overall impact on Kv channels 
should be different in the physiological range of membrane potentials. It is therefore 
important to consider if  a mechanism involving a mitochondrial dependent regulation of 
IKv had effects upon the regulation of intact artery contractility, as would be predicted 
by the proposed theoretical window currents. From the predicted window currents it 
would be expected that that application of mETC inhibitors will increase the excitability 
of PAs when the cell membrane is depolarised above the resting potential of -30 mV. In 
MAs an increased excitability would be expected reflecting the predicted window 
currents.
Therefore, the effects of mETC inhibition with CCCP and antimycin and increased ROS 
were studied in intact small PAs with a particular focus on K+ dependent mechanisms. 
All the data presented thus far is precisely focussed on the regulation of Kv channel 
currents, it must be remembered that the situation is a whole artery is much more 
complex as other channels/exchangers are known to be present (see Chapter 1) and 
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Figure 6.1. Effect of mETC inhibitors on Kv channel window currents in PA and MA 
SMCs. Theoretical window currents for CCCP, antimycin and oligomycin in PASMCs 
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Figure 6.2. Effect of H2 O2 on Kv channel window currents in PA and MA SMCs (A) 




It is important to note that all experiments were carried out in pairs in a two vessel 
myograph where for each experiment one PA and one MA from the same rat were 
mounted, ensuring consistency of the data. The vessel internal diameters were routinely 
estimated for all vessels used in myograph experiments; the average vessel size was 
351.4±12 pm in PA (n=86) and 215.7±5.6 pm in MA (n=78). To assess the 
physiological significance of the mitochondrial dependent regulation of Ikv in PAs 
preliminary data was acquired looking at the effects of 1) uncoupling mitochondrial 
membrane potential with CCCP, 2) blocking the mETC distally with antimycin, and 3) 
increasing ROS levels with H2 O2 , either directly on vessel tone or on a DR to increasing 
K+ concentration (reflecting stepping changes in the membrane potential, predominantly 
via inhibition of K+ channels causing depolarisation).
6.2.1 Effect o f mitochondrial uncoupling on intact PA and MA
Uncoupling of the mitochondrial proton gradient using CCCP (2 pM, 10 minute 
exposure) caused an increase in vessel tone in only the PA, which was significantly 
larger then the effect in the MA {p<0.042) where there was no change in vessel tone 
observed (Fig. 6.3).
p < 0 . 0 4 2
2 j iM  C C C P
Figure 6.3. Effect of CCCP on intact PA and MA. Exposure o f PA and MA to 2 pM 
CCCP for 10 minutes, peak contraction obtained in the 10 minute period is shown.
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6.2.2 Effect o f extracellular Ca2+ on CCCP response in MA and PA
'y j
The dependence of the CCCP induced contraction on extracellular Ca was assessed in 
two experiments; one using 5 pM diltiazem to inhibit L-type VDCC and one in the 
presence of Ca free Krebs supplemented with 1 pM EGTA. In the PA, where CCCP 
induced an increase in vessel tone, diltiazem (5 pM) reduced the contraction by approx
I
50% (Fig. 6.4 A&B) and removal of extracellular Ca also reduced but did not prevent 
the contraction, supporting a component of depolarisation mediated contraction. 
Interestingly, in MA where CCCP itself did not cause contraction, removal of 
extracellular Ca2+ markedly increased the vessel tone; the addition of diltiazem had no 
obvious effects (Fig. 6.4 A).
co n t r o l  + Dilt + 0 Ca c o n t r o l  + Dilt + 0 Ca
MA n=3 PA n=3
80 mM K
D i l t
C C C P
C C C P  2 jiM Dilt 5 |iM
5 m in
Figure 6.4. Effect of extracellular Ca2+ entry on the CCCP induced contraction in MA 
and PA. (A) Response to 5 min incubation in CCCP (2 pM). MA are clear bars and PA 
are black bars. Experiments were carried out in control, with 5 pM diltiazem applied
i
after CCCP or pre-incubation for 10 minutes in Ca free Krebs solution. (B) 
Representative trace in PAs showing contraction to CCCP with subsequent application 
of diltiazem, the vessel had an internal diameter of 170 pm. Insert shows a 
representative trace for the paired MA, internal diameter 152 pm.
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6.2.3 Effect o f CCCP on dose response curves to K f and U46619
To further investigate a possible relevance of the observed effects of CCCP on K+ 
channels a cumulative DR to K+ in the absence and presence of the agent was 
constructed (equimolar replacement of NaCl for KCI, with final [K+] of 10, 20, 40. 80 
and 100 mM K+ applied at 5 minute intervals). Arteries were pre-incubated for 10 
minutes with CCCP. Fig. 6.5 shows representative traces comparing K+ DR curves, in 
the absence and presence of CCCP, in MA (A) and PA (B). Reflecting the decrease in 
maximal contraction, a significant leftward shift in the DR curve to K+ was observed for 
CCCP in PA ( E C 50 = 37.7±1.6 mM, control and 19.9±1 mM, in CCCP, n=3, p<0.009) 
(highlighted in the normalised DR in Fig. 6 . 6  A&B), however in MA there was a 
complete inhibition of contraction (Fig 6.7). Additionally, CCCP almost entirely 
inhibited contraction in response to U46619 in the MA, a thromboxane A2 analogue 
causing agonist mediated contraction. The contraction to U46619 was blocked to a 
lesser extent in the PA and, in contrast to the effects upon the DR to K+, no effect was 
observed upon the E C 50 in the absence (27.7 nM, n=l) and presence (28.7 nM, n=l) of 























Figure 6.5. Effect of CCCP on dose response curves to K+ and U46619. Pre­
contraction was carried out before the control and test dose response (DR) to 80 mM K+ 
(indicated at beginning of traces). Representative DR curves to K+ (10, 20, 40, 80 and 
100 mM K+) in MA (A) and PA (B). The vessels have an internal diameter of 210 pm 
(mesenteric) and of 375 pm (pulmonary). Representative DR curves to U46619 (1, 5, 
10, 15, 20, 50, 100, 200, 500 and 1000 nM U46619) in MA(C) and PA (D). The vessels 
have an internal diameter of 165 pm (mesenteric) and of 255 pm (pulmonary). Arteries 
were pre-incubated in CCCP for 20 minutes prior to commencing the test DR.
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Figure 6.6. Effect of CCCP on K+ induced contraction in PAs. DR curve normalised to 
the maximum contraction for that DR, in the absence (open circles) and presence (filled 
circles) o f CCCP (2 pM) (A). (B) the same DR curves normalised to the maximal 
response to 80 mM K+ (used to establish maximal contractility of the vessel). Lines 
represent a fit with the Hill equation [EQN 6.1].
[EQN6.1]  £l__
(x"+ EC 50")
where p is the proportion of ligand bound to a population of receptors, x is 
concentration, EC50 is the concentration for p= 0.5 and n estimates the number of 











Figure 6.7. Effect of CCCP on K+ induced contraction in MAs. DR curve in the 
absence (open circles) and presence (filled circles) of CCCP (2 pM) to K+.
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6.2.4 Effect o f ROS and mETC complex III inhibition on contraction to Kf
Exposure o f the vessels to 300 pM H2 O2 for 10 minutes evoked a transient contraction 
in both vessels. The MA predominantly relaxed to baseline whereas the PA maintained 
a degree of increased tension (Fig. 6.8 A&B). There was, however, no significant 
difference on the maximum contraction (when expressed as a % of the averaged 
maximum contraction to 80 mM K+ in either vessel) between the mesenteric and 
pulmonary arteries (Fig. 6.8 C).
Antimycin, whilst mimicking CCCP and ROS in MA did not have such a substantial 
effect of the K+ induced increase in vessel tone. Interestingly, in contrast to previously 
reported observations, antimycin (data not shown) alone did not cause contraction of PA 
nor MA (Leach et al., 2001).
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Figure 6.8. Effect of 300 pM H2 O2 on intact PA and MA. Representative traces 
showing the application of 300 pM H2 O2 in PA (A) and MA (B). The estimated
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internal diameter of the vessels was 362 pm (pulmonary) and 302 pm (mesenteric). (C) 
Exposure of PA and MA to H2 O2 for 10 minutes, peak contraction obtained in the 10 
minute period is shown.
To additionally consider the effects of antimycin and H2 O2 on K+ channels in PAs they 
were each studied on a cumulative DR to K+. As with CCCP, vessels were pre­
incubated for 10 minutes prior to the DR and a significant leftward shift in the DR curve 
to K+ was also observed for H2 O2 (EC5 0 = 20.5±0.1 mM , control and 16.7±0.2 mM, in 
H2 O2 , n=2, /K0.005) (highlighted in the normalised DR in Fig. 6.9 C), reflecting the 
decrease in maximal contraction. The data aquired with antimycin was not able to be 
fitted at this stage due to the low number of experiments (Fig. 6.8 A).
Figure 6.9. Effect of antimycin and H2O2 on K+ induced contraction in PAs. DR curve 
normalised to the maximum contraction for that DR, in the absence (open circles) and 
presence (filled circles) of antimycin (1 pM) (A) and H2 O2 (300 pM) (C). (B & D) are 
the same DR curves normalised to the maximal contraction to 80 mM K+. Lines 
represent a fit with the Hill equation [EQN 6.1 ].
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It is also worth noting that contraction in response to elevated extracellular K+ was 
virtually completely inhibited in the presence of antimycin, contraction remaining was 
equal to 19.4±7.6 %, n=3, /?<0.007, CCCP (0.38±0.6 %, n=2) and 100 pM H20 2 (4.3±4 
%, n=3, /?<0.012) in MA (Fig. 6.10). In the PA, despite not reaching significance 
(possibly due to the low experiment numbers) there was a substantial inhibition of the 
maximal contraction in response to CCCP (27.1±1.2 %, n=2), 100 pM H20 2 (35.7±13.9 
%, n=3) and 300 pM H20 2 (26±3 %, n=2); antimycin, on the other hand, did not inhibit 
the K+ dependent contraction (64.7±11 %, n=3) (Fig. 6.10). It is worth noting that the 
inhibition o f contraction in the MA was significantly larger than that in the PA for 
antimycin (p<0.028) and CCCP (p<0.0007) (Fig. 6.10)
p<0.028
p<0.001
antimycin CCCP 100 pM 300 pM
H, ° 2
Fig 6.10. Effect of mETC inhibitors and H20 2 on maximal K+ contraction in PA and 
MA PAs (black bars) and MAs (open bars) were pre-incubated fro 10 minutes in either 
antimycin (lpM ), CCCP (2 pM) or H20 2, (100 and 300 pM) prior to recording a 




As predicted by the window current models application of CCCP uncoupling A^m, 
increased the excitability of PAs when the cell membrane is depolarised using 
extracellular K+. For instance, if the resting membrane potential on average is -55 mV 
(range between -52 and -58 mV from microelectrode studies (Gonczi et al, 2006; 
Casteels et al., 1977; Bonnet et al, 2001; Suzuki & Twarog, 1982)), then 10 and 20 
mM KCI should depolarise PAs by 17 and 37 mV respectively (calculated by the Nemst 
equation). According to the model this would result in Ikv inhibiton and increased 
excitability of PAs as were observed with CCCP. When PAs were contracted using 
thromboxane analogue, U46619, such an increase in tissue excitability was not 
observed, suggesting the specificity of these effects to depolarising action of KCI.
Interestingly, the CCCP mediated contraction was partially inhibited by either block of
04- 04-Ca entry via L-type VDCC or removal of extracellular Ca , suggesting that the CCCP
04-induced contraction, is mediated by other mechanisms in addition to Ca entry in
04-response to depolarisation caused by Kv channel. Indeed, Ca release from the 
mitochondria can be stimulated by both CCCP (Komatsu et al., 2004) and H2O2 
(Roychoudhury et al., 1996) and could represent an alternative mechanism for increased 
Ca i. Recent evidence also strongly supports an important role for CCE in response to 
hypoxia in the PA (Becker et al., 2006).
Under my experimental conditions antimycin did not cause contraction in either PAs or 
MAs. Other researchers have shown antimycin to have a vasoconstrictor effect 
however, this was either in whole lung preparations (Rounds & McMurtry, 1981;Waypa 
et al., 2001; Weissmann et al., 2003) or in PASMCs ((Waypa et al., 2001) and not in 
isolated PAs as was performed in this thesis. Additionally, 10 pM antimycin has been 
shown not to induce contraction in rat aorta (Zhou et a l, 1997).
In the MA complete inhibition of contraction in response to pre-incubation with CCCP, 
antimycin and H2O2 observed irrespective of the contractile stimulus. H2O2 did induce a 
similar level of contraction to that seen in PA, which was transient in duration. Such 
results do corroborate with the dilation of systemic circulation in response to hypoxia.
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The transient contractile response to H2O2 in the MA, which has been also observed by 
others (Gao et a l, 2003a), is more difficult to explain based on the theoretical 
prediction of the behaviour of Kv channels which should favour relaxation. Overall 
data regarding the effects of H2O2 on mesenteric arteries is conflicting, with some 
arteries contracting and others dilating, in rabbit MASMCs H2O2 is proposed to increase 
vasodilator prostaglandins and cause hyperpolarisation via K atp channel activation 
(Hattori et a l, 2003) whereas in the rat, however, H2O2 caused constriction (Gao & Lee, 
2001, Gao et al, 2003b). It is possible that higher concentrations of ROS are necessary 
for activation of a vasodilatory pathway. Differential regulation of the smooth muscle 
contractility may be due to activation of other types of K+ channels. Additionally, ROS 
have been previously shown to regulate BKca channels relaxing systemic circulation 
(Brakemeier et a l, 2003; Liu & Folz, 2004) and K atp  channels are proposed to be 
involved in rabbit mesenteric arteries (Hattori et a l,  2003).
In summary, mitochondrial dependent pathway(s) are possibly important in the 
regulation of both PA and MA contractility by differential mechanisms resulting in 
contraction of PA and relaxation in MA. Many more experiments are necessary to fully 
elucidate the precise mechanisms which are involved in this very complex modulation 
of vessel contractility. The results in this chapter serve to suggest the in the pulmonary 
circulation mitochondrial dependent signalling is involved in regulation depolarisation 
mediated contraction, not, however, necessarily via VDCC. Depolarisation may also be 
enhanced by Ca activated Cl' channels, known to be present and induce contraction in 
PA (Piper & Greenwood, 2003). In addition ROS (namely H2O2) displays a similar 
effect on PA contractility as in MAs, though combined with the electrophysiological 
data this is most probably independent of the effect on Kv channel currents.
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Chapter 7
INVOLVEMENT OF THE NA+ DEPENDENT EXCHANGERS IN THE 
REGULATION OF I k v
7.1 Introduction
Differences in the WC and perforated patch data may be indicative that extrusion 
mechanisms, which may be more active in non-dialysed cells, could be involved. One 
of the main mechanisms for Mg2+ extrusion is through the Na+ dependent Mg2+ 
antiporter (NME). Several additional pathways may be functionally linked to the NME, 
for example consequential changes in the Na+ gradient after NME activation could 
regulate the other Na+ dependent exchangers. Other exchangers currently identified in 
the pulmonary circulation include the Na+-Ca2+ exchanger (NCE) and the Na+-H+ 
exchanger (NHE), with the Na+-K+ ATPase being the main mechanism for Na+ 
extrusion. Such extrusion mechanisms are functionally important in ion homeostasis. 
The following sections will discuss the role of each of the above-mentioned Na+ 
dependent mechanisms and their proposed role in the pulmonary circulation.
7.1.1 Sodium dependent exchangers
7.1.1.1 NME
4” 9.4*Activation of the NHE has recently been shown to modulate Na -Mg transport in 
VSMCs and, additionally, increased activity of NHE could influence the change in Na+- 
dependent regulation of [Mg2+]i observed in spontaneously hypertensive rats (SHR) 
(Touyz & Schiffrin, 1999). As with the other exchangers, the NME has been identified 
in a range of tissues including; human trophoblast cells (Standley & Standley, 2002), 
sheep ruminal epithelial cells (Schweigel et al., 2006) and erythrocytes (Rivera et al.,
4” 7 I2005). There is also experimental evidence supporting the Na dependence of Mg 
extrusion in VSMCs. Romani et al., (1993) demonstrated that the removal of 
extracellular Na inhibits Mg extrusion, while Gunther & Vormann, (1985) showed an 
inhibition of Mg extrusion in Na containing solution but in the presence of amiloride
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or imipramine inhibiting the exchanger. Inhibitors of NME have been shown to 
attenuate development of hypertension in rats infused with Ang II (Touyz & Yao, 
2003). However, the NME is yet to be cloned and has not been extensively studied in 
the pulmonary vasculature.
7.1.1.2NCE
The NCE was first described in the 1960’s when groups working in the UK, Germany 
and the USA all concluded from their work that there was a coupled transport system 
for Na+ and Ca2+ exchange, an entity they termed the Na+-Ca2+ exchanger. The 
importance of the NCE as a primary mechanism of calcium extrusion and the 
knowledge that small changes its activity lead to large effects on cell function has been 
recognised by four international conferences dedicated to NCE research (2001, 1996,
94*1991). The NCE operates in parallel with Ca channels and pumps in the plasma
94-membrane and can either move Ca into or out of cells. Its activity is regulated by the 
electrochemical gradient across the membrane and operates using Na+ gradients as a 
source of energy. The presence of the NCE in cardiac cells, for example atrial smooth 
muscle (Reuter et a l , 1973), has been extensively investigated and established to
94-perform a “house-keeping” role to maintain low intracellular Ca levels. Such
94-mechanisms of Ca overload have putative roles in myocardial ischemia, myocardial 
infarction, reperfusion and cardiac arrhythmias (reviewed by Hobai & O'Rourke, 2004). 
It is thus suggested that NCE inhibitors may have cardio-protective roles (Takahashi et 
al., 2003). Indeed, the NCE is currently being investigated as a target for anti-
94-arrhythmic therapy; there is strong evidence for arrhythmias related to Ca overload 
caused by increased Na+ load and activation of the NCE (Sipido et a l , 2006). Its 
functional presence in many other species and tissues has also been documented 
including guinea pig uretha (Aickin et a l , 1984), brain synaptosomes (Blaustein et a l ,
1996), neurones, astrocytes (Juhaszova et a l , 1996) and pancreatic beta cells (Van
4”  9.^hEylen et a l , 1997). Existence of Na -Ca exchange was first documented in vascular 
smooth muscle by Bohr et a l , (1969). Since then its activity has been established in 
cultured VSMCs (Nabel et a l , 1988) and cultured bovine PAECs (Sage et a l , 1991),
24-before Aaronson et a l, (1991) provided evidence for a role of Na -Ca exchange in 
human resistance vasculature in the recovery from contraction. The NCE activity is
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noticeably inhibited decreasing the rate of Ca2+ extrusion from the cytosol in PASMCs 
exposed to mild hypoxia (Wang et a l , 2000).
In 1990, the NCE was cloned from dog heart muscle (Nicoll et al., 1990). The NCE has 
three currently identified isoforms the NCE1, 2 and 3, who have a similar overall 
structure (Blaustein & Lederer, 1999). An intracellular loop, thought to comprise the 
exchanger modulation by protein kinases and intracellular ions, connects to a 5TM 
domain at the N-terminal and a 6 TM domain at the C-terminal. Most recently, mRNA
O |
for the NCE1 and NCKX3 (a potassium dependent Ca exchanger) isoforms of the 
NCE has been isolated from cultured PASMC (Zhang et a l, 2005). This study also
^  I
suggested that the NCE expressed in cultured PASMCs contributed to Ca entry due to 
the reverse mode of the NCE, elevating cytosolic Ca by store depletion. It was 
therefore predicted that blockade of the reverse mode NCE may be a possible 
therapeutic target in the treatment of PH (Zhang et a l, 2005). The most recent 
evidence, however, shows that a response resembling that observed in HPV in PAs 
induced by the removal of Na+0 was not due to inhibition of the NCE but was inhibited 
by the inhibitors of CCE, and thus is not supportive of a role for NCE in HPV (Becker 
et a l, 2006).
7.1.13 NHE
The NHE exchanger is electrogenic exchanging Na+ for H+ and is primarily involved in 
pH homeostasis in many mammalian cell types acting alongside several other ion 
transport systems such as the Na+ independent CI/HCO3 and Na+ dependent CI/HCO3 
transporters. The NHE is activated by an increase in intracellular H+ concentration. 
Extracellular Na+ is exchanged for intracellular H+ in a 1:1 stoichiometry. Excessive 
stimulation of the exchanger will ultimately increase intracellular Na+, which, in turn, 
can drive the Na+-K+ ATPase increasing the energy demands of the cell and/or activate
9 +  9-4-the NCE driving Ca into the cell. In cardiac tissue such Ca overload can lead to 
ischemia/reperfusion injury or myocardial infarction (Piper et a l, 1996). Also, in 
patients with hypertension, abnormalities in NHE exchange have been noted in several 
cell types including red blood cells (Canessa et a l, 1991; Rosskopf et a l, 1992), 
cultured VSMCs (Berk et a l, 1989) and skeletal muscle (Dudley et a l, 1990).
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The NHE has, more recently, been studied in PASMCs and significant roles in 
apoptosis, proliferation (Yao et al., 2002) and in hypoxic mechanisms are evident (Rios 
et a l , 2005). In PASMCs from 3 week hypoxic rats it was found that pHi and NHE-1 
mRNA expression levels were significantly elevated and that DMA (an inhibitor of the 
NHE) also elevated the rate of apoptosis (Yao et a l, 2002). Additionally, exposure of 
mouse PASMCs to CH increased pHi, NHE activity, and NHE1 expression; such 
changes are thought to contribute to the development of PH (Rios et al., 2005). The 
NHE has additionally been shown to aid in recovery from acid loads during hypoxia 
(Madden et a l, 2000). Since the cloning of the first Na+ H+ exchanger (NHE1) by 
Pouyssegui’s lab in 1989 nine isoforms of the exchanger have been identified (NHE 1- 
9) (Sardet et a l, 1989). NHE 2-9 are more restricted in their distribution, unlike NHE 
1, which is ubiquitously expressed in the plasma membrane. The structure of the TM 
proteins are similar containing 1 2  helical hydrophobic membrane spanning domains, a 
-500 amino acid N terminus functionally responsible for catalysing the amiloride 
sensitive NHE and a -300 amino acid C terminal acting as a regulatory domain.
7.1.1.4 Na+-K* ATPase
N a+-K+ ATPase or N a+-K + pump is ubiquitously expressed and is the first enzyme to 
gain recognition as an ion pump. The N a+-K+ ATPase is electrogenic transporting three 
N a+ in exchange for two K + and therefore induces changes in the membrane potential. 
Recently, small membrane proteins characterised by an FXYD motif have been shown 
to associate with the N a+-K + ATPase and modulate its properties for the transport of 
N a+ or K+, possibly implicating a role in pathophysiological states (Geering, 2006). It 
has previously been proposed that the regulation of the N a+-K+ ATPase may have a 
crucial role in the regulation of the contractility of VSM (Aronson, 1984) and indeed in 
the canine pulmonary artery hypoxia inhibits the N a+-K+ ATPase (Tamaoki et a l,
1997). The basic function of the Na+-K+ ATPase is to maintain low [Na+]j and high 
[K+]i. Located in the plasma membrane it is composed of a  and (3 subunits. The a  
subunit, containing the binding sites for ATP and the cardiac glycoside ouabain, is also 
the active catalytic subunit. The p subunit acts as a chaperone that ensures correct
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insertion of the a subunit in the plasma membrane and additionally modulates the 
affinity of the enzyme for cations.
7.1.2 Inhibitors o f the exchangers
Amiloride was the first NHE inhibiting drug to be discovered. Its properties as a K+ 
sparing diuretic and subsequently a Na+ channel blocker were discovered back in the 
1960’s. Subsequently, in 1977 the first observations that external Na+ and amiloride 
had effects upon pH* were noticed (Aickin & Thomas, 1977). Inhibition of the NHE 
was noted initially in renal microvilli (Kinsella & Aronson, 1981), mouse 
neuroblastoma cells (Moolenaar et al., 1981), cultured skeletal muscle (Vigne et al., 
1982) and in VSMCs (Little et al., 1986). In animal models NHE inhibitors have been 
shown to offer substantial protection from myocardial infarction (Masereel et al., 2003). 
Derivatives of amiloride were developed to create a higher specificity for the NHE. N- 
methyl-isobutyl amiloride (MIA) has a IQ of 2.3 nM for the NCE1 (Talor et a l, 1989), 
its higher selectivity towards the NHE is created by substitution of the nitrogen of the 5- 
amino group in the pyrazine structure, other improved derivatives include DMA, EIPA 
and HAM.
Amiloride also blocks the NME at concentrations 10-50 times lower (around 100 pM) 
than those at which it blocks the NHE. In addition, amiloride is known to block the 
Na+-K+ATPase (Soltoff & Mandel, 1983) and to decrease the open state conductivity of 
the epithelial sodium channel in a dose dependent manner (Sariban-Sohraby et al., 
1984). Amongst the blockers used to inhibit NME, imipramine and quinidine are 
considered to be relatively selective (Gunther, 1993b).
^  I q  i
For the NCE initially di- and tri- valent cations such as Na and La were known to act 
as inhibitors; however they also blocked many other ion channels and transporters at 
low doses. KB-R7943 was the first “fairly specific” inhibitor of the NCE, blocking it in 
its reverse mode ( I C 50 =  2  pM, Iwamoto et al., 1996) developed as a prototype in 1996 
and at up to 10 pM is shown to exert little influence over other transport mechanisms. 
Above 10 pM, however, there are questions over its selectivity, there are reports that at 
this concentration there is inhibition of the Ca2+-ATPase, the Na+ -K+ ATPase (Iwamoto
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et al., 1996), SOC (Arakawa et al., 2000) and of voltage gated Na* channels (Watano et 
al., 1999). Since KB-R7943 other benzyloxyphenyl derivatives have been formed 
exhibiting improved potency and specificity for the NCE1 isoform, SEA0400 (Matsuda 
et al., 2001) and SN-6 , which inhibits in the forward mode of the exchanger (Iwamoto, 
2004, Iwamoto et a l,  2004). Additionally, benzamil (a benzyl substituted derivative of 
amiloride) is commonly used to inhibit the exchanger in its forward mode (Kleyman & 
Cragoe, Jr., 1988).
7.1.3 Putative link between Ikv and Na+-dependent transport mechanisms.
o  i
The exchangers are directly involved in regulating intracellular ion homeostasis. Mg , 
Ca and H can all be regulated by activation of the respective exchangers, the NME, 
NCE and NHE, respectively. In the process of regulating these ions via the exchangers, 
N a+i is indirectly regulated.
7.1.3.1 Ion homeostasis
Na dependent exchangers can regulate intracellular concentrations of Ca and 
particularly Mg2*. In support of this, Romani et al., (1993) demonstrated that the 
removal of extracellular Na+ inhibits Mg2+ extrusion, while Gunther & Vormann, (1985) 
showed an inhibition of Mg extrusion in Na containing solution but in the presence of 
amiloride inhibiting the NME. Inhibition of this exchanger by amiloride may thus 
cause an increase in intracellular Mg2+. Removal of Na+0 could also inhibit the NHE, 
which may be driven by the inward Na* gradient under our experimental conditions, 
resulting in an increased intracellular proton concentration.
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7.13.2 Ion interactions with Ikv
•y i ^  i
Reports exist suggesting that mono- and di- valent cations (such as Mg and Ca ) can 
affect the activity of Kv channels in various tissues (Ludewig et al., 1993; Lopatin & 
Nichols, 1994; Gomez-Hemandez et al., 1997; Tammaro et al., 2005). It has been 
previously demonstrated that increased concentrations of these intracellular divalent 
cations can inhibit Ikv in VSMCs (Gelband et al., 1993; Tammaro et al., 2001;Tammaro 
et al., 2005). It is also worth noting that neither of the above papers discriminated 
between the effects of Mg and Ca on Kv channels. Altura and Altura (1984) 
extensively reviewed the importance of Mg and K interactions in VSMCs
*y i
highlighting the small changes in free [Mg ] near VSMC membranes could exert 
significant effects on both the mechanical and electrical properties of the cell (Altura & 
Altura, 1984). Furthermore, elevation of intracellular proton concentration can alter the 
activity of K+ channels either 1) by blocking the channel (Starkus et al., 2003a), 2) by 
altering the voltage sensitivity of the channel gating (Nimigean et al., 2003) or 3) 
indirectly, for example via altering other ion homeostasis (Farrukh et al., 1996).
•yt
As demonstrated in previous chapters Mg i is important in mitochondrial dependent 
regulation of Ikv, the current investigation therefore considered the activity of the NME 
and other Na+ dependent exchangers and their effects upon Kv currents in rat small 
PASMCs. It is currently unknown whether Kv channels are functionally linked to the 
activity of Na+ dependent exchangers. Although evidence in the pulmonary vasculature 
has shown that the transmembrane Na+ gradient can be utilized to energize the exchange 
of Mg2+ (Touyz & Schiffrin, 1996), in addition to Ca2+ (Sage et al., 1991; Yuan et al., 




To initially consider whether the exchangers are involved in the modulation of Ikv in 
PAMSCs, external Na+ was removed blocking all Na+ dependent exchangers in their 
forward direction.
7.2.1 Effect ofNa+0 removal on Ikv
To effectively analyse and compare changes in key characteristics of Ikv activation 
whilst maximising experimental productivity, under a variety of experimental 
conditions, data obtained with the ramping voltage protocol (described in chapter 2 ) was 
leak-subtracted offline and expressed as current density. Resulting I-Vs were fitted to 
[EQN 2.7] to derive and compare the Ikv steady state activation parameters of the half­
activation potential (Va), slope factor (ka) and maximal conductance (Gm^). To 
facilitate comparison the relative changes in Va (referred to as AVa) were calculated as 
the difference between absolute Va parameters in control (PSS) and test external 
solutions in the same cell (as described in detail in Chapter 2). To evaluate the effects 
on Ikv amplitude changes in Gmax were considered.
7.2.2 Comparison ofN a+0 removal by ramp and tail current protocols
Removal of Na+0 by equimolar replacement with NMDG caused a marked 
augmentation of the 7kv amplitude in the negative voltage range. Notably, both 
representations of the I-V  relationship (the tail current and ramping protocol) caused 
similar significant AVa shifts (-17.3±2.4 and -16.9±3.4 mV, 0.00002<p<0.0006, n = ll, 
respectively) (Fig. 7.1). Changes in were also comparable for tail and ramp protocols 
(10.3±1.3 to 9.1+1.2 mV and 14.5+1.7 to 11.2±2 mV, 0.02</><0.05, n = ll, respectively). 
It is worth mentioning that direct comparison of Gmax block and Ikv block measured at 
+100mV in 11 cells showed a similar effect of Na+ removal with a decreased current of 
7.6±5.8 and 8.7+3.4 %, respectively; the percentage Gmax block has therefore been 
considered for the remainder of this chapter. Furthermore, a Na+0-dependent decrease 
in the Gmax measured at +100 mV using a 200ms voltage step protocol was similar to
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the changes in Gmax calculated from the ramp (14.2±8.3 %). Therefore, the voltage 
ramp protocol was subsequently used to compare the effect of Na+ removal on Ikv. The 
individual data is presented in Table 7.1.
-50 50
V (mV)
R a m p  Tail
Figure 7.1. Effect of Na+0 removal on Ikv tail currents. (A) Normalised Ikv tail currents 
in the presence (filled circles) and absence (open circles) of Na+0. (B) AVa measured 
using a ramping protocol and with Ikv tail currents.
To assess the possibility that whole cell dialysis may be interfering with the intracellular 
ionic activity experiments were additionally carried out in the non-dialysed cells using 
the perforated patch technique. In non-dialysed cells a significant shift of -15±1.9 mV 
(n=8, /K0.00009) was observed, with no effect upon Gmax block, mimicking the effect 
of Na+ free extracellular solution in dialysed cells (Table 7.1).
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TABLE 7.1. Effect of different voltage protocols on changes in the voltage-dependent
parameters of Ikv.










PSS - 2 . 6 ± 3 . 2 1 4 . 5 ± 1 . 7
N M D G
(Ramp)
- 1 9 . 5 ± 3 . 9
( p < 0 . 0 0 0 5 7 )
11. 2 ± 2
( p < 0 . 0 2 1 )
- 1 6 . 9 ± 3 . 4 7 . 6 ± 5 . 8 11
PSS 1 4 . 8 ± 2 .8 2 4 . 9 ± 1 . 1
N M D G
(Step)
- 2 . 8 ± 4 . 3
( p < 0 . 0 0 4 3 )
2 7 . 2 ± 1 - 1 7 . 7 ± 4 . 8 1 4 . 2 ± 8 .3 11
PSS - 1 1 . 7 ± 1 . 7 1 0 . 3 ± 1 .3 - 1 7 . 3 ± 2 . 4 11
N M D G
(tail)
- 2 9 ± 2 . 6
( p < 0 . 0 0 0 0 2 7 )
9 . 1 ± 1 . 2  
{p<0 . 0 4 2 )
Perforated Patch 
PSS 
N M D G  
(Ramp)
1 5 ± 2 . 5
0 ± 3 . 3
( p < 0 . 0 0 0 0 9 )
22. 2 ± 1  
2 3 . 1 ± 3  *
- 1 5 ± 1 . 9 2 2 . 3 ± 1 1 8
Here and in subsequent tables p  values show significant difference between the values 
measured in control conditions and in test conditions obtained in the same PASMC 
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Figure 7.2. Effect of extracellular Na+ removal on 7kv activation. (A) 7kv recordings 
using a 2 s ramp protocols between -100 and +100 mV, from the holding potential -80 
mV from a representative PASMC, Cm = 10.8 pF. (B) Resulting I-Vs were fitted to the 
standard Boltzmann function to derive and compare half-activation potential (Va), slope 
factor (£a) and maximal conductance (Gmax). The effect of removal of extracellular Na+ 
(NMDG replacement) is highlighted in the insert showing the negative shift in 7kv 
between 0 and -60 mV. (C) Shows absolute Va values for PSS and NMDG and the 
relative change in Va to which all subsequent data is compared to.
7.2.3 Involvement o f  the Na+ dependent shifts in mitochondrial dependent regulation o f
Ikv
For continuity with the previous chapters and to assess a potential contribution of the 
NME to the mitochondrial dependent regulation of Ikv the effect of CCCP on the Na+ 
dependent shift in tail currents (fitted to +100 mV) was considered. An interaction
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between the mitochondrial regulated Mg dependent effects on Ikv and the Na 
dependent exchangers was therefore considered by pre-incubation of cells for 5 minutes 
in CCCP prior to recording control I-Vs and removal of extracellular Na+.
C C C P
Na* f ree  Na* free
p < 0 . 0 5
Figure 7.3. Effect of mitochondrial uncoupling on the Na+ dependent modulation of Ikv- 
Changes in the AVa by removal of Na+0 in the presence and absence of CCCP (2 pM).
The AVa was significantly (p<0.04) inhibited in the presence of mitochondrial 
uncoupler CCCP (2 pM) from -17.1+2.3 mV (n= ll, /?<0.00003) to -10.5±1.8 mV 
(n= ll, /?<0.0002) (Fig. 7.3). The significant increase in the slope of the steady state 
activation dependencies induced by Na+0 removal (from 9.5+1.1 mV to 7.8±0.7 mV 
(n=l l,/?<0.05)) was also inhibited in the presence of CCCP (Table 7.2). No significant 
Gmax block at either +50 or +100 mV was observed.
7.2.4 Effect o fN a+0 removal on whole cell Ikv in rat small PASMCs
Fig. 7.2 summarises the effect of the removal of Na+0 studied in 26 PASMCs studied 
with the ramp protocol. As can be clearly seen in the figure, 7kv amplitude was 
markedly increased in the negative voltage range of -50 to 10 mV (by >115%). For 
example, the mean 7kv density was increased from 2.4+1 to 16.5+2.9 pA/pF, (p<0.0001) 
at -30 mV. This increase was associated with a significant reduction in the mean Va 
from 3.8+2.1 mV (PSS) to -15.5+2.4 mV (NMDG) (p<0.001, Fig. 7.2 C), corresponding 
to a mean leftward shift of -19.3+2.5 mV in IKv. The insert in Fig. 7.2 B highlights the 
resulting marked enhancement of 7kv at negative voltages and thus the leftward shift in
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the steady state activation. Notably, the theoretical approximation of Ikv was also 
improved in the negative voltage range o f -30 mV in the Na+0-free solution. 
Accompanying the shift in Va was a significant reduction in from 17.9±0.9 (PSS) to 
15.1±1.2 mV (NMDG) (p<0.0001). Also, a small decrease of 8.7±3.4 % in Gmax was 
observed (n=26,/?<0.02).
TABLE 7.2. Effect of CCCP on Na+ dependent changes in Ikv activation, studied using 
tail currents to +50mV.

















-17.1±2.3 13.5±8.2 1 1
CCCP (2 p M ) -15±2.3 10.8±0.7
CCCP (2 p M )  







a represents a non paired Mest to control Na+ free shift (above) 
Gmax % was calculated from the fitted peak Ikv
It is important to note that the shift in Ikv activation was reversible and reproducible. 
Three applications of Na+ free extracellular solution for 5 minutes with 5 minute 
recovery in PSS produced shifts of -26.4±6 mV, -18.7±2.6 mV and -19.1± 2.4 mV, 
respectively (n=5).
7.2.5 Na o dependence o f the effects on Ikv
The effects of different Na+0 replacement were also considered to verify the shift 
observed by buffering with NMDG. Na+0 replacement with isotonic K+ (AVa = - 
21.9±0.9 mV, n=7,/T<0.0001) or Tris-Cl (AVa = -14±1.7 mV, n=5,/?<0.01) also caused 
significant leftward shifts in Ikv activation comparable to those observed in NMDG
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(Fig. 7.4). Equally consistent were changes in ka from 19.1±0.7 to 3.9±0.4 mV (KCI, 
n=7, /K0.0001) and from 18±1 to 14.3±1.7 mV (Tris-Cl, n=5, /K0.05). Na+ 
replacement with LiCl, however, produced a significantly smaller shift than that in 
NMDG (p<0.05, Fig. 7.4), although the slope of Ikv activation dependency was 
similarly increased from 17.6±2.6 (PSS) to 12.9±2.5 mV (LiCl), n=4, /?<0.0003. The 
magnitude of Gmax inhibition in Tris-Cl and LiCl was also comparable to that in NMDG 
(5.9±4.5% and 7.5±3.9%, respectively, jo>0.05, whereas Gmax was enhanced by 
14.8±12.6% (n=7,/?<0.001) in isotonic K+, as expected due to changes in Ek.
KCI TRIS-CI LiClNMDG
p  < 0 .0 4 7
Figure 7.4. Comparison of different extracellular Na+ replacement on / kv activation. 
Effects of Na+ replacement by NMDG buffer, isotonic K+, TRIS buffer and LiCl on 
AVa. Grey control bars on the left represent the effect of NMDG replacement for 
extracellular Na~ and are present for comparison.
Removal of Na+0 would, in theory 1) inhibit the NME causing an increase in 
intracellular Mg2+, 2) inhibit the NCE leading to a reduction in the extrusion of Ca2+ 
from the cell and 3) inhibit the NHE reducing H+ extrusion from the cell. This would, in 
theory, cause intracellular accumulation of either Ca2+ and/or H+ in addition to Mg2+, or 
even a combination of these cations, each of which is capable of modulating K+ 
conductance (Grissmer & Cahalan, 1989; Lopatin & Nichols, 1994). Therefore, all the 
Na+ dependent exchangers need to be taken into consideration to explain the observed 
effects on Ikv activation.
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TABLE 7.3. Effect of different extracellular Na+ replacements on the voltage-dependent
parameters of Ikv-




















































represents p  values compared to the control (NMDG) shift.
7.2.6 Role o f  the NME
The NME was initially assessed using a low concentration of amiloride (IOOjiM), 
thought to preferentially block NME with a potency comparable to that of imipramine 
(Kleyman & Cragoe, Jr., 1988). Cell incubation with amiloride alone caused has no 
significant effect on AVa, though notably the NaVdependent shift in 7kv activation of - 
6.5±2.1 mV, n = ll, was significantly reduced (p<0.015) (Fig. 7.5 A). Furthermore, no 
significant changes in the slope of Ikv activation were observed (12.3± 2.1 to 13.4± 3.3 
mV, n= ll). A significant 7kv block both in the presence of amiloride (17.6±2.7 %, 
p<0.004) and after the subsequent removal of Na+0 (14.2±6.2 %, /?<0.007) was also 
found (Fig. 7.5 B). It was not possible to use imipramine, an inhibitor of the NME, as it 
suppressed Ikv by 83±3.7% (n=3) at 10 pM, a concentration which is 5-10 times smaller 
than that used to block the NME (Ebel et a l , 2004; Tashiro & Konishi, 2000).
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Equimolar replacement of EGTA with a more potent Mg buffer, EDTA, in the pipette 
solution substantially attenuated the Na+0- dependent shift in 7kv activation (Fig. 7.4 A). 
A significant block in 7kv amplitude, comparable to that in the control, was also 
observed (Fig. 7.5 B); however there was no effect on the slope factor (ka = 17.6±0.8 
mV in PSS vs. 16.8±1 mV in NMDG, n=18).
^  I
The relatively weak effect of EDTA may suggest a constant influx of Mg from
I
outside, hence causing extracellular Mg removal. Therefore, the role of extracellular 
Mg2+ was investigated by i) removal of extracellular Mg2+ from the PSS (‘Mg2+-free’ 
solution) and ii) equimolar replacement of 1.2 mM extracellular Mg2+ with Ca2+ (‘Mg2+- 
free+Ca , solution). In Mg -free PSS Ikv activation dependency was significantly 
shifted leftward by -7.6±2.9, n=7, p<0.041, however this effect was not observed when 
Mg2+ was replaced with Ca2+ with AVa = -0.9±1.9, n=10 (Fig. 7.5 C). This indicates that 
it is likely to be mediated by the interaction of divalent cations with fixed extracellular 
surface charges in the vicinity of the Kv channel. ka was not significantly affected in 
either condition. Although the subsequent removal of Na+0 caused a further leftward 
shift in Ikv activation (AVa =-8±0.8, n=7, j?<0.0001), the effect was significantly 
reduced in both conditions compared to the control (p<0.03) (Fig. 7.5 C), suggesting 
that extracellular Mg2+, but not Ca2+, influx is likely to contribute to the Na+0-dependent 
shift of Ikv activation. The slope of the activation dependency was significantly 
increased in both conditions with = 16.3± 2 and 15.3± 2.2 mV (Mg -free’, n=7, 
/?<0.03) and £a = 15.8±1.4 and 13.1±1.5 mV (Mg2+-free+ Ca2+’, n=10,/><0.018) inNa+0- 
containing and Na+0-free solutions, respectively. It should be noted that only the 
removal of Mg2+ alone had a significant effect on Gmax blocking by 15.3± 4.5 % (n=7, 
/?<0.011, Fig. 7.5 D), comparable to that in control. Any subsequent effect of Na+0-free 
solution was similarly not significant in both conditions (Fig. 7.5 D).
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Figure 7.5. NME in the Na+ dependent regulation of 7kv. (A) & (B) Effects of selective 
inhibition of the NME with 100 pM amiloride (perfused for 6 minutes prior to
recording) and (C) & (D) increasing Mg2+i to 10 mM and buffering Mg2+j with more
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potent Mg buffer EDTA (10 mM) on AVa and Gmax block, respectively. Open bars 
represent the shift caused by the change in condition alone and black bars represent the 
shift due to Na+ replacement with NMDG. Grey control bars are present for 
comparison. a denotes comparison with one tailed f-test.
150
ITABLE 7.4. Effect of intracellular [Mg ] on the voltage-dependent parameters of Ikv-
Steady-state Ikv activation and Gmax block
Va ka AVa Gmax n
(mV) (mV) (mV) block (%)
PSS 3.8±2.1 17.9±0.9
NMDG -5.5±2.4 15.1±1.2 -19.3±2.5 8.7±3.4 26
(/?<0.00000004) {p<0.00007) (p<0.018)
PSS -3.6±3.9 14.2±2.2
PSS -6.9±3.8 12.3±2.1 -3.3±1.8 17.6±2.7 11
(100 pM Amiloride) (p<0.0003)a (p<0.0038)
NMDG -13.4±4.6 13.4±3.3 -6.5±2.1 14.2±6.2 11
(100 pM Amiloride) (p<0.013) (p<0.0034)a
r-H
oooV
PSS (10 mM Mg2*) -11.3±4.5 11.5±1.9
(p<0.0016)a (p<0.0016)a
NMDG -24.8±3.4 9.8±1.8 -13.5±1.9 16.9±3.5 11
(10 mM Mg2+) (p<0.000032) (p<0.0031) (p<0.00045)
PSS (10 mM EDTA) 6.9±1.9 17.6±0.8
NMDG -5.4±2 16.8±1 -1 2 .1±2 . 2 8.3±2.9 18
(10 mM EDTA) (p<0.000016) (p<0.026)^ 
b
(p<0.031)
a represents p  values compared to the control (NMDG) shift.
b denotes one tailed /-test.
If the effect of amiloride on the Na+0-dependent modulation of Ikv activation is due to its 
inhibition of NME and removal of Mg2+0 causes a decrease in Mg2*, then increasing
o  i ^  I
Mg i would also be expected to mimic these effects. Increased Mg i from 0.5 mM to 
10 mM in the pipette solution with MgCl2 alone caused a leftward shift in the /kv 
activation, with the difference between the two conditions being 10.1 mV, (p<0.002, 
unpaired /-test) (Fig. 7.6 A), mimicking the shift in the Na+0 free in PASMCs dialysed 
with 0.5 mM MgCL. Additionally, in 10 mM Mg2+, there is a significant increase in the 
slope of the steady state activation dependency from 17.9±0.9 mV (0.5 mM Mg2+, 
n=26) to 14.7±1.2 mV (10 mM Mg2+, n=19), p<0.035 (unpaired /-test). Notably, cell 
dialysis with 10 mM MgCl2 alone resulted in significant inhibition of Ikv amplitude; 
Gmax block was decreased from 1.4±0.1 mV (0.5mM Mg2+) to 0.56±0.1 mV (10 mM 
Mg2+), /kO.000004 (unpaired /-test). The relative shift in the 7kv steady-state activation 
in the NMDG buffer was diminished in 11 paired cells dialysed with 10 mM MgCl2, 
though not significantly (AVa = -13.5±1.9 mV, n=l 1) (Fig. 7.6 B).
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Figure 7.6. Effect of increased intracellular Mg2+. (A) Comparison of 10 mM Mg2+ on 
Va and (B) effect of increased Mg2+ on the Na+-dependent shift in Va.
7.2.7 Role o f  the NCE in the regulation o f Ikv in rat PASMCs
To investigate the involvement of the NCE, the effects of elevated (from 10 to 220 nM)
2*4" 2 *4*free intracellular Ca" and increased buffering capacity for Ca by equimolar BAPTA 
replacement of EGTA on 7kv activation, were investigated. If the NCE is involved, it 
was expected that the effect of the Na+ free solution would be attenuated. Neither of 
these conditions however significantly altered the effect of NMDG on AVa compared to 
the control pipette solution (Fig. 7.7 A). A significant increase in 7kv amplitude at -30 
mV (4.2±1.2 pA/pF, n=5, 2.9±1.1 pA/pF, n=6, 0.02</?<0.05, BAPTA and 220nM
2“F[Ca ]i, respectively; data not shown) also support the changes in AVa. Nevertheless, a 
significant decrease in ka from 16±1.5 to 12.9±1.4 mV (n=5, /?<0.028) and from 
19.3±2.1 to 13.3±2.2 mV (n=5, /?<0.0002) was observed for both elevated Ca2+i and in 
the presence of BAPTA, respectively. Also, it is worth noting that in both these
a  |
conditions, where [Ca" ]; is increased or decreased, a significantly enhanced block of 7kv 
is observed, (Fig. 7.7 B). Overall, these data suggest that the NCE activity could be at 
least partly responsible for some of the effects of Na+0 removal on 7kv activation.




Figure 7.7. NCE in the Na dependent regulation of 7kv- (A) Effects of increasing Ca j 
to 220 nM and buffering Ca2+j with more potent Ca2+ buffer BAPTA (10 mM) on AVa 
and (C) on Gmax block. (B) Effect of NCE inhibitor KB-R7943 on AVa. Gmax block is 
measured as 1- the ratio of the Gmax in control and test (NMDG) and is expressed as a 
percentage. Open bars represent the shift caused by the change in condition alone and 
black bars represent the shift due to Na+ replacement with NMDG. Grey control bars 
are present for comparison.
Pre-treatment of PASMCs with 3 pM KB-R7943, an inhibitor of the reverse mode of 
the NCE has further confirmed this. KB-R7943 alone mimicked the effect of Na+0 
removal on both Va (Fig. 7.7 B) (causing a leftward shift o f -8.2±1.1 mV, n=13, 
jpO.OOOI) and the slope of Ikv activation (reducing ka from 15.3±1.4 mV (PSS) to 
10.5±1 mV (KBR), (n=13, /?<0.0001). Moreover, subsequent Na+ removal caused a 
significantly smaller additional shift in the 7kv activation (Fig. 7.6 B) with no significant 
effect on ka (8.2±0.8 and 6.3±1 mV, n=9, before and after Na+ removal respectively, 
n=9). The Ikv block was also significantly increased both in KB-R7943 alone and after 
subsequent removal ofN a+0(Fig. 7.7 C).
C o n t r o l K B - R 7 9 4 3i
K B - R 7 9 4 3
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TABLE 7.5. Effect of intracellular [Ca ] on the voltage-dependent parameters of Ikv-
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a represents p  values compared to the control (NMDG) shift.
7.2.8 Role o f the NHE
To investigate the possibility of a change in H+ several approaches were used; 1) 
elevation of intracellular HEPES from 10 mM to 110 mM, 2) extracellular acidosis (pH 
6 .6 ), 3) alkalosis (pH 7.8) and 4) NHE inhibitor MIA.
The HEPES concentration was increased in order to increase intracellular proton 
buffering capacity. Removal of Na+ under such conditions had an effect on AVa similar 
to that under control conditions measured after 5 minutes exposure to Na+0-free solution 
(AVa = -18.1± 2.1 mV, n=10) (Fig. 7.8 A). However, the analysis of the time-dependent 
changes in Va showed a significant slow-down of the development of the effects of Na+ 
removal in the presence of 1 lOmM HEPES (x = 2.5±0.7 s, n=6 ) compared to that in the
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control conditions (x =1.1±0.2 s, n=20,/?<0.016). In addition, changes in the slope of Ikv 
activation dependency were no longer significant (ka = 15.8±2 mV vs k^= 14.9±4.2 mV, 
in PSS and NMDG, respectively). Furthermore, the relative degree of Ikv block caused 
by Na+0 removal (19.2±2.9%, n=10, p<0.006) was significantly greater than that under 
control conditions (p<0.05, Fig. 7.8 C). The results indicate the potential involvement 
of intracellular protons could contribute to the observed effect of Na+0 -free solution on 
Ikv in PASMCs.
A  110 mM HEPES B
Control (NMDG) NMDG
* * * *
* * * *
□ Control —_L 
■ 110 mM HEPES
Control 110 mM HEPES o 60 120 180 240 300
(NMDG) Time (s)
Figure 7.8. Effect of buffering H+* on Na+ dependent regulation of 7kv. Effects of 
buffering H+i with potent H+ buffer HEPES (110 mM) on AVa (A) and Gmax block (C). 
(B) The time dependency of Na+ removal compared in control and in the presence of H+ 
buffer HEPES. Grey control bars on the left are present for comparison.
The role of the NHE was therefore further evaluated by investigating the effect of Na+0 
removal upon extracellular pH and in the presence of the NHE specific inhibitor MLA. 
Extracellular acidification to pH 6.6, favouring an influx of protons into the cell, had no 
effect upon steady state 7kv activation alone, though did cause a significant decrease of 
the maximal Kv conductance (Fig. 7.9 A&B). Na+0 dependent changes in Va (Fig. 7.9 
A) and ka were preserved; AVa =-15.8±1.2, n=4 and ka 10.6±3.6 (PSS, pH 6.6) and ka =
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8.1±3.5 mV (NMDG, pH 6 .6 ) (p<0.037). Interestingly, no further effect on the Gmax 
was observed in Na+0-ffee solution at pH 6 . 6  (Fig. 7.9 B). Extracellular alkalosis 
(which should facilitate proton efflux from the cell) caused a significant shift in 7kv 
activation; AVa = -9.2±1.7 mV, n=5, £><0.01 (Fig. 7.9 A). Furthermore, unlike 
extracellular acidification, the extracellular alkalinisation caused a significant decrease 
in K  from 17.9±2.1 mV (pH=7.2) to 12.7±2.3 mV (pH=7.8) (pO.0015), thus 
mimicking the effects of Na+0 -free solution under control conditions. Subsequent 
removal of Na+0 caused a small, but no longer significant, additional shift in 7kv 
activation dependency (AVa = -6.8±4.8 mV, n=5) (Fig. 7.9 A). A further increase in the 
slope of activation dependency (ka to 9.3±1.5 mV, £><0.02 when compared to pH = 7.8 
alone) was also observed.
These results suggest that conditions facilitating the reduction of intracellular proton 
concentration attenuated the effect of Na+0 removal on the steady-state activation, but 
not on the Ikv block. In this case inhibition of the NHE, if it is constantly active under 
our experimental conditions, would be expected to mimic the effect of extracellular 
acidosis.
Blockade of the NHE with specific inhibitor 5-(N-methyl-N-isobutyl) amiloride (MIA) 
(25pM) alone had no significant effect upon 7kv activation (Fig. 7.9 A). However, the 
slope of the dependencies was increased with ka = 17.7±2.5 mV (PSS) and ka= 14.4 
±2.1 mV (MIA, £><0.031), associated with a significant Ikv block (Fig. 7.9 B), 
resembling the effect of extracellular acidosis. In the presence of MIA Na+0 removal 
caused a reduced leftward shift in Ikv activation, AVa= -11.4±1.2 mV (n=5, Fig. 7.9 A), 
with no significant changes in ka (14.4±2.1 vs 14±2.4 mV, n=5). The Ikv block was also 
further increased (26.5±7 %, n=5, £><0.036). This suggests that overall the inhibition of 
NHE by removal of Na+ contributes to the modulation of Ikv, but is not the only 
mechanism involved in this process.
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Figure 7.9. NHE in the Na+ dependent regulation of 7kv. Effects of extracellular pH 
and NHE specific inhibitor MIA (25 pM) on AVa (a) and Gmax block (b). Open bars 
represent the shift caused by the change in condition alone and black bars represent the 
shift due to Na+ replacement with NMDG. Grey control bars are present for 
comparison.
1.2.9 Effect o fN a f removal on Ikv in MASMCs.
Specificity of the effect of Na+0 removal on 7kv in pulmonary circulation was evaluated 
by comparison to systemic circulation using MASMCs. When studied under the same 
experimental conditions, although Na+0 removal caused a leftward shift in Ikv activation 
(Fig. 7.10 A), the effect was 2.6 times smaller than that in PASMCs (Fig. 7.10 B). 
Furthermore, no significant effect on the slope factor was found (k  ^ = 15.2±0.7 mV in
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PSS and 17.112.1 mV in NMDG). This evidence strongly suggests that the Na+0- 
dependent moculation of Ikv activation is relatively specific for PASMCs. Gmax, 
however, was similarly reduced by 10.4±3.9 % (n= ll. ;?<0.01) upon removal of Na+0 
(Further details in Table 7.7).
10 -
□  NMDG
0 100-100 -50 50
B
V (mV)
Figure 7.10. Effect of Na+ removal in MASMCs. (A) I-V relationship in MASMCs in 
control and where extracellular Na+ has been removed. (B) Shows the relative changes 
in Va in MASMCs and PASMCs.
PASMC MASMC
I
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TABLE 7.6. Effect of intracellular [H+] on the voltage-dependent parameters of Ikv-
Steady-state Ikv activation and Gmax block
Va ka AVa Gmax n
(mV) (mV) (mV) block (%)
PSS 3.8±2.1 17.9±0.9
NMDG -5.5±2.4 15.1±1.2 -19.3±2.5 8.7±3.4 26
(p<0.00000004) (p<0.00007) (p<0.018)
PSS 2 .8 ±2 .1 15.8±2
(110 mM HEPES)
NMDG -15.3±1.4 14.9±4.2 -18.1±2.1 19.2±2.9 6
(110 mM HEPES) (p<0 .0 0 0 0 1 2 ) (p<0.0053)
(p<0.041)a
PSS -4.4±7.1 13.2±4.8




NMDG -19±6.5 8.1±3.5 -15.8±1.2 -3±13 4
pH 6 . 6 (p<0.0063) (p<0.037)
PSS 3.1±7.4 17.9±2.1
pH 7.8 -6.1±5.8 12.7±2.3 -9.2±1.7 -0.7±9.7 5
(p<0.0063) (p<0.0015)
NMDG -12.9±4.5 9.3±1.5 -6.8±4.8 18.8±2.9 5
pH 7.8 (p< 0 .0 2 ) (p<0.048)a
PSS 2.7±2.1 17.7±2.5
MIA (25 pM) 0.3±1.4 14.4±2.1 -2.4±1.4 22.6±3.7 5
(p<0.031) {p<0.065)a (p<0 .0 1 2 )
NMDG -11.1±0.9 1.4±2.4 -11.4±1.7 26.5±7 5
MIA (25 pM) (p<0.00074) (p<0.036)
(p<0.043)a
a represents p  values compared to the control (NMDG) shift.
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TABLE 7.7. The effects of Na+ removal in MASMC on the voltage-dependent
parameters of Ikv
Steady-state Ikvactivation 3Tld G max block
Va ka AVa Gmax ft
(mV) (mV) (mV) block (%)
PSS 15±5.1 15.2±0.7
ft?<0 .0 2 1 )a
N M D G 7.5±6 17.1±2.1 -7.5±2.5 10.4±3.9 11
(p<0.014) (p<0.0078)a
a represents p  values compared to the control (NMDG) shift
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7.3 Discussion
In this part o f the study changes in the voltage-dependent parameters of 7kv activation 
induced by the removal of Na+0 were used to investigate an involvement of the Na+- 
dependent exchangers in the regulation of Ikv in rat small PASMCs. The main 
observations include: i) removal of Na+C, which is expected to block the activity of the 
Na+-dependent exchangers caused a significant leftward shift and an increase in slope of 
the activation dependency of Ikv activation and a significant reduction in the whole cell 
maximal conductance, ii) this effect was significantly attenuated by the mitochondrial 
uncoupler CCCP, suggesting a possible cross talk between the mitochondrial inhibition 
(described in previous chapters) and Na+ dependent extrusion mechanisms, iii) a 
putative involvement of the NME and a complex interaction with the NCE and NHE 
was shown to be involved in regulation of Ikv iv) Na+0-dependent effects on Ikv 
activation were significantly greater in pulmonary as opposed to systemic (mesenteric) 
SMCs, suggesting that the observed effects are more specific for PASMCs. The 
investigation then focused on identifying a possible underlying mechanism and 
focussed on a role for the three there sodium dependent exchangers present in vascular 
SMCs, the NHE, NCE and NME, which should all be blocked in the forward direction 
by Na+0 removal.
7.3.1 Validation o f  the ramp voltage protocol
Since the voltage ramp protocol was used throughout this study, the validity of the data 
was initially confirmed by comparison to the tail protocol, which was routinely used in 
previous chapters. Comparable shifts in Ikv activation were observed with both voltage 
protocols when Na+0 was removed.
It is worth noting that a better theoretical approximation of the experimental values in 
the physiological range of Vm in the absence than in the presence of Na+0 was evident 
(Fig. 7.2 B). Discrepancy between the theory and experimental data were not observed 
in I-Vs derived from tail current, suggesting that the reduced Ikv amplitude in the 
negative voltage range is Na+ dependent. It has been observed that Kv channels, 
particularly the Kvl sub-type expressed in this cell type (Smirnov & Beck, 2002), can 
be permeable for other monovalent cations such as Na+, Cs+, Li+ (Kom & Ikeda, 1995;
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Fedida et al., 1999). It is therefore possible that inward Na+ flux may interfere with K+ 
efflux at negative potentials due to a greater electro-chemical driving force for sodium 
in this voltage range (Gomez-Lagunas, 2001). However, more complex interactions 
between Na+-dependent transport processes influencing the Kv current activation in rat
I ^  |
PASMCs cannot be entirely excluded, for example intracellular cations, Na and Mg , 
could be responsible.
7.3.2 N a ’o specificity
Removal of Na+0 has a considerable effect upon whole cell steady state 7kv activation 
shifting it by almost 2 0  mV to more negative potentials. The effect of the NaVffee 
solution on Irv was independent of the type of Na+0 substitution. All substitutions 
(except the LiCl-based buffer has a significantly smaller effect (Fig. 7.3)) caused 
significant and comparable negative shifts in 7kv activation, suggesting the involvement 
of active Na+-dependent membrane transport mechanisms under our experimental 
conditions. Further investigation was therefore focussed on the identification of 
whether the NCE, NHE and/or NME (all known to be present in PASMCs (Wang et al., 
2000; Ziegler et al., 1992; Rios et al., 2005) are involved in the observed effects. These 
three exchangers were primarily focussed on due to their involvement of cellular 
homeostasis of Ca2+, H+, Mg2+ and Na+, which are known to affect 7kv (Gelband et a l, 
1993; Berger et a l, 1998). The lesser effect of the LiCl substitution, which can activate 
the NHE (Kobayashi et al., 2000), but not the NCE (Wang et a l, 2000), on Ikv 
activation indirectly suggested a possible involvement of the NHE.
A potential effect of each ion and contribution of the exchangers to the Na+ dependent 
exchange mechanism was assessed using various pipette buffers (cells were dialysed for 
5 min prior to recording), different extracellular solutions and inhibitors of the Na+- 
dependent transport systems.
7.3.3 Role o f the NME
The NME, has not been so extensively studied particularly in vascular smooth muscle 
In this chapter experiments carried out with different solutions and inhibitors provides 
evidence favouring a functional link between the NME and Ikv- In chapter 3 evidence
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for a putative link between mitochondrial dependent increased Mg i and the regulation 
of Ikv. In this chapter CCCP, which was shown to increase Mg i in chapter 3, 
significantly attenuate the effect of Na+ free extracellular solution. To summarise the 
findings presented in this chapter the evidence in favour of an active NME under my 
experimental conditions includes:
1) Replacement of EGTA with EDTA, a more potent buffer of Mg2+ (Fig. 7.5 C&D) in 
the pipette solution showed a marked attenuation of the Na+ -dependent shift in the 7kv 
activation.
2) Application of a low concentration of amiloride (100 pM) alone, which has been 
shown to be relatively selective for blocking NME (Gunther & Vormann, 1985) 
significantly inhibited the Na+-dependent shift in Ikv. It is worth mentioning that the 
effects of amiloride were more potent than those of MIA, however an additional effect 
of amiloride on the NHE cannot be entirely excluded (Masereel et a l , 2003). Any 
effect on the NCE may be regarded as unlikely since its selectivity for amiloride is 10- 
50 times higher than that for the NME (Blaustein & Lederer, 1999). Imipramine, a 
putative NME inhibitor (Gunther & Vormann, 1985), due to its potent Ikv inhibitory 
property, was deemed an unsuitable pharmacological tool for this study.
o  j
3) Inhibition of this exchanger by amiloride may cause an increase in Mg i by
I 9 “t*restricting its extrusion in exchange for Na Q. The removal of extracellular M g 
represents the most important evidence in favour of the involvement of the NME and 
M g2+i in the observed Na+0-dependent Ikv modulation. Importantly, the overall effect of 
the removal of Na+ on the Ikv activation was significantly reduced in both reduced
^  i ^  I
extracellular Mg (0 mM MgCk) and increased intracellular Mg (10 mM MgCb), but 
unaffected by Ca2+0. Furthermore these experiments suggest the presence of a
94-continuous influx of Mg into PASMCs, which is balanced by the activity of the NME
I
as the main mechanism of Mg extrusion.
Movement of Mg2+ across the cell membrane has been extensively studied using Mg2+ 
sensitive dyes, for example mag-fura-2, indicating a free [Mg ]i in the range of 0.6- 
0.8mM (Gunther, 1993). A fluctuation around this physiological range has also been 
shown to block the outward currents of potassium channels, interfering directly with the
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passage of K+ iDns. This can induce inward rectification of the channel current-voltage 
relationship at positive potentials or a complete block of the channel pore (Harris & 
Isacoff, 1996). Gelband et al., (1993) showed that an increase in intracellular divalent 
cation concentration significantly suppressed 7kv in isolated SMCs. The possibility of a
94-direct effect of Mg i on Ikv was also investigated and it was found that an increase to 
10 mM MgCl2 in the pipette solution, produced further shifts in Ikv availability.
7.3.3 Effect ofNa+ removal on Ikv block
If Na+ is mainly acting via inhibition of the NME leading to increased M g2+i, the Ikv
94-block may be similar to the effects observed with the mitochondrial inhibitors. Mg i 
has been shown to block the outward currents of potassium channels, interfering 
directly with the passage of K+ ions. This can induce inward rectification of the channel 
current-voltage relationship at positive potentials or a complete block of the channel 
pore (Harris & Isacoff, 1996). In support of this Gelband et al., (1993) showed an 
increase in the intracellular divalent cation concentration significantly suppressed Ikv in 
isolated SMCs and Tammaro et al. (2001) have demonstrated an analogous dependence 
of Mg2+i on Mg2+0 in rat aortic SMCs. Additionally, an increase in Na* in KB-R7943 
and in pH0=7.8 may be responsible for driving the shifts in Na+0-free solution. 
Extracellular protons are known to decrease whole cell Ikv (Fedida et al., 2005; Starkus 
et al., 2003b). A direct effect of the inhibitors (KB-R7943 and MIA) on the Kv 
channels also cannot be excluded. Neither this data nor the proposed model can explain 
the enhanced effect of BAPTA and HEPES on Gmax, therefore further investigation of 
this is necessary to gain full understanding.
7.3.4 Involvement o f the NCE and NHE
The ability of KB-R7943, a reverse mode NCE inhibitor i) to mimic and ii) significantly 
attenuate the effect of Na+0-ffee solution, suggests that the reverse mode of the NCE 
could be important for the Na+0-dependent modulation of Ikv. However, the presence of 
10 mM EGTA in the control conditions makes a direct effect of increased Ca2+i on Ikv 
activation unlikely. Since the reverse mode of the NCE is generally activated by 
elevated Na* (Blaustein & Lederer, 1999), it is possible that sub-membrane Na+i 
accumulation represents the main driving force for reverse NCE activity under our
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experimental conditions and also suggests that under our conditions the forward mode 
of the exchanger is inoperative. Notably, operation of the NCE in the reverse mode
f j  I
under resting Ca i was demonstrated in PASMCs (Wang et al., 2000). This study 
demonstrated that the removal of Na+0 during normoxic conditions increased the peak 
Ca i and slowed the decay rate of the Ca peak. Additionally, the NCE current was 
inhibited during mild hypoxia. The reverse mode has also been shown to be the
9 4 -predominant NCE activity contributing to basal C a i in the umbilical vein SM Cs 
(Rebolledo et al, 2006); KB-R7943 decreased [Ca ]i, caused a relaxation of the artery 
rings and lowered N a+0 increased [Ca2+]j proportionally. Removal of extracellular Ca2+
94-should therefore inhibit the NCE in its forward mode and subsequently reduce Ca
9 . 9 .
extrusion from the cytosol and increase [Ca ]*. However, no extracellular Ca - 
dependence of the effects were found under the experimental conditions used in this
9+work (Fig. 7.5), also, neither elevation of [Ca ]i from 10 to 220 nM nor buffering of 
[Ca2+]i with lOmM BAPTA (Fig. 7.5) had any effect upon the N a+ dependent shift in 
steady state 7kv that we observed. Interestingly, there was a significant reduction in 7kv
9 .
density, which may be due to a direct block of the Kv channel by Ca . Thus NCE 
activity, if involved, is likely to affect the Kv channels indirectly, perhaps via changes 
in intracellular Na+ concentration.
The NHE is considered to be one of the main sources for Na+ influx under physiological 
conditions (Rebolledo et al., 2006). Despite the lack of proton gradient under our 
conditions, which should prevent the NHE activity, some Na+ influx could not be 
entirely ruled out. The existence of a relatively low activity of the NHE, under my 
experimental conditions, is further supported by the following experimental 
observations; 1) cell dialysis with 110 mM HEPES was unable to attenuate the N a+0- 
dependent modulation of Ikv activation after 5 mins, however it did significantly reduce 
the time-dependence of the effect, and 2) MIA, a selective inhibitor of the NHE, was 
unable to significantly affect the activation, although did reduce the effect of the Na+0- 
free solution. The effect of extracellular acidification had no significant effect upon Ikv 
activation, as was expected since the activity of the NHE is generally inhibited under 
decreased pH0 (Ahn & Hume, 1997). Conversely, an increase in the outward directed 
proton gradient with pH0=7.8, which should increase the NHE activity and lead to an 
increased Na+ influx, significantly attenuated the effect of Na+-free solution on Ikv, thus 
resembling the effect of KB-R7943. The common feature of both processes is that they
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result in accumulation of Na i. This may inhibit the NME and increase Mg i, reducing 
the overall Na+ dependent shift in Ikv activation. During HPV pH* decreases and the 
NHE is then driven by inwardly directed Na+ and outwardly directed H+ gradients, 
facilitating the recovery from intracellular acidity (Madden et a l , 2000).
The observed effects of N a+0 removal on Ikv activation in PA M SCs is explained in the 
simplified diagram in Fig 7.11. A  continuous flux of M g 0 activated the N M E, which 
leads to an increase in N a+. In turn this activates the reverse mode of the NCE to 
remove some of the N a+ and thus maintain a low N a+i. Removal of N a+0 will inhibit the
I
NME, resulting in accumulation of Mg i which will subsequently alter Ikv activation 
(Zhang & Melvin, 1995). Since the NME activity is also dependent upon the Na+ 
gradient (Nakayama et a l , 2003; Tashiro & Konishi, 1997), then, for example inhibition 
of the NME with amiloride or activation of the NHE by extracellular acidosis, which 
should lead to increased local N a \  would mimic the effects of the Na+0-free solution, 
this was not the case. Despite not currently having a plausible explanation of this effect 
it is entirely possible that amiloride also suppresses Mg2+0 influx. Mechanisms of Mg2+ 
entry into VSMCs are yet to be identified and recently He and colleagues (2005) have 
reported that TRPM7 could be responsible for Mg i entry into VSMC. Further 













Figure 7.11. Schematic diagram describing a proposed interaction between the Na+- 
dependent transport mechanisms and Kv channels in PASMCs.
To conclude, this data suggests that Kv channel activity at physiological membrane
o  i
potentials is chiefly dependent upon Mg j, whose concentration is determined by the 
balance between Mg2+0 influx and its extrusion by the NME. This therefore represents a 
novel regulatory mechanism for Ikv in PASMCs. The results are also consistent with 
NME activity being dependent upon Na+i, which is, in turn, regulated by the NHE and 
perhaps the NCE, which are the main regulators of Na+ influx. Under physiological 
conditions it its therefore the NHE which is most likely to have the greatest influence in 
the regulation of Na+j, the forward mode of the NCE would become more important 
during periods o f agonist induced stimulation. The Na+-K+ ATPase, which has not been
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considered in this study, is also likely to contribute to this process by removing 
intracellular Na+ in exchange for extracellular K+. The relationships between the 
components of the proposed mechanism are multifaceted and their interdependence 
makes the prediction for the changes in intact preparations difficult. In addition the 
complexity of the regulation of Kv channels in PASMCs may partly be responsible for 
controversies surrounding K channel roles in HPV. It is worth mentioning that hypoxia
^  I
is known to modify the activity of the NHE (Rios et a l,  2005), and Mg i is deemed 
important for the regulation of the mitochondria. Altogether, the proposed
^  I
mitochondrial regulated Mg dependent modulation of Ikv proposed in Chapter 3, may 
also alter the activity of the NME (and subsequently the other Na+ dependent 
exchangers), enhancing the effects on Ikv activation. This also suggests that modulation 
of Ikv via the proposed mechanism may be employed in HPV and further consideration 





A similarity between the effect of hypoxia on Ikv activation in PASMCs (but not in 
MASMCs) and those of mitochondrial inhibitors and hypoxia-induced increases in 
Mg2+i suggest, albeit indirectly, that the mitochondrial induced Mg2+ dependent 
mechanism of Ikv modulation could be involved in HPV. The predicted dual effect of 
mETC inhibition by CCCP and antimycin on the whole cell Kv channel open 
probability could explain both hypoxia mediated effects on Ikv in PASMCs; 
enhancement of the current and its subsequent inhibition at more positive potentials. 
Both observations have been observed in PASMCs previously. Also the model 
prediction partly agreed with the functional studies
Notably, although it is difficult to evaluate the level of hypoxia-induced increases in 
Mg2+i from our experiments, local changes in Mg2+i close to the Kv channels may be 
substantial providing that ion diffusion is restricted. The existence of a restricted 
diffusion space has been previously demonstrated by measuring the changes in the K+ 
gradient during the development of Ikv in rat intra-PASMCs and was thought to be 
caused by extracellular K+ accumulation (Smirnov & Aaronson, 1994). It is however 
possible that intracellular compartmentalisation can also contribute to this process. This 
phenomenon (not observed in other VSMCs) might potentially be responsible for 
greater local changes in Mg2+i in PASMCs than in systemic SMCs.
The observation that reduced antimycin-induced effects and the absence of rotenone- 
and oligomycin-mediated effects in non-dialysed compared to dialysed PASMCs 
suggests the involvement of other mechanisms attenuating the effect of mitochondrial 
inhibitors in intact cells. The experimental evidence shows that an increased cellular 
redox state and/or lower local Mg i (due to a higher levels of intracellular ATP, Mg
fy I
uptake by mitochondria or Mg extrusion) could be responsible. A similarity between 
the mean Va values measured in intact PASMCs and cells dialysed with Na2ATP or
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EDTA in the absence of inhibitors may indirectly support the latter possibility.
94-However, little is known about Mg i homeostasis and mechanisms of its regulation in 
the pulmonary circulation, and further experimentation is necessary to better understand
•j,
the role of Mg in such a complex phenomenon as HPV.
The findings additionally suggest that 7kv activity at physiological membrane potentials
9+chiefly depends on Mg j, whose concentration is determined by the balance between
9 .
the extracellular Mg influx and its extrusion by the NME, thus representing a novel 
regulatory mechanism for 7kv in PASMCs. NME activity which depends on Na+i is 
implicated and is consecutively regulated by the NCE and particularly the NHE, as the 
main regulator of Na+ influx. Therefore, the NHE is likely to play a greater role in the 
regulation of Na* under physiological conditions, whilst the forward mode of the NCE 
should become more important during agonist-induced stimulation. Notably, the Na+- 
K+-ATPase, whose role has not been evaluated in this study, is likely to contribute to 
this process. Possible complexity of the relationship between various components and 
their reciprocal dependence make difficult the prediction of the changes in 7kv in intact 
preparations. The complexity of the regulation of Kv channels in PASMCs might partly 
be responsible for the controversies surrounding the role of Kv channels in HPV (Ward 
et al., 2006). It is noteworthy that hypoxia alters both NCE and NHE activity (Madden
94-et al., 2001; Wang et al., 2000), whereas Mg i is important for the regulation of 
mitochondria, a putative oxygen sensor for HPV, suggesting that modulation of 7kv via 
this mechanism could also be engaged in HPV.
It is important to also consider that this study, selectively investigating Kv channels, 
does not, however, exclude the likely contribution of heteromultimeric Kvl channels 
which might be expressed in PASMCs in different proportions and contribute to 
variability of parameters. This possibility can be indirectly supported by the evidence 
shown in chapter 7 whereby cell dialysis with increased [M gCy caused a significantly 
greater effect on Ikv inactivation than activation in PASMCs, whereas similar changes
94-in Mg i caused virtually identical shifts in both dependencies for the current mediated 
by expressed K vl.5 a-subunit (Tammaro et a l , 2005), which are thought to be one of 
the channel components in these cells.
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Figure 8.1 summarises the data discussed in this thesis and proposes a mechanism by 
which M g2+i is changed by a, yet unidentified, mitochondrial dependent mechanism 
affecting Kv channel activity.
(1) Hypoxia (P02 < 40mmHg) has two proposed effects relating to the regulation of Kv 
channels in the pulmonary circulation. The mechanism postulated from evidence in this 
thesis suggests an inhibitory effect of hypoxia on the mETC causing a decrease in ATm 
and alters the rate of Mg uptake and release from the mitochondria. The proposed
1
increase in M g j activates Kv channels.
(2) Simultaneously, hypoxia has been shown to inhibit TASK channels causing 
membrane depolarisation and activation of L-Type VDCC and entry of Ca into the 
cell (Gurney & Joshi, 2006). In succession CICR from the SR occurs further elevating 
intracellular Ca2+, additionally a role for CCE has been proposed to occur in response to 
hypoxia (Becker et al., 2006), SOC are postulated to be the molecular correlates for 
CCE in PASMCs (Kunichika et al., 2004). Increased sensitivity of the contractile 
apparatus to Ca2+ may be responsible for the sustained phase of HPV (Robertson et al., 
2003).
(3) Inhibition of Ikv occurs at more depolarised membrane potentials. Decreased Ikv has 
also been widely established to occur in response to hypoxia (Post et al., 1992; Yuan et 
a l, 1993).
f j i
Additionally changes Mg may subsequently change the ATP-to-ADP ratio which may 
alter Kv channel phosphorylation (Perozo & Bezanilla, 1991; Perozo & Bezanilla, 
1990). This thesis also postulates a role for ROS in the regulation of Ikv, however in 
intact cells and arteries this seems to be a less prominent effect. ROS, predominantly 
via mETC complex III, may be involved in the regulation of vessel contractility 
involving more prominent mechanisms to regulation of Ikv.
o  1 o  1
(4) A continuous flux of M g 0 and increased M g from mitochondria activates the 
N M E, which leads to an increase in N a+. In turn this activates the reverse mode of the 
N C E  to remove some of the N a+ and thus maintain a low N a+j. Removal of Na+0 will
171
o  I
inhibit the NME, resulting in accumulation of Mg i which will subsequently alter Ikv 
activation.
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Figure 8.1. A hypothetical 
diagram demonstrating the 
proposed involvement of Kv 
channels in HPV.
8.2 Future Directions
Several questions have arisen from this thesis which requires further experimental 
investigation to answer.
o  I
1) What is the exact involvement of the mitochondrial Mg dependent pathway in 
HPV and how does it differ from the mesenteric circulation?
2) What is the exact mechanism of mitochondrial mediated Kv channel regulation 
in the mesenteric circulation?
A more comprehensive investigation of the involvement of the mETC and 
intracellular Mg2+, as was carried out for the PASMCs, will be necessary to answer 
this question and elucidate the differences in the mechanisms between the two 
tissues.
3) Importance of Kv channel structural organisation?
4) To what extent are phosphorylation mediated processes involved in this
mechanism?
. 5) Is the Na+-K+ ATPase involved in this mitochondrial dependent regulation of Ikv 
in PASMCs?
6 ) The involvement of cellular redox state.
7) To understand the relationship between the activity of the exchange
mechanisms, particularly those of the NCE and NME.
Importantly, simultaneous patch clamp and fluorescence measurements of pH, Ca 
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